10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

(Mark One)

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended August 31, 2023

or

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from __ to __

Commission File Number: 001-14669

HELEN OF TROY LIMITED

(Exact name of registrant as specified in its charter)

Bermuda	74-2692550
(State or other jurisdiction	(I.R.S. Employer
of incorporation or organization)	Identification No.)

Clarendon House

2 Church Street

Hamilton, Bermuda

(Address of principal executive offices)

1 Helen of Troy Plaza

El Paso, Texas 79912

(Registrant's United States Mailing Address) (Zip Code)

(915) 225-8000

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act: 

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Shares, $0.10 par value per share	HELE	The NASDAQ Stock Market LLC

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).       Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☒	Accelerated filer	☐
Non-accelerated filer	☐	Smaller reporting company	☐
		Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.

As of September 28, 2023, there were 23,742,747 common shares, $0.10 par value per share, outstanding.

HELEN OF TROY LIMITED AND SUBSIDIARIES

FORM 10-Q

TABLE OF CONTENTS

		PAGE
PART I.	FINANCIAL INFORMATION
Item 1.	Financial Statements	2
	Note 1 - Basis of Presentation and Related Information	7
	Note 2 - New Accounting Pronouncements	8
	Note 3 - Assets Held for Sale	9
	Note 4 - Acquisition of Curlsmith	10
	Note 5 - Accrued Expenses and Other Current Liabilities	11
	Note 6 - Share-Based Compensation Plans	11
	Note 7 - Repurchases of Common Stock	12
	Note 8 - Restructuring Plan	13
	Note 9 - Commitments and Contingencies	15
	Note 10 - Long-Term Debt	18
	Note 11 - Fair Value	19
	Note 12 - Financial Instruments and Risk Management	20
	Note 13 - Accumulated Other Comprehensive Income (Loss)	23
	Note 14 - Segment Information	23
	Note 15 - Income Taxes	24
	Note 16 - Earnings Per Share	25
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	26
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	50
Item 4.	Controls and Procedures	51
PART II.	OTHER INFORMATION
Item 1.	Legal Proceedings	51
Item 1A.	Risk Factors	51
Item 2.	Unregistered Sales of Equity Securities, Use of Proceeds, and Issuer Purchases of Equity Securities	52
Item 5.	Other Information	52
Item 6.	Exhibits	53
SIGNATURES		54

1

PART I.   FINANCIAL INFORMATION

ITEM 1.   FINANCIAL STATEMENTS

HELEN OF TROY LIMITED AND SUBSIDIARIES

Condensed Consolidated Balance Sheets (Unaudited)

(in thousands, except shares and par value)	August 31, 2023		February 28, 2023
Assets
Assets, current:
Cash and cash equivalents	$	24,214	$	29,073
Receivables, less allowances of $5,144 and $1,678	387,498		377,604
Inventory	435,681		455,485
Prepaid expenses and other current assets	28,950		24,721
Income taxes receivable	12,349		5,158
Total assets, current	888,692		892,041
Property and equipment, net of accumulated depreciation of $156,406 and $178,961	336,349		351,793
Goodwill	1,066,730		1,066,479
Other intangible assets, net of accumulated amortization of $177,825 and $168,574	544,958		553,883
Operating lease assets	37,555		38,751
Deferred tax assets, net	2,996		2,781
Assets held for sale	17,179		—
Other assets	7,201		7,987
Total assets	$	2,901,660	$	2,913,715
Liabilities and Stockholders' Equity
Liabilities, current:
Accounts payable	$	258,669	$	190,598
Accrued expenses and other current liabilities	195,359		200,718
Income taxes payable	12,132		14,778
Long-term debt, current maturities	6,235		6,064
Total liabilities, current	472,395		412,158
Long-term debt, excluding current maturities	838,668		928,348
Lease liabilities, non-current	41,036		42,672
Deferred tax liabilities, net	34,747		28,048
Other liabilities, non-current	12,931		13,678
Total liabilities	1,399,777		1,424,904
Commitments and contingencies
Stockholders' equity:
Cumulative preferred stock, non-voting, $1.00 par. Authorized 2,000,000 shares; none issued	—		—
Common stock, $0.10 par. Authorized 50,000,000 shares; 23,719,204 and 23,994,405 shares issued and outstanding	2,372		2,399
Additional paid in capital	330,227		317,277
Accumulated other comprehensive income	3,686		4,947
Retained earnings	1,165,598		1,164,188
Total stockholders' equity	1,501,883		1,488,811
Total liabilities and stockholders' equity	$	2,901,660	$	2,913,715

See accompanying notes to condensed consolidated financial statements.

2

HELEN OF TROY LIMITED AND SUBSIDIARIES

Condensed Consolidated Statements of Income (Unaudited) 

	Three Months Ended August 31,				Six Months Ended August 31,
(in thousands, except per share data)	2023		2022		2023		2022
Sales revenue, net	$	491,563	$	521,400	$	966,235	$	1,029,478
Cost of goods sold	261,910		299,954		520,951		596,861
Gross profit	229,653		221,446		445,284		432,617
Selling, general and administrative expense (“SG&A”)	179,191		169,724		346,826		346,954
Restructuring charges	3,617		4,776		10,972		4,778
Operating income	46,845		46,946		87,486		80,885
Non-operating income, net	148		113		285		180
Interest expense	13,654		9,166		27,706		13,539
Income before income tax	33,339		37,893		60,065		67,526
Income tax expense	5,958		7,221		10,103		12,259
Net income	$	27,381	$	30,672	$	49,962	$	55,267
Earnings per share (“EPS”):
Basic	$	1.14	$	1.28	$	2.08	$	2.31
Diluted	1.14		1.28		2.07		2.29
Weighted average shares used in computing EPS:
Basic	23,918		23,969		23,984		23,917
Diluted	24,041		24,056		24,088		24,089

See accompanying notes to condensed consolidated financial statements.

3

HELEN OF TROY LIMITED AND SUBSIDIARIES

Condensed Consolidated Statements of Comprehensive Income (Unaudited) 

	Three Months Ended August 31,				Six Months Ended August 31,
(in thousands)	2023		2022		2023		2022
Net income	$	27,381	$	30,672	$	49,962	$	55,267
Other comprehensive income (loss), net of tax:
Cash flow hedge activity - interest rate swaps	2,768		1,301		(324)		3,507
Cash flow hedge activity - foreign currency contracts	(314)		2,538		(937)		3,491
Total other comprehensive income (loss), net of tax	2,454		3,839		(1,261)		6,998
Comprehensive income	$	29,835	$	34,511	$	48,701	$	62,265

See accompanying notes to condensed consolidated financial statements.

4

HELEN OF TROY LIMITED AND SUBSIDIARIES

Condensed Consolidated Statements of Stockholders’ Equity (Unaudited)

	Common Stock			Additional Paid in Capital		Accumulated Other Comprehensive Income		Retained Earnings		Total Stockholders' Equity
(in thousands, including shares)	Shares	Par Value
Balances at February 28, 2022	23,800	$	2,380	$	303,740	$	202	$	1,021,017	$	1,327,339
Net income	—	—		—		—		24,595		24,595
Other comprehensive income, net of tax	—	—		—		3,159		—		3,159
Exercise of stock options	8	1		658		—		—		659
Issuance and settlement of restricted stock	235	24		(24)		—		—		—
Issuance of common stock related to stock purchase plan	13	1		2,274		—		—		2,275
Common stock repurchased and retired	(89)	(9)		(18,113)		—		(102)		(18,224)
Share-based compensation	—	—		16,619		—		—		16,619
Balances at May 31, 2022	23,967	$	2,397	$	305,154	$	3,361	$	1,045,510	$	1,356,422
Net income	—	—		—		—		30,672		30,672
Other comprehensive income, net of tax	—	—		—		3,839		—		3,839
Issuance and settlement of restricted stock	2	—		(1)		—		—		(1)
Common stock repurchased and retired	—	—		(81)		—		—		(81)
Share-based compensation	—	—		7,495		—		—		7,495
Balances at August 31, 2022	23,969	$	2,397	$	312,567	$	7,200	$	1,076,182	$	1,398,346

Balances at February 28, 2023	23,994	$	2,399	$	317,277	$	4,947	$	1,164,188	$	1,488,811
Net income	—	—		—		—		22,581		22,581
Other comprehensive loss, net of tax	—	—		—		(3,715)		—		(3,715)
Exercise of stock options	5	1		211		—		—		212
Issuance and settlement of restricted stock	120	12		(12)		—		—		—
Issuance of common stock related to stock purchase plan	23	2		2,166		—		—		2,168
Common stock repurchased and retired	(45)	(4)		(4,442)		—		—		(4,446)
Share-based compensation	—	—		9,297		—		—		9,297
Balances at May 31, 2023	24,097	$	2,410	$	324,497	$	1,232	$	1,186,769	$	1,514,908
Net income	—	—		—		—		27,381		27,381
Other comprehensive income, net of tax	—	—		—		2,454		—		2,454
Issuance and settlement of restricted stock	4	—		—		—		—		—
Common stock repurchased and retired	(382)	(38)		(1,499)		—		(48,552)		(50,089)
Share-based compensation	—	—		7,229		—		—		7,229
Balances at August 31, 2023	23,719	$	2,372	$	330,227	$	3,686	$	1,165,598	$	1,501,883

See accompanying notes to condensed consolidated financial statements.

5

HELEN OF TROY LIMITED AND SUBSIDIARIES

Condensed Consolidated Statements of Cash Flows (Unaudited)

	Six Months Ended August 31,
(in thousands)	2023		2022
Cash provided (used) by operating activities:
Net income	$	49,962	$	55,267
Adjustments to reconcile net income to net cash provided (used) by operating activities:
Depreciation and amortization	24,606		21,617
Amortization of financing costs	616		512
Non-cash operating lease expense	3,941		5,186
Provision for credit losses	3,671		963
Non-cash share-based compensation	16,526		24,114
Gain on sale of Personal Care business	—		(1,336)
Gain on the sale or disposal of property and equipment	(246)		(20)
Deferred income taxes and tax credits	6,845		3,977
Changes in operating capital, net of effects of acquisitions of businesses:
Receivables	(14,427)		(46,754)
Inventory	19,804		(77,348)
Prepaid expenses and other current assets	(5,391)		575
Other assets and liabilities, net	(253)		(2,040)
Accounts payable	71,990		3,333
Accrued expenses and other current liabilities	(10,317)		(43,767)
Accrued income taxes	(9,595)		(19,731)
Net cash provided (used) by operating activities	157,732		(75,452)
Cash used by investing activities:
Capital and intangible asset expenditures	(20,557)		(112,635)
Net payments to acquire businesses, net of cash acquired	—		(148,111)
Proceeds from sale of Personal Care business	—		1,804
Proceeds from the sale of property and equipment	246		20
Net cash used by investing activities	(20,311)		(258,922)
Cash (used) provided by financing activities:
Proceeds from revolving loans	261,150		573,500
Repayment of revolving loans	(348,150)		(465,000)
Proceeds from term loans	—		250,000
Repayment of long-term debt	(3,125)		(1,900)
Payment of financing costs	—		(586)
Proceeds from share issuances under share-based compensation plans	2,380		2,934
Payments for repurchases of common stock	(54,535)		(18,305)
Net cash (used) provided by financing activities	(142,280)		340,643
Net (decrease) increase in cash and cash equivalents	(4,859)		6,269
Cash and cash equivalents, beginning balance	29,073		33,381
Cash and cash equivalents, ending balance	$	24,214	$	39,650
Supplemental non-cash investing activity:
Capital expenditures included in accounts payable	$	2,790	$	8,484

See accompanying notes to condensed consolidated financial statements.

6

HELEN OF TROY LIMITED AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)

August 31, 2023

Note 1 - Basis of Presentation and Related Information

Corporate Overview

The accompanying condensed consolidated financial statements contain all adjustments (consisting of normal recurring adjustments) necessary to present fairly our consolidated financial position as of August 31, 2023 and February 28, 2023, and the results of our consolidated operations for the interim periods presented. We follow the same accounting policies when preparing quarterly financial data as we use for preparing annual data. These statements should be read in conjunction with the consolidated financial statements and the notes included in our latest annual report on Form 10-K for the fiscal year ended February 28, 2023 (“Form 10-K”), and our other reports on file with the Securities and Exchange Commission (the “SEC”).

When used in these notes, unless otherwise indicated or the context suggests otherwise, references to “the Company”, “our Company”, “Helen of Troy”, “we”, “us”, or “our” refer to Helen of Troy Limited and its subsidiaries, which are all wholly-owned. We refer to our common shares, par value $0.10 per share, as “common stock.” References to “the FASB” refer to the Financial Accounting Standards Board. References to “GAAP” refer to accounting principles generally accepted in the United States of America (the “U.S.”). References to “ASU” refer to the codification of GAAP in the Accounting Standards Updates issued by the FASB. References to “ASC” refer to the codification of GAAP in the Accounting Standards Codification issued by the FASB.

We incorporated as Helen of Troy Corporation in Texas in 1968 and were reorganized as Helen of Troy Limited in Bermuda in 1994. We are a leading consumer products company offering creative products and solutions for our customers through a diversified portfolio of brands. As of August 31, 2023, we operated two reportable segments: Home & Outdoor and Beauty & Wellness. During the fourth quarter of fiscal 2023, we made changes to the structure of our organization in connection with our global restructuring plan (as further described below and in Note 8) that resulted in our previous Health & Wellness and Beauty operating segments being combined into a single reportable segment, which is referred to herein as “Beauty & Wellness.” In connection with these organizational structure changes, corresponding changes were made to how our business is managed, how results are reported internally and how our Chief Executive Officer (“CEO”), our chief operating decision maker, assesses performance and allocates resources. We believe that these changes better align internal resources and external go to market activities in order to create a more efficient and effective organizational structure. There were no changes to the products or brands included within our Home & Outdoor reportable segment as part of these organizational changes nor to the way in which our CEO assesses performance and allocates resources for the Home & Outdoor segment. As a result of these changes, our disclosures reflect two reportable segments, Home & Outdoor and Beauty & Wellness. Comparative prior period segment information in this report has been recast to conform to this change in our reportable segments. Our external reportable segments will continue to align with our internal reporting to enable users of the financial statements to better understand our performance, better assess our future net cash flows, and make more informed judgments about the Company as a whole.

Our Home & Outdoor segment provides a broad range of outstanding world-class brands that help consumers enjoy an outdoor lifestyle and make everyday living better. Our innovative products for home activities include food preparation, cooking, cleaning, organization, and beverage service. Our outdoor performance range includes hydration products, backpacks, and travel gear to ease your journey and inspire your next adventure. The Beauty & Wellness segment provides consumers with a broad range of

7

outstanding world-class brands for beauty and wellness. In Beauty, we deliver innovation through products such as hair styling appliances, grooming tools, and liquid-, solid-, and powder-based personal care products that help make everyone look and feel more beautiful. On the Wellness side, we are there when you need us most with highly regarded humidifiers, thermometers, water and air purifiers, heaters, and fans.

Our business is seasonal due to different calendar events, holidays and seasonal weather and illness patterns. Our fiscal reporting period ends on the last day in February. Historically, our highest sales volume and operating income occur in our third fiscal quarter ending November 30th. We purchase our products from unaffiliated manufacturers, most of which are located in China, Mexico, Vietnam and the U.S.

During the second quarter of fiscal 2023, we focused on developing a global restructuring plan intended to expand operating margins through initiatives designed to improve efficiency and reduce costs (referred to as “Project Pegasus”). See Note 8 for additional information.

On April 22, 2022, we completed the acquisition of Recipe Products Ltd., a producer of innovative prestige hair care products for all types of curly and wavy hair under the Curlsmith brand (“Curlsmith”). The total purchase consideration was $147.9 million in cash, net of a final net working capital adjustment and cash acquired. The Curlsmith brand and products were added to the Beauty & Wellness segment. See Note 4 for additional information.

During fiscal 2022 and fiscal 2023, we divested certain assets within our Beauty & Wellness segment's mass channel personal care business, which included liquid, powder and aerosol products under brands such as Pert, Brut, Sure and Infusium (“Personal Care”). On June 7, 2021, we completed the sale of our North America Personal Care business to HRB Brands LLC, for $44.7 million in cash and recognized a gain on the sale in SG&A totaling $0.5 million. On March 25, 2022, we completed the sale of the Latin America and Caribbean Personal Care business to HRB Brands LLC, for $1.8 million in cash and recognized a gain on the sale in SG&A totaling $1.3 million.

Principles of Consolidation

The accompanying condensed consolidated financial statements are prepared in accordance with GAAP and include all of our subsidiaries. Our condensed consolidated financial statements are prepared in U.S. Dollars. All intercompany balances and transactions are eliminated in consolidation.

The preparation of consolidated financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the amounts reported in our condensed consolidated financial statements and accompanying notes. Actual results may differ materially from those estimates.

Reclassifications

We have reclassified or combined certain amounts in the prior year's accompanying footnotes to conform with the current year's presentation.

Note 2 - New Accounting Pronouncements

Except for the changes discussed below, there have been no changes in the information provided in our Form 10-K.

8

Adopted

In September 2022, the FASB issued ASU 2022-04, Liabilities—Supplier Finance Programs (Subtopic 405-50): Disclosure of Supplier Finance Program Obligations, which requires a buyer in a supplier finance program to disclose qualitative and quantitative information about its program to allow a user of the financial statements to understand the program’s nature, activity during the period, changes from period to period, and potential magnitude. The amendments in ASU 2022-04 are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2022, with the exception for the amendment on rollforward information, which is effective for fiscal years beginning after December 15, 2023. The guidance should be applied retrospectively, except for the amendment on rollforward information, which should be applied prospectively. This ASU was effective for us in the first quarter of fiscal 2024, with the exception of the amendment on rollforward information, which will be effective for us in our Form 10-K for fiscal 2025. We adopted this ASU during the first quarter of fiscal 2024 and the adoption did not have an impact on our consolidated financial statement disclosures.

In October 2021, the FASB issued ASU 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers, which requires contract assets and contract liabilities acquired in a business combination to be recognized and measured by the acquirer on the acquisition date in accordance with ASC 606, Revenue from Contracts with Customers. Prior to the issuance of this guidance, contract assets and contract liabilities were recognized by the acquirer at fair value on the acquisition date. The amendments in ASU 2021-08 are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2022, and should be applied prospectively to acquisitions occurring on or after the effective date. We adopted this ASU during the first quarter of fiscal 2024 and the adoption did not have an impact on our consolidated financial statements.

Note 3 - Assets Held for Sale

On August 29, 2023, we entered into an agreement to sell our distribution and office facilities in El Paso, Texas, which provides for closing subsequent to a due diligence period. Accordingly, we classified the associated property and equipment totaling $17.2 million, net of accumulated depreciation of $36.8 million, as held for sale as of August 31, 2023.

Subsequent to the end of our second quarter of fiscal 2024, on September 28, 2023, we completed the sale of our distribution and office facilities in El Paso, Texas for a sales price of $50.6 million, less transaction costs of $1.1 million. Concurrently, we entered into an agreement to leaseback the office facilities for a period of up to 18 months substantially rent free, which we estimate to have a fair value of approximately $1.9 million. The transaction qualifies for sales recognition under the sale leaseback accounting requirements. Accordingly, we increased the sales price by the $1.9 million of prepaid rent and expect to recognize a gain on the sale of approximately $34.2 million within SG&A during the third quarter of fiscal year 2024, of which approximately $18.0 million and $16.2 million will be recognized by our Beauty & Wellness and Home & Outdoor segments, respectively. The related assets will be derecognized from the consolidated balance sheet, and at lease commencement, we will record an operating lease asset, which includes the imputed rent payments described above, and an operating lease liability. We plan to use the proceeds from the sale to repay amounts outstanding under our long-term debt agreement.

9

Note 4 - Acquisition of Curlsmith

On April 22, 2022, we completed the acquisition of Recipe Products Ltd., a producer of innovative prestige hair care products for all types of curly and wavy hair under the Curlsmith brand. Curlsmith's products are a category leader in the market for prestige haircare products for curly hair and include conditioners, shampoos and co-washes purposefully designed for the unique joys and challenges of all types of curls and textured hair. The Curlsmith brand and products were added to the Beauty & Wellness segment. The total purchase consideration was $147.9 million in cash, net of a final net working capital adjustment of $2.1 million and cash acquired. The acquisition was funded with cash on hand and borrowings under our existing revolving credit facility. We incurred pre-tax acquisition-related expenses of $2.7 million during the six months ended August 31, 2022, which were recognized in SG&A within our condensed consolidated statement of income.

We accounted for the acquisition as a purchase of a business and recorded the excess of the purchase price over the estimated fair value of the assets acquired and liabilities assumed as goodwill. The goodwill recognized is attributable primarily to expected synergies including leveraging our Beauty & Wellness segment's existing marketing and sales structure, as well as our global sourcing, distribution, shared service, and international go-to-market capabilities. The goodwill is not expected to be deductible for income tax purposes. We have determined the appropriate fair values of the acquired intangible assets and completed our analysis of the economic lives of the assets acquired. We assigned $21.0 million to trade names and are amortizing over a 20 year expected life. We assigned $12.0 million to customer relationships and are amortizing over a 19.5 year expected life, based on historical attrition rates.

During fiscal 2023, we made adjustments to provisional asset and liability balances, which resulted in a corresponding net increase to goodwill of $0.1 million. We also finalized the net working capital adjustment during fiscal 2023, which resulted in a $1.8 million reduction to the total purchase consideration and goodwill. During the first quarter of fiscal 2024, we made final adjustments to provisional liability balances, which resulted in a corresponding increase to goodwill of $0.3 million.

The following table presents the estimated fair values of assets acquired and liabilities assumed at the acquisition date:

(in thousands)
Assets:
Receivables	$	4,211
Inventory	7,890
Prepaid expenses and other current assets	119
Property and equipment	212
Goodwill	117,108
Trade names - definite	21,000
Customer relationships - definite	12,000
Deferred tax assets, net	360
Total assets	162,900
Liabilities:
Accounts payable	1,401
Accrued expenses and other current liabilities	2,813
Income taxes payable	2,572
Deferred tax liabilities, net	8,187
Total liabilities	14,973
Net assets recorded	$	147,927

10

Both the fair value and gross contractual amount of receivables acquired was $4.2 million, as an immaterial amount was expected to be uncollectible.

The impact of the acquisition of Curlsmith on our condensed consolidated statements of income for the periods presented was as follows:

(in thousands, except earnings per share data)	Three Months Ended August 31, 2022 (1)		Six Months Ended August 31, 2022 (1) (2)
Sales revenue, net	$	10,207	$	13,453
Net income	1,437		1,876
EPS:
Basic	$	0.06	$	0.08
Diluted	$	0.06	$	0.08

(1)Net income and EPS amounts include allocations for corporate expenses, interest expense and income tax expense.

(2)Represents approximately nineteen weeks of operating results from Curlsmith, acquired April 22, 2022.

The following supplemental unaudited pro forma information presents our financial results as if the acquisition of Curlsmith had occurred on March 1, 2021. This supplemental pro forma information has been prepared for comparative purposes and does not necessarily indicate what may have occurred if the acquisition had been completed on March 1, 2021, and this information is not intended to be indicative of future results.

(in thousands, except earnings per share data)	Three Months Ended August 31, 2022		Six Months Ended August 31, 2022
Sales revenue, net	$	521,400	$	1,036,570
Net income	30,672		57,180
EPS:
Basic	$	1.28	$	2.39
Diluted	$	1.28	$	2.37

These amounts have been calculated after applying our accounting policies and adjusting the results of Curlsmith to reflect the effect of definite-lived intangible assets recognized as part of the business combination on amortization expense as if the acquisition had occurred on March 1, 2021.

Note 5 - Accrued Expenses and Other Current Liabilities

A summary of accrued expenses and other current liabilities was as follows:

(in thousands)	August 31, 2023		February 28, 2023
Accrued compensation, benefits and payroll taxes	$	31,947	$	17,380
Accrued sales discounts and allowances	48,908		63,881
Accrued sales returns	23,240		28,498
Accrued advertising	35,112		36,931
Other	56,152		54,028
Total accrued expenses and other current liabilities	$	195,359	$	200,718

Note 6 - Share-Based Compensation Plans

As part of our compensation structure, we grant share-based compensation awards to certain employees and non-employee members of our Board of Directors during the fiscal year. These awards may be subject to attainment of certain service conditions, performance conditions and/or market conditions.

11

During the first quarter of fiscal 2024, we granted 94,807 service condition awards (“Service Condition Awards”) with a weighted average grant date fair value of $110.85. Additionally, we granted 252,522 performance-based awards during the first quarter of fiscal 2024, of which 126,318 contained performance conditions (“Performance Condition Awards”) and 126,204 contained market conditions (“Market Condition Awards”), with weighted average grant date fair values of $110.85 and $80.50, respectively. Refer to our Form 10-K for further information on the Company's share-based compensation plans.

We recorded share-based compensation expense in SG&A as follows:

	Three Months Ended August 31,				Six Months Ended August 31,
(in thousands)	2023		2022		2023		2022
Directors stock compensation	$	196	$	222	$	393	$	395
Service Condition Awards	2,878		2,160		6,198		5,277
Performance Condition Awards	1,113		3,196		3,136		14,041
Market Condition Awards	3,042		1,917		6,189		3,827
Employee stock purchase plan	—		—		610		574
Share-based compensation expense	7,229		7,495		16,526		24,114
Less income tax benefits	(385)		(570)		(1,026)		(1,654)
Share-based compensation expense, net of income tax benefits	$	6,844	$	6,925	$	15,500	$	22,460

Unrecognized Share-Based Compensation Expense

As of August 31, 2023, our total unrecognized share-based compensation for all awards was $32.9 million, which will be recognized over a weighted average amortization period of 2.0 years. The total unrecognized share-based compensation reflects an estimate of target achievement for Performance Condition Awards granted during the first quarter of fiscal 2024, and an estimate of zero percent of target achievement for Performance Condition Awards granted in fiscal 2023 and fiscal 2022.

Note 7 - Repurchases of Common Stock

In August 2021, our Board of Directors authorized the repurchase of up to $500 million of our outstanding common stock. The authorization became effective August 25, 2021, for a period of three years, and replaced our former repurchase authorization. As of August 31, 2023, our repurchase authorization allowed for the purchase of $349.1 million of common stock.

Our current equity-based compensation plans include provisions that allow for the “net exercise” of share-settled awards by all plan participants. In a net exercise, any required payroll taxes, federal withholding taxes and exercise price of the shares due from the option or other share-based award holders are settled by having the holder tender back to us a number of shares at fair value equal to the amounts due. Net exercises are treated as purchases and retirements of shares.

12

The following table summarizes our share repurchase activity for the periods shown:

	Three Months Ended August 31,				Six Months Ended August 31,
(in thousands, except share and per share data)	2023		2022		2023		2022
Common stock repurchased on the open market:
Number of shares	381,200		—		381,200		—
Aggregate value of shares	$	50,006	$	—	$	50,006	$	—
Average price per share	$	131.18	$	—	$	131.18	$	—
Common stock received in connection with share-based compensation:
Number of shares	765		501		45,397		89,959
Aggregate value of shares	$	83	$	81	$	4,529	$	18,305
Average price per share	$	108.00	$	163.28	$	99.75	$	203.49

Note 8 - Restructuring Plan

During the second quarter of fiscal 2023, we focused on developing Project Pegasus, a global restructuring plan intended to expand operating margins through initiatives designed to improve efficiency and reduce costs. Project Pegasus includes initiatives to further optimize our brand portfolio, streamline and simplify the organization, accelerate cost of goods savings projects, enhance the efficiency of our supply chain network, optimize our indirect spending, and improve our cash flow and working capital, as well as other activities. We anticipate these initiatives will create operating efficiencies, as well as provide a platform to fund future growth investments.

During the fourth quarter of fiscal 2023, we made changes to the structure of our organization in connection with Project Pegasus that resulted in our previous Health & Wellness and Beauty operating segments being combined into a single reportable segment, which is referred to herein as “Beauty & Wellness.” In connection with these organizational structure changes, corresponding changes were made to how our business is managed, how results are reported internally and how our CEO, our chief operating decision maker, assesses performance and allocates resources. We believe that these changes better align internal resources and external go to market activities in order to create a more efficient and effective organizational structure. There were no changes to the products or brands included within our Home & Outdoor reportable segment as part of these organizational changes.

As part of our initiative focused on streamlining and simplifying the organization, we made further changes to the structure of our organization, during the fourth quarter of fiscal 2023, which include the creation of a North America Regional Market Organization (“RMO”) responsible for sales and go to market strategies for all categories and channels in the U.S. and Canada, and further centralization of certain functions under shared services, particularly in operations and finance to better support our business segments and RMOs. This new structure, inclusive of the organizational structure changes described above resulting in the reportable segment change, will reduce the size of our global workforce by approximately 10%. The majority of these role reductions were completed by March 1, 2023. We believe that these changes better focus business segment resources on brand development, consumer-centric innovation and marketing, the RMOs on sales and go to market strategies, and shared services on their respective areas of expertise while also creating a more efficient and effective organizational structure.

During the second quarter of fiscal 2024, we announced plans to geographically consolidate the U.S. Beauty business, currently located in El Paso, Texas, and Irvine, California, and co-locate it with our Wellness business in the Boston, Massachusetts area. This geographical consolidation and relocation is the next step in our initiative to streamline and simplify the organization and it is expected to be

13

completed during fiscal 2025. We expect these changes will enable a greater opportunity to capture synergies and enhance collaboration and innovation within the Beauty & Wellness segment.

We have updated our expectations regarding Project Pegasus charges. We now estimate lower total one-time pre-tax restructuring charges of approximately $60 million to $65 million over the duration of the plan. We now expect these charges to be completed during fiscal 2025. We previously had estimated total pre-tax restructuring charges of approximately $85 million to $95 million, which was initially expected to be substantially completed by the end of fiscal 2024. In addition, we now have the following expectations regarding Project Pegasus charges:

•Pre-tax restructuring charges to be comprised of approximately $22 million to $25 million of severance and employee related costs, $30 million of professional fees, $5 million of contract termination costs, and $3 million to $5 million of other exit and disposal costs.

•All of our operating segments and shared services will be impacted by the plan and pre-tax restructuring charges include approximately $17 million to $19 million in Home & Outdoor and $43 million to $46 million in Beauty & Wellness.

•Pre-tax restructuring charges represent primarily cash expenditures, which are expected to be substantially paid by the end of fiscal 2025.

We continue to have the following expectations regarding Project Pegasus savings:

•Targeted annualized pre-tax operating profit improvements of approximately $75 million to $85 million, which we expect to substantially begin in fiscal 2024 and be substantially achieved by the end of fiscal 2026.

•Estimated cadence of the recognition of the savings will be approximately 25% in fiscal 2024, approximately 50% in fiscal 2025 and approximately 25% in fiscal 2026.

•Total profit improvements to be realized approximately 60% through reduced cost of goods sold and 40% through lower SG&A.

During the three and six month periods ended August 31, 2023, we incurred $3.6 million and $11.0 million, respectively, of pre-tax restructuring costs in connection with Project Pegasus, which were recorded as “Restructuring charges” in the condensed consolidated statement of income. We recognized $4.8 million of pre-tax restructuring costs during both the three and six month periods ended August 31, 2022 in connection with Project Pegasus.

The following tables summarize restructuring charges recorded as a result of Project Pegasus for the periods presented:

	Three Months Ended August 31, 2023
(in thousands)	Home & Outdoor		Beauty & Wellness		Total
Severance and employee related costs	$	87	$	501	$	588
Professional fees	1,182		1,719		2,901
Contract termination	—		108		108
Other	2		18		20
Total restructuring charges	$	1,271	$	2,346	$	3,617

	Three Months Ended August 31, 2022
(in thousands)	Home & Outdoor		Beauty & Wellness		Total
Severance and employee related costs	$	472	$	2,369	$	2,841
Professional fees	—		128		128
Contract termination	—		1,500		1,500
Other	—		307		307
Total restructuring charges	$	472	$	4,304	$	4,776

14

	Six Months Ended August 31, 2023						Total Incurred Since Inception
(in thousands)	Home & Outdoor		Beauty & Wellness		Total
Severance and employee related costs	$	571	$	909	$	1,480	$	10,933
Professional fees	3,451		5,076		8,527		25,276
Contract termination	—		796		796		1,331
Other	39		130		169		794
Total restructuring charges	$	4,061	$	6,911	$	10,972	$	38,334

	Six Months Ended August 31, 2022
(in thousands)	Home & Outdoor		Beauty & Wellness		Total
Severance and employee related costs	$	472	$	2,371	$	2,843
Professional fees	—		128		128
Contract termination	—		1,500		1,500
Other	—		307		307
Total restructuring charges	$	472	$	4,306	$	4,778

The tables below present a rollforward of our accruals related to Project Pegasus, which are included in accounts payable and accrued expenses and other current liabilities:

(in thousands)	Balance at February 28, 2023		Charges		Payments		Balance at August 31, 2023
Severance and employee related costs	$	3,173	$	1,480	$	(3,422)	$	1,231
Professional fees	3,201		8,527		(10,635)		1,093
Contract termination	160		796		(956)		—
Other	34		169		(203)		—
Total	$	6,568	$	10,972	$	(15,216)	$	2,324

(in thousands)	Balance at February 28, 2022		Charges		Payments		Balance at August 31, 2022
Severance and employee related costs	$	—	$	2,843	$	(802)	$	2,041
Professional fees	—		128		(128)		—
Contract termination	—		1,500		—		1,500
Other	—		307		(307)		—
Total	$	—	$	4,778	$	(1,237)	$	3,541

Note 9 - Commitments and Contingencies

Legal Matters

We are involved in various legal claims and proceedings in the normal course of operations. We believe the outcome of these matters will not have a material adverse effect on our consolidated financial position, results of operations or liquidity, except as described below.

On December 23, 2021, Brita LP filed a complaint against Kaz USA, Inc. and Helen of Troy Limited in the United States District Court for the Western District of Texas (the “Patent Litigation”), alleging patent infringement by the Company relating to its PUR gravity-fed water filtration systems. In the Patent Litigation, Brita LP seeks monetary damages and injunctive relief relating to the alleged infringement. Brita LP simultaneously filed a complaint with the United States International Trade Commission (“ITC”) against Kaz USA, Inc., Helen of Troy Limited and five other unrelated companies that sell water filtration systems (the “ITC Action”). The complaint in the ITC Action also alleges patent infringement by the Company with respect to a limited set of PUR gravity-fed water filtration systems. In the ITC Action, Brita LP requested the ITC to initiate an unfair import investigation relating to such filtration systems. This

15

action seeks injunctive relief to prevent entry of certain accused PUR products (and certain other products) into the U.S. and cessation of marketing and sales of existing inventory that is already in the U.S. On January 25, 2022, the ITC instituted the investigation requested by the ITC Action. Discovery closed in the ITC Action in May 2022, and approximately half of the originally identified PUR gravity-fed water filters were removed from the case and are no longer included in the ITC Action. In August 2022, the parties participated in the evidentiary hearing, with additional supplemental hearings in October 2022. On February 28, 2023, the ITC issued an Initial Determination in the ITC Action, tentatively ruling against Kaz USA, Inc. and the other unrelated respondents. The ITC has a guaranteed review process, and thus all respondents, including Kaz USA, Inc., filed a petition with the ITC for a full review of the Initial Determination. On September 19, 2023, the ITC issued its Final Determination in the Company’s favor. The ITC determined there was no violation by the Company and terminated the investigation. The Patent Litigation remains stayed for the time being, but we believe the stay will be lifted in the near future. We cannot predict the outcome of these legal proceedings, the amount or range of any potential loss, when the proceedings will be resolved, or customer acceptance of any replacement water filter. Litigation is inherently unpredictable, and the resolution or disposition of these proceedings could, if adversely determined, have a material and adverse impact on our financial position and results of operations.

Regulatory Matters

Our operations are subject to national, state, local, and provincial jurisdictions’ environmental, health and safety laws and regulations and industry-specific product certifications. Many of the products we sell are subject to product safety laws and regulations in various jurisdictions. These laws and regulations specify the maximum allowable levels of certain materials that may be contained in our products, provide statutory prohibitions against misbranded and adulterated products, establish ingredients and manufacturing procedures for certain products, specify product safety testing requirements, and set product identification, labeling and claim requirements. Some product lines within our Beauty & Wellness segment are subject to product identification, labeling and claim requirements, which are monitored and enforced by regulatory agencies, such as the U.S. Environmental Protection Agency (the “EPA”), U.S. Customs and Border Protection, the U.S. Food and Drug Administration, and the U.S. Consumer Product Safety Commission.

During fiscal 2022, we were in discussions with the EPA regarding the compliance of packaging claims on certain of our products in the air and water filtration categories and a limited subset of humidifier products within the Beauty & Wellness segment that are sold in the U.S. The EPA did not raise any product quality, safety or performance issues. As a result of these packaging compliance discussions, we voluntarily implemented a temporary stop shipment action on the impacted products as we worked with the EPA towards an expedient resolution. We resumed normalized levels of shipping of the affected inventory during fiscal 2022 and we completed the repackaging of our existing inventory of impacted products during fiscal 2023. Additionally, as a result of continuing dialogue with the EPA, we executed further repackaging and relabeling plans on certain additional humidifier products and certain additional air filtration products, which were also completed during fiscal 2023. Although we are not aware of any fines or penalties related to this matter imposed against us by the EPA at this time, there can be no assurances that such fines or penalties will not be imposed in the future.

We recorded charges to cost of goods sold to write-off obsolete packaging for the affected products in our inventory on-hand and in-transit. We have also incurred additional compliance costs comprised of obsolete packaging, storage and other charges from vendors, which were recognized in cost of goods sold and incremental warehouse storage costs and legal fees, which were recognized in SG&A. We refer to these charges as “EPA compliance costs.”

16

The following table provides a summary of EPA compliance costs incurred during the periods presented:

	Three Months Ended August 31,				Six Months Ended August 31,
(in thousands)	2023		2022		2023		2022
Cost of goods sold	$	—	$	7,103	$	—	$	16,558	1
SG&A	—		1,251		—		3,440
Total EPA compliance costs	$	—	$	8,354	$	—	$	19,998

(1)Includes a $4.4 million charge to write-off the obsolete packaging for the affected additional humidifier products and affected additional air filtration products in our inventory on-hand and in-transit as of the end of the first quarter of fiscal 2023.

In addition, we incurred and capitalized into inventory costs to repackage a portion of our existing inventory of the affected products beginning in the second quarter of fiscal 2022 through completion of the repackaging in the third quarter of fiscal 2023. For additional information refer to Part I, Item 2., “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” including “EPA Compliance Costs”.

Weather-Related Incident

On March 30, 2022, a third-party facility that we utilized for inventory storage incurred severe damage from a weather-related incident. The inventory that was stored at this facility primarily related to our Beauty & Wellness segment. While the inventory was insured, some seasonal inventory and inventory designated for specific customer promotions was not accessible and subsequently determined to be damaged, and as a result, unfavorably impacted our net sales revenue during the first quarter of fiscal 2023. As a result of the damages to the inventory stored at the facility, we recorded a charge to write-off the damaged inventory totaling $34.4 million during the first quarter of fiscal 2023. These charges were fully offset by probable insurance recoveries of $34.4 million also recorded during the first quarter of fiscal 2023, which represented anticipated insurance proceeds, not to exceed the amount of the associated losses, for which receipt was deemed probable. The charges for the damaged inventory and the expected insurance recoveries are included in cost of goods sold in our condensed consolidated statement of income for the six months ended August 31, 2022. During the third and fourth quarters of fiscal 2023, we received proceeds totaling $46.0 million from our insurance carriers related to this incident, which were included in cash flows from operating activities in our condensed consolidated statements of cash flows. As a result, during the third quarter of fiscal 2023, the Company recorded a gain of $9.7 million, net of costs incurred to dispose of the inventory, as a reduction of SG&A expense in our condensed consolidated statement of income.

17

Note 10 - Long-Term Debt

A summary of our long-term debt follows:

(in thousands)	August 31, 2023		February 28, 2023
Credit Agreement (1):
Revolving loans	603,000		690,000
Term loans	243,750		246,875
Total borrowings under Credit Agreement	846,750		936,875
Unamortized prepaid financing fees	(1,847)		(2,463)
Total long-term debt	844,903		934,412
Less: current maturities of long-term debt	(6,235)		(6,064)
Long-term debt, excluding current maturities	$	838,668	$	928,348

(1)The weighted average interest rates on borrowings outstanding under the Credit Agreement (defined below) as of August 31, 2023 and February 28, 2023 were 7.1% and 6.6%, respectively.

Capitalized Interest

During the three month period ended August 31, 2023, we incurred interest costs totaling $13.7 million, of which none was capitalized, compared to $10.1 million for the same period last year, of which we capitalized $0.9 million as part of property and equipment in connection with the construction of a new distribution facility. During the six month periods ended August 31, 2023 and August 31, 2022, we incurred interest costs totaling $28.6 million and $15.2 million, respectively, of which we capitalized $0.9 million and $1.6 million, respectively, in connection with the previously mentioned distribution facility.

Credit Agreement

We have a credit agreement (the “Credit Agreement”) with Bank of America, N.A., as administrative agent, and other lenders that provides for an unsecured total revolving commitment of $1.25 billion and a $300 million accordion, which can be used for term loan commitments. In June 2022, we exercised $250 million of the $300 million accordion under the Credit Agreement and borrowed $250 million as term loans. The proceeds from the term loans were used to repay revolving loans under the Credit Agreement. The term loans are payable at the end of each fiscal quarter in equal installments of 0.625% of the term loans made, which began in the third quarter of fiscal 2023, with the remaining balance due at the maturity date. The maturity date of the term loans and the revolving loans under the Credit Agreement is March 13, 2025. Borrowings under the Credit Agreement bear floating interest at either the Base Rate or Term SOFR (as defined in the Credit Agreement), plus a margin based on the Net Leverage Ratio (as defined in the Credit Agreement) of 0% to 1.0% and 1.0% to 2.0% for Base Rate and Term SOFR borrowings, respectively, plus a credit spread of 0.10% for Term SOFR borrowings.

The floating interest rates on our borrowings under the Credit Agreement are hedged with interest rate swaps to effectively fix interest rates on $625 million and $425 million of the outstanding principal balance under the revolving loans as of August 31, 2023 and February 28, 2023, respectively. See Notes 11, 12, and 13 for additional information regarding our interest rate swaps.

As of August 31, 2023, the balance of outstanding letters of credit was $17.8 million and the amount available for revolving loans under the Credit Agreement was $629.2 million. Covenants in the Credit Agreement limit the amount of total indebtedness we can incur. As of August 31, 2023, these covenants effectively limited our ability to incur more than $231.1 million of additional debt from all sources, including the Credit Agreement, or $465.8 million in the event a qualified acquisition is consummated.

18

Debt Covenants

As of August 31, 2023, we were in compliance with all covenants as defined under the terms of the Credit Agreement.

Note 11 - Fair Value 

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Valuation techniques under the accounting guidance related to fair value measurements are based on observable and unobservable inputs. These inputs are classified into the following hierarchy:

Level 1:Quoted prices for identical assets or liabilities in active markets;

Level 2:Observable inputs other than quoted prices that are directly or indirectly observable for the asset or liability, including quoted prices for similar assets or liabilities in active markets; quoted prices for similar or identical assets or liabilities in markets that are not active; and model-derived valuations whose inputs are observable or whose significant value drivers are observable; and

Level 3:Unobservable inputs that reflect the reporting entity’s own assumptions.

Our financial assets and liabilities are classified as Level 2 because their valuation is dependent on observable inputs and other quoted prices for similar assets or liabilities, or model-derived valuations whose significant value drivers are observable. The following table presents the carrying amount and fair value of our financial assets and liabilities measured and recorded at fair value on a recurring basis and classified as Level 2:

	Carrying Amount and Fair Value
(in thousands)	August 31, 2023		February 28, 2023
Assets:
Cash equivalents (money market accounts)	$	469	$	381
Interest rate swaps	5,322		5,746
Foreign currency derivatives	617		1,423
Total assets	$	6,408	$	7,550
Liabilities:
Foreign currency derivatives	1,153		711
Total liabilities	$	1,153	$	711

The carrying amounts of cash, accounts payable, accrued expenses and other current liabilities and income taxes payable approximate fair value because of the short maturity of these items. The carrying amounts of receivables approximate fair value due to the effect of the related allowance for credit losses. The carrying amount of our floating rate long-term debt approximates its fair value.

We use derivatives to manage our exposure to changes in foreign currency exchange rates, which include foreign currency forward contracts and cross-currency debt swaps. In addition, we use interest rate swaps to manage our exposure to changes in interest rates. All of our derivative assets and liabilities are recorded at fair value. See Notes 12 and 13 for more information on our derivatives.

19

Note 12 - Financial Instruments and Risk Management

Foreign Currency Risk

The U.S. Dollar is the functional currency for the Company and all of its subsidiaries and is also the reporting currency for the Company. By operating internationally, we are subject to foreign currency risk from transactions denominated in currencies other than the U.S. Dollar (“foreign currencies”). Such transactions include sales and operating expenses. As a result of such transactions, portions of our cash, trade accounts receivable and trade accounts payable are denominated in foreign currencies. Approximately 12% and 14% of our net sales revenue was denominated in foreign currencies during the three and six month periods ended August 31, 2023, respectively, compared to 12% for both of the same periods last year. These sales were primarily denominated in Euros, British Pounds and Canadian Dollars. We make most of our inventory purchases from manufacturers in Asia and primarily use the U.S. Dollar for such purchases.

During the three and six month periods ended August 31, 2023, we recorded foreign currency exchange rate net losses of $0.8 million and $0.4 million, respectively, in SG&A, compared to net losses of $2.7 million and $2.5 million, respectively, for the same periods last year. We mitigate certain foreign currency exchange rate risk by using forward contracts and cross-currency debt swaps to protect against the foreign currency exchange rate risk inherent in our transactions denominated in foreign currencies. We do not enter into any derivatives or similar instruments for trading or other speculative purposes. Certain of our forward contracts are designated as cash flow hedges (“foreign currency contracts”) and are recorded on the balance sheet at fair value with changes in fair value recorded in Other Comprehensive Income (Loss) (“OCI”) until the hedge transaction is settled, at which point amounts are reclassified from Accumulated Other Comprehensive Income (Loss) (“AOCI”) to our condensed consolidated statements of income. Foreign currency derivatives for which we have not elected hedge accounting consist of certain forward contracts and cross-currency debt swaps, and any changes in the fair value of these derivatives are recorded in our condensed consolidated statements of income. These undesignated derivatives are used to hedge monetary net asset and liability positions. Cash flows from our foreign currency derivatives are classified as cash flows from operating activities in our condensed consolidated statements of cash flows, which is consistent with the classification of the cash flows from the underlying hedged item. We evaluate our derivatives designated as cash flow hedges each quarter to assess hedge effectiveness.

Interest Rate Risk

Interest on our outstanding debt as of August 31, 2023 is based on floating interest rates. If short-term interest rates increase, we will incur higher interest expense on any future outstanding balances of floating rate debt. Floating interest rates are hedged with interest rate swaps to effectively fix interest rates on a portion of our outstanding principal balance under the Credit Agreement, which totaled $846.8 million and $936.9 million as of August 31, 2023 and February 28, 2023, respectively. As of August 31, 2023 and February 28, 2023, $625.0 million and $425.0 million of the outstanding principal balance under the Credit Agreement, respectively, was hedged with interest rate swaps to fix the interest rate we pay. Our interest rate swaps are designated as cash flow hedges and are recorded on the balance sheet at fair value with changes in fair value recorded in OCI until the hedge transaction is settled, at which point amounts are reclassified from AOCI to our condensed consolidated statements of income. Cash flows from our interest rate swaps are classified as cash flows from operating activities in our condensed consolidated statements of cash flows, which is consistent with the classification of the cash flows from the underlying hedged item. We evaluate our derivatives designated as cash flow hedges each quarter to assess hedge effectiveness.

20

The following tables summarize the fair values of our derivative instruments as of the end of the periods presented:

(in thousands)	August 31, 2023
Derivatives designated as hedging instruments	Hedge Type	Final Settlement Date	Notional Amount		Prepaid Expenses and Other Current Assets		Other Assets		Accrued Expenses and Other Current Liabilities		Other Liabilities, Non- Current
Forward contracts - sell Euro	Cash flow	2/2024	€	21,500	$	67	$	—	$	165	$	—
Forward contracts - sell Canadian Dollars	Cash flow	12/2024	$	25,250	370		77		—		—
Forward contracts - sell Pounds	Cash flow	2/2024	£	20,925	—		—		949		—
Forward contracts - sell Norwegian Kroner	Cash flow	2/2024	kr	20,000	103		—		—		—
Interest rate swaps	Cash flow	2/2026	$	625,000	3,582		1,740		—		—
Subtotal					4,122		1,817		1,114		—
Derivatives not designated under hedge accounting
Forward contracts - buy Euro	(1)	9/2023	€	2,200	—		—		33		—
Forward contracts - buy Pounds	(1)	9/2023	£	1,100	—		—		6		—
Subtotal					—		—		39		—
Total fair value					$	4,122	$	1,817	$	1,153	$	—

(in thousands)	February 28, 2023
Derivatives designated as hedging instruments	Hedge Type	Final Settlement Date	Notional Amount		Prepaid Expenses and Other Current Assets		Other Assets		Accrued Expenses and Other Current Liabilities		Other Liabilities Non- Current
Forward contracts - sell Euro	Cash flow	2/2024	€	29,310	$	257	$	—	$	—	$	—
Forward contracts - sell Canadian Dollars	Cash flow	2/2024	$	30,000	962		11		—		—
Forward contracts - sell Pounds	Cash flow	1/2024	£	19,400	—		—		711		—
Forward contracts - sell Norwegian Kroner	Cash flow	2/2024	kr	40,000	185		—		—		—
Interest rate swaps	Cash flow	2/2026	$	425,000	3,941		1,805		—		—
Subtotal					5,345		1,816		711		—
Derivatives not designated under hedge accounting
Forward contracts - buy Euro	(1)	3/2023	€	500	6		—		—		—
Forward contracts - buy Pounds	(1)	3/2023	£	400	2		—		—		—
Subtotal					8		—		—		—
Total fair value					$	5,353	$	1,816	$	711	$	—

(1)These forward contracts, for which we have not elected hedge accounting, hedge monetary net asset and liability positions for the notional amounts reported, creating an economic hedge against currency movements.

The pre-tax effects of derivative instruments designated as cash flow hedges were as follows for the periods presented:

	Three Months Ended August 31,
	Gain (Loss) Recognized in AOCI				Gain (Loss) Reclassified from AOCI into Income
(in thousands)	2023		2022		Location	2023		2022
Foreign currency contracts - cash flow hedges	$	(779)	$	6,226	Sales revenue, net	$	(383)	$	2,715
Interest rate swaps - cash flow hedges	5,644		1,423		Interest expense	2,027		(281)
Total	$	4,865	$	7,649		$	1,644	$	2,434

21

	Six Months Ended August 31,
	Gain (Loss) Recognized in AOCI				Gain (Loss) Reclassified from AOCI into Income
(in thousands)	2023		2022		Location	2023		2022
Foreign currency contracts - cash flow hedges	$	(1,246)	$	8,545	Sales revenue, net	$	(45)	$	3,911
Interest rate swaps - cash flow hedges	3,010		3,629		Interest expense	3,434		(961)
Total	$	1,764	$	12,174		$	3,389	$	2,950

The pre-tax effects of derivative instruments not designated under hedge accounting were as follows for the periods presented:

	Gain (Loss)  Recognized in Income
		Three Months Ended August 31,				Six Months Ended August 31,
(in thousands)	Location	2023		2022		2023		2022
Forward contracts	SG&A	$	(16)	$	(250)	$	(40)	$	(250)
Cross-currency debt swaps - principal	SG&A	—		—		—		875
Total		$	(16)	$	(250)	$	(40)	$	625

We expect a net gain of $3.0 million associated with foreign currency contracts and interest rate swaps currently recorded in AOCI to be reclassified into income over the next twelve months. The amount ultimately realized, however, will differ as exchange rates and interest rates change and the underlying contracts settle. See Notes 11 and 13 to these condensed consolidated financial statements for more information.

Counterparty Credit Risk

Financial instruments, including foreign currency contracts, forward contracts, cross-currency debt swaps and interest rate swaps, expose us to counterparty credit risk for non-performance. We manage our exposure to counterparty credit risk by only dealing with counterparties who are substantial international financial institutions with significant experience using such derivative instruments. We believe that the risk of incurring credit losses is remote.

22

Note 13 - Accumulated Other Comprehensive Income (Loss)

The changes in AOCI by component and related tax effects for the periods presented were as follows:

(in thousands)	Interest Rate Swaps		Foreign Currency Contracts		Total
Balance at February 28, 2022	$	(2,126)	$	2,328	$	202
Other comprehensive income before reclassification	3,629		8,545		12,174
Amounts reclassified out of AOCI	961		(3,911)		(2,950)
Tax effects	(1,083)		(1,143)		(2,226)
Other comprehensive income	3,507		3,491		6,998
Balance at August 31, 2022	$	1,381	$	5,819	$	7,200
Balance at February 28, 2023	$	4,394	$	553	$	4,947
Other comprehensive income (loss) before reclassification	3,010		(1,246)		1,764
Amounts reclassified out of AOCI	(3,434)		45		(3,389)
Tax effects	100		264		364
Other comprehensive loss	(324)		(937)		(1,261)
Balance at August 31, 2023	$	4,070	$	(384)	$	3,686

See Notes 10, 11 and 12 to these condensed consolidated financial statements for additional information regarding our cash flow hedges.

Note 14 - Segment Information

We currently operate two reportable segments consisting of Home & Outdoor and Beauty & Wellness. During the fourth quarter of fiscal 2023, we made changes to the structure of our organization in connection with our global restructuring plan that resulted in our previous Health & Wellness and Beauty operating segments being combined into a single reportable segment, which is referred to herein as “Beauty & Wellness.” Comparative prior period segment information in this report has been recast to conform to this change in our reportable segments. See Note 1 to these condensed consolidated financial statements for additional information.

The following tables summarize segment information for the periods presented:

	Three Months Ended August 31, 2023
(in thousands)	Home & Outdoor		Beauty & Wellness		Total
Sales revenue, net	$	239,977	$	251,586	$	491,563
Restructuring charges	1,271		2,346		3,617
Operating income	36,099		10,746		46,845
Capital and intangible asset expenditures	4,879		3,801		8,680
Depreciation and amortization	6,606		7,285		13,891

	Three Months Ended August 31, 2022
(in thousands)	Home & Outdoor		Beauty & Wellness		Total
Sales revenue, net	$	240,559	$	280,841	$	521,400
Restructuring charges	472		4,304		4,776
Operating income	42,082		4,864		46,946
Capital and intangible asset expenditures	32,420		4,013		36,433
Depreciation and amortization	4,493		6,626		11,119

23

	Six Months Ended August 31, 2023
(in thousands)	Home & Outdoor		Beauty & Wellness		Total
Sales revenue, net	$	457,121	$	509,114	$	966,235
Restructuring charges	4,061		6,911		10,972
Operating income	58,215		29,271		87,486
Capital and intangible asset expenditures	15,839		4,718		20,557
Depreciation and amortization	11,008		13,598		24,606

	Six Months Ended August 31, 2022
(in thousands)	Home & Outdoor		Beauty & Wellness		Total
Sales revenue, net	$	474,822	$	554,656	$	1,029,478
Restructuring charges	472		4,306		4,778
Operating income	71,875		9,010		80,885
Capital and intangible asset expenditures	105,151		7,484		112,635
Depreciation and amortization	8,988		12,629		21,617

The following table presents net sales revenue by geographic region, in U.S. Dollars:

	Three Months Ended August 31,								Six Months Ended August 31,
(in thousands)	2023				2022				2023				2022
Domestic sales revenue, net (1)	$	388,049	78.9	%	$	419,905	80.5	%	$	747,608	77.4	%	$	816,651	79.3	%
International sales revenue, net	103,514		21.1	%	101,495		19.5	%	218,627		22.6	%	212,827		20.7	%
Total sales revenue, net	$	491,563	100.0	%	$	521,400	100.0	%	$	966,235	100.0	%	$	1,029,478	100.0	%

(1)Beginning in the fourth quarter of fiscal 2023, we included net sales revenue from the U.S. and Canada as domestic net sales revenue. Previously, we reported sales revenue from Canada within international net sales revenue. We have recast the prior period domestic and international net sales revenue presented to conform with this current presentation.

Note 15 - Income Taxes

We reorganized the Company in Bermuda in 1994 and many of our foreign subsidiaries are not directly or indirectly owned by a U.S. parent. As such, a large portion of our foreign income is not subject to U.S. taxation on a permanent basis under current law. Additionally, our intellectual property is largely owned by foreign subsidiaries, resulting in proportionally higher earnings in jurisdictions with lower statutory tax rates, which decreases our overall effective tax rate. The taxable income earned in each jurisdiction, whether U.S. or foreign, is determined by the subsidiary's operating results and transfer pricing and tax regulations in the related jurisdictions.

For interim periods, our income tax expense and resulting effective tax rate are based upon an estimated annual effective tax rate adjusted for the effects of items required to be treated as discrete to the period, including changes in tax laws, changes in estimated exposures for uncertain tax positions and other items.

For the three months ended August 31, 2023, income tax expense as a percentage of income before income tax was 17.9% compared to 19.1% for the same period last year. The year-over-year decrease in the effective tax rate is primarily due to a decrease in tax expense for discrete items, partially offset by shifts in the mix of income in our various tax jurisdictions. For the six months ended August 31, 2023, income tax expense as a percentage of income before income tax was 16.8% compared to 18.2% for the same period last year primarily due to a decrease in tax expense for discrete items, partially offset by shifts in the mix of income in our various tax jurisdictions.

24

Note 16 - Earnings Per Share

We compute basic earnings per share using the weighted average number of shares of common stock outstanding during the period. We compute diluted earnings per share using the weighted average number of shares of common stock outstanding plus the effect of dilutive securities. Dilutive securities at any given point in time may consist of outstanding options to purchase common stock and issued and contingently issuable unvested restricted stock units, performance stock units, restricted stock awards and performance restricted stock awards and other stock-based awards. Anti-dilutive securities are not included in the computation of diluted earnings per share under the treasury stock method. See Note 6 to these condensed consolidated financial statements for more information regarding stock-based awards.

The following table presents our weighted average basic and diluted shares outstanding for the periods shown:

	Three Months Ended August 31,		Six Months Ended August 31,
(in thousands)	2023	2022	2023	2022
Weighted average shares outstanding, basic	23,918	23,969	23,984	23,917
Incremental shares from share-based compensation arrangements	123	87	104	172
Weighted average shares outstanding, diluted	24,041	24,056	24,088	24,089
Anti-dilutive securities	7	54	81	42

25

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

This Management’s Discussion and Analysis of Financial Condition and Results of Operations (“MD&A”) should be read in conjunction with our condensed consolidated financial statements included under Part I, Item 1., “Financial Statements.” The various sections of this MD&A contain a number of forward-looking statements, all of which are based on our current expectations. Actual results may differ materially due to a number of factors, including those discussed in the section entitled “Information Regarding Forward-Looking Statements” following this MD&A, and in Part I, Item 3., “Quantitative and Qualitative Disclosures About Market Risk” in this report, as well as in Part I, Item IA., “Risk Factors” in the Company’s most recent annual report on Form 10-K for the fiscal year ended February 28, 2023 (“Form 10-K”) and its other filings with the Securities and Exchange Commission (the “SEC”). When used in this MD&A, unless otherwise indicated or the context suggests otherwise, references to “the Company”, “our Company”, “Helen of Troy”, “we”, “us”, or “our” refer to Helen of Troy Limited and its subsidiaries. Throughout this MD&A, we refer to our Leadership Brands, which are brands that have number-one and number-two positions in their respective categories and include OXO, Hydro Flask, Osprey, Vicks, Braun, Honeywell, PUR, Hot Tools and Drybar.

This MD&A, including the tables under the headings “Operating Income, Operating Margin, Adjusted Operating Income (non-GAAP), and Adjusted Operating Margin (non-GAAP) by Segment” and “Net Income, Diluted EPS, Adjusted Income (non-GAAP), and Adjusted Diluted EPS (non-GAAP),” reports operating income, operating margin, net income and diluted earnings per share (“EPS”) without the impact of acquisition-related expenses, a charge for uncollectible receivables due to the bankruptcy of Bed, Bath & Beyond (“Bed, Bath & Beyond bankruptcy”), EPA compliance costs, restructuring charges, amortization of intangible assets, and non-cash share-based compensation for the periods presented, as applicable. These measures may be considered non-GAAP financial measures as defined by SEC Regulation G, Rule 100. The tables reconcile these measures to their corresponding GAAP-based financial measures presented in our condensed consolidated statements of income. We believe that adjusted operating income, adjusted operating margin, adjusted income, and adjusted diluted EPS provide useful information to management and investors regarding financial and business trends relating to our financial condition and results of operations. We believe that these non-GAAP financial measures, in combination with our financial results calculated in accordance with GAAP, provide investors with additional perspective regarding the impact of such charges and benefits on applicable income, margin and earnings per share measures. We also believe that these non-GAAP measures facilitate a more direct comparison of our performance to our competitors. We further believe that including the excluded charges and benefits would not accurately reflect the underlying performance of our operations for the period in which the charges and benefits are incurred, even though such charges and benefits may be incurred and reflected in our GAAP financial results in the near future. The material limitation associated with the use of the non-GAAP financial measures is that the non-GAAP measures do not reflect the full economic impact of our activities. Our adjusted operating income, adjusted operating margin, adjusted income, and adjusted diluted EPS are not prepared in accordance with GAAP, are not an alternative to GAAP financial measures and may be calculated differently than non-GAAP financial measures disclosed by other companies. Accordingly, undue reliance should not be placed on non-GAAP financial measures. These non-GAAP financial measures are discussed further and reconciled to their applicable GAAP-based financial measures contained in this MD&A beginning on page 40.

There were no material changes to the key financial measures discussed in our Form 10-K.

26

Overview

We incorporated as Helen of Troy Corporation in Texas in 1968 and were reorganized as Helen of Troy Limited in Bermuda in 1994. We are a leading global consumer products company offering creative products and solutions for our customers through a diversified portfolio of brands. We have built leading market positions through new product innovation, product quality and competitive pricing. We currently operate two segments consisting of Home & Outdoor and Beauty & Wellness.

During the fourth quarter of fiscal 2023, we made changes to the structure of our organization in connection with our global restructuring plan (as further described below and in Note 8 to the accompanying condensed consolidated financial statements) that resulted in our previous Health & Wellness and Beauty operating segments being combined into a single reportable segment, which is referred to herein as “Beauty & Wellness.” In connection with these organizational structure changes, corresponding changes were made to how our business is managed, how results are reported internally and how our Chief Executive Officer (“CEO”), our chief operating decision maker, assesses performance and allocates resources. We believe that these changes better align internal resources and external go to market activities in order to create a more efficient and effective organizational structure. There were no changes to the products or brands included within our Home & Outdoor reportable segment as part of these organizational changes nor to the way in which our CEO assesses performance and allocates resources for the Home & Outdoor segment. As a result of these changes, our disclosures reflect two reportable segments, Home & Outdoor and Beauty & Wellness. Comparative prior period segment information in this report has been recast to conform to this change in our reportable segments. Our external reportable segments will continue to align with our internal reporting to enable users of the financial statements to better understand our performance, better assess our future net cash flows, and make more informed judgments about the Company as a whole.

Fiscal 2020 began Phase II of our transformation, which was designed to drive the next five years of progress. The long-term objectives of Phase II include improved organic sales growth, continued margin expansion, and strategic and effective capital deployment. Phase II includes continued investment in our Leadership Brands, with a focus on growing them through consumer-centric innovation, expanding them more aggressively outside the United States of America (the “U.S.”), and adding new brands through acquisition. We are building further shared service capability and operating efficiency, as well as focusing on attracting, retaining, unifying and training the best people. Additionally, we are continuing to enhance and consolidate our environmental, social and governance efforts and accelerate programs related to diversity, equity, inclusion and belonging to support our Phase II transformation.

During the second quarter of fiscal 2023, we focused on developing a global restructuring plan intended to expand operating margins through initiatives designed to improve efficiency and reduce costs (referred to as “Project Pegasus”). Project Pegasus includes initiatives to further optimize our brand portfolio, streamline and simplify the organization, accelerate cost of goods savings projects, enhance the efficiency of our supply chain network, optimize our indirect spending, and improve our cash flow and working capital, as well as other activities. We anticipate these initiatives will create operating efficiencies, as well as provide a platform to fund future growth investments. During the three and six month periods ended August 31, 2023, we incurred $3.6 million and $11.0 million, respectively, of pre-tax restructuring costs in connection with Project Pegasus, which were recorded as “Restructuring charges” in the condensed consolidated statement of income. We recognized $4.8 million of pre-tax restructuring costs during both the three and six month periods ended August 31, 2022 in connection with Project Pegasus. See further discussion below within “Significant Trends Impacting the Business” under “Project Pegasus” and Note 8 to the accompanying condensed consolidated financial statements.

On April 22, 2022, we completed the acquisition of Recipe Products Ltd., a producer of innovative prestige hair care products for all types of curly and wavy hair under the Curlsmith brand (“Curlsmith”).

27

The Curlsmith brand and products were added to the Beauty & Wellness segment. The total purchase consideration was $147.9 million in cash, net of a final net working capital adjustment and cash acquired.

On March 30, 2022, a third-party facility that we utilized for inventory storage incurred severe damage from a weather-related incident. The inventory that was stored at this facility primarily related to our Beauty & Wellness segment. While the inventory was insured, some seasonal inventory and inventory designated for specific customer promotions was not accessible and subsequently determined to be damaged, and as a result, unfavorably impacted our net sales revenue during the first quarter of fiscal 2023. As a result of the damages to the inventory stored at the facility, we recorded a charge to write-off the damaged inventory totaling $34.4 million during the first quarter of fiscal 2023. These charges were fully offset by probable insurance recoveries of $34.4 million also recorded during the first quarter of fiscal 2023, which represented anticipated insurance proceeds, not to exceed the amount of the associated losses, for which receipt was deemed probable. The charges for the damaged inventory and the expected insurance recoveries are included in cost of goods sold in our condensed consolidated statement of income for the six months ended August 31, 2022. During the third and fourth quarters of fiscal 2023, we received proceeds totaling $46.0 million from our insurance carriers related to this incident, which were included in cash flows from operating activities in our condensed consolidated statements of cash flows. As a result, during the third quarter of fiscal 2023, the Company recorded a gain of $9.7 million, net of costs incurred to dispose of the inventory, as a reduction of SG&A expense in our condensed consolidated statement of income.

Subsequent to the end of our second quarter of fiscal 2024, on September 28, 2023, we completed the sale of our distribution and office facilities in El Paso, Texas for a sales price of $50.6 million, less transaction costs of $1.1 million. Concurrently, we entered into an agreement to leaseback the office facilities for a period of up to 18 months substantially rent free, which we estimate to have a fair value of approximately $1.9 million. The transaction qualifies for sales recognition under the sale leaseback accounting requirements. Accordingly, we increased the sales price by the $1.9 million of prepaid rent and expect to recognize a gain on the sale of approximately $34.2 million within SG&A during the third quarter of fiscal year 2024, of which approximately $18.0 million and $16.2 million will be recognized by our Beauty & Wellness and Home & Outdoor segments, respectively. The related assets will be derecognized from the consolidated balance sheet, and at lease commencement, we will record an operating lease asset, which includes the imputed rent payments described above, and an operating lease liability. We plan to use the proceeds from the sale to repay amounts outstanding under our long-term debt agreement.

Significant Trends Impacting the Business

Project Pegasus

During the second quarter of fiscal 2023, we focused on developing Project Pegasus, a global restructuring plan intended to expand operating margins through initiatives designed to improve efficiency and reduce costs. Project Pegasus includes initiatives to further optimize our brand portfolio, streamline and simplify the organization, accelerate cost of goods savings projects, enhance the efficiency of our supply chain network, optimize our indirect spending, and improve our cash flow and working capital, as well as other activities. We anticipate these initiatives will create operating efficiencies, as well as provide a platform to fund future growth investments.

As part of our initiative focused on streamlining and simplifying the organization, we made further changes to the structure of our organization, during the fourth quarter of fiscal 2023, which include the creation of a North America Regional Market Organization (“RMO”) responsible for sales and go to market strategies for all categories and channels in the U.S. and Canada, and further centralization of certain functions under shared services, particularly in operations and finance to better support our business segments and RMOs. This new structure, inclusive of the organizational structure changes

28

described above resulting in the reportable segment change, will reduce the size of our global workforce by approximately 10%. The majority of these role reductions were completed by March 1, 2023. We believe that these changes better focus business segment resources on brand development, consumer-centric innovation and marketing, the RMOs on sales and go to market strategies, and shared services on their respective areas of expertise while also creating a more efficient and effective organizational structure.

During the second quarter of fiscal 2024, we announced plans to geographically consolidate the U.S. Beauty business, currently located in El Paso, Texas, and Irvine, California, and co-locate it with our Wellness business in the Boston, Massachusetts area. This geographical consolidation and relocation is the next step in our initiative to streamline and simplify the organization and it is expected to be completed during fiscal 2025. We expect these changes will enable a greater opportunity to capture synergies and enhance collaboration and innovation within the Beauty & Wellness segment.

We have updated our expectations regarding Project Pegasus charges. We now estimate lower total one-time pre-tax restructuring charges of approximately $60 million to $65 million over the duration of the plan. We now expect these charges to be completed during fiscal 2025. We previously had estimated total pre-tax restructuring charges of approximately $85 million to $95 million, which was initially expected to be substantially completed by the end of fiscal 2024. In addition, we now have the following expectations regarding Project Pegasus charges:

•Pre-tax restructuring charges to be comprised of approximately $22 million to $25 million of severance and employee related costs, $30 million of professional fees, $5 million of contract termination costs, and $3 million to $5 million of other exit and disposal costs.

•All of our operating segments and shared services will be impacted by the plan and pre-tax restructuring charges include approximately $17 million to $19 million in Home & Outdoor and $43 million to $46 million in Beauty & Wellness segments, respectively.

•Pre-tax restructuring charges represent primarily cash expenditures, which are expected to be substantially paid by the end of fiscal 2025.

We continue to have the following expectations regarding Project Pegasus savings:

•Targeted annualized pre-tax operating profit improvements of approximately $75 million to $85 million, which we expect to substantially begin in fiscal 2024 and be substantially achieved by the end of fiscal 2026.

•Estimated cadence of the recognition of the savings will be approximately 25% in fiscal 2024, approximately 50% in fiscal 2025 and approximately 25% in fiscal 2026.

•Total profit improvements to be realized approximately 60% through reduced cost of goods sold and 40% through lower SG&A.

In addition, we implemented plans to reduce inventory levels, increase inventory turns, and improve cash flow and working capital during the second quarter of fiscal 2023. Improvements related to these initiatives began in the second half of fiscal 2023, and we expect improvements to continue during fiscal 2024. Expectations regarding our Project Pegasus initiatives and our ability to realize targeted savings, including expectations concerning costs and savings, are based on management’s estimates available at the time and are subject to a number of assumptions that could materially impact our estimates.

During the three and six month periods ended August 31, 2023, we incurred $3.6 million and $11.0 million, respectively, of pre-tax restructuring costs in connection with Project Pegasus, which were recorded as “Restructuring charges” in the condensed consolidated statement of income. We recognized $4.8 million of pre-tax restructuring costs during both the three and six month periods ended August 31, 2022 in connection with Project Pegasus. We made total cash restructuring payments of $15.2 million and $1.2 million during the six month periods ended August 31, 2023 and August 31, 2022, respectively,

29

and had a remaining liability of $2.3 million as of August 31, 2023. See Note 8 to the accompanying condensed consolidated financial statements for additional information.

Water Filtration Patent Litigation

On December 23, 2021, Brita LP filed a complaint against Kaz USA, Inc. and Helen of Troy Limited in the United States District Court for the Western District of Texas (the “Patent Litigation”), alleging patent infringement by the Company relating to its PUR gravity-fed water filtration systems. Brita LP simultaneously filed a complaint with the United States International Trade Commission (“ITC”) against Kaz USA, Inc., Helen of Troy Limited and five other unrelated companies that sell water filtration systems (the “ITC Action”). The complaint in the ITC Action also alleges patent infringement by the Company with respect to a limited set of PUR gravity-fed water filtration systems. This action seeks injunctive relief to prevent entry of certain accused PUR products (and certain other products) into the U.S. and cessation of marketing and sales of existing inventory that is already in the U.S. On February 28, 2023, the ITC issued an Initial Determination in the ITC Action, tentatively ruling against Kaz USA, Inc. and the other unrelated respondents. The ITC has a guaranteed review process, and thus all respondents, including Kaz USA, Inc., filed a petition with the ITC for a full review of the Initial Determination. On September 19, 2023, the ITC issued its Final Determination in the Company’s favor. The ITC determined there was no violation by the Company and terminated the investigation. The Patent Litigation remains stayed for the time being, but we believe the stay will be lifted in the near future. We cannot predict the outcome of these legal proceedings, the amount or range of any potential loss, when the proceedings will be resolved, or customer acceptance of any replacement water filter. Litigation is inherently unpredictable, and the resolution or disposition of these proceedings could, if adversely determined, have a material and adverse impact on our financial position and results of operations. For additional information regarding the Patent Litigation and the ITC Action, see Note 9 to the accompanying condensed consolidated financial statements.

Impact of Macroeconomic Trends

The Federal Open Market Committee has been raising interest rates, and may continue to raise interest rates during the remainder of calendar year 2023. The Federal Open Market Committee increased the benchmark interest rate by 450 basis points during fiscal year 2023. As a result, we incurred higher average interest rates during the first and second quarters of fiscal 2024 compared to the same periods last year, and we expect this trend to continue during the remainder of fiscal 2024. While the actual timing and extent of future changes in interest rates remains unknown, higher average interest rates are expected to increase interest expense on our outstanding debt. The financial markets, the global economy and global supply chain may also be adversely affected by the current or anticipated impact of military conflict, including the current conflict between Russia and Ukraine, or other geopolitical events. High inflation and interest rates have also negatively impacted consumer disposable income, credit availability and spending, among others, which have adversely impacted our business, financial condition, cash flows and results of operations during the first and second quarters of fiscal 2024 and may continue to have an adverse impact during the remainder of fiscal year 2024. See further discussion below under “Consumer Spending and Changes in Shopping Preferences.” We expect continued uncertainty in our business and the global economy due to pressure from inflation, volatility in employment trends and consumer confidence, any of which may adversely impact our results.

Consumer Spending and Changes in Shopping Preferences

Our business depends upon discretionary consumer demand for most of our products and primarily operates within mature and highly developed consumer markets. The principal driver of our operating performance is the strength of the U.S. retail economy. Approximately 74% of our consolidated net sales revenue was from U.S. shipments during both the three month periods ended August 31, 2023 and 2022.

For the six month periods ended August 31, 2023 and 2022, U.S. shipments were approximately 73% and 74% of our consolidated net sales revenue, respectively.

30

Among other things, high levels of inflation and interest rates may negatively impact consumer disposable income, credit availability and spending. Consumer purchases of discretionary items, including the products that we offer, generally decline during recessionary periods or periods of economic uncertainty, when disposable income is reduced or when there is a reduction in consumer confidence. Dynamic changes in consumer spending and shopping patterns are also having an impact on retailer inventory levels. Our ability to sell to retailers is predicated on their ability to sell to the end consumer. During fiscal year 2023, we experienced an adverse impact on orders from retail customers as they aimed to rebalance their inventory levels due to lower consumer demand and shifts in consumer spending patterns. We experienced some improvement in replenishment orders from certain retail customers in certain product categories during the first and second quarters of fiscal 2024. If orders from our retail customers continue to be adversely impacted, our sales, results of operations and cash flows may continue to be adversely impacted. We expect continued uncertainty in our business and the global economy due to inflation and changes in consumer spending patterns. Accordingly, our liquidity and financial results could be impacted in ways that we are not able to predict today.

Our concentration of sales reflects the evolution of consumer shopping preferences to online or multichannel shopping experiences. Our net sales to retail customers fulfilling end-consumer online orders and online sales directly to consumers comprised approximately 27% and 26% of our total consolidated net sales revenue for the three and six month periods ended August 31, 2023, respectively, and grew approximately 17% and 12%, respectively, compared to the same periods in the prior year. For both the three and six month periods ended August 31, 2022, our net sales to retail customers fulfilling end-consumer online orders and online sales directly to consumers comprised approximately 22% of our total consolidated net sales revenue, and grew approximately 8% for the three month period ended August 31, 2022 and declined approximately 0.3% for the six month period ended August 31, 2022, as compared to the same period in the prior year.

With the continued importance of online sales in the retail landscape, many brick and mortar retailers are aggressively looking for ways to improve their customer delivery capabilities to be able to meet customer expectations. As a result, it has become increasingly important for us to leverage our distribution capabilities in order to meet the changing demands of our customers, including increasing our online capabilities to support our direct-to-consumer sales channels and online channel sales by our retail customers. In March 2023, we completed the construction of an additional distribution facility in Gallaway, Tennessee that became operational during the first quarter of fiscal 2024 and includes state-of-the-art automation. Additionally, we continue to invest in a centralized cloud-based e-commerce platform that we anticipate will enable us to leverage a common system and rapidly deploy new capabilities across all of our brands, as well as more easily integrate new brands. We anticipate this platform will enhance the customer experience by strengthening the digital presentation and product browsing capabilities and improving the checkout process, order delivery and post-order customer care.

EPA Compliance Costs

Some product lines within our Beauty & Wellness segment are subject to product identification, labeling and claim requirements, which are monitored and enforced by regulatory agencies, such as the U.S. Environmental Protection Agency (the “EPA”), U.S. Customs and Border Protection, the U.S. Food and Drug Administration, and the U.S. Consumer Product Safety Commission.

During fiscal 2022, we were in discussions with the EPA regarding the compliance of packaging claims on certain of our products in the air and water filtration categories and a limited subset of humidifier products within the Beauty & Wellness segment that are sold in the U.S. The EPA did not raise any product quality, safety or performance issues. As a result of these packaging compliance discussions, we voluntarily implemented a temporary stop shipment action on the impacted products as we worked with the EPA towards an expedient resolution. We resumed normalized levels of shipping of the affected inventory during fiscal 2022 and we completed the repackaging of our existing inventory of impacted

31

products during fiscal 2023. Additionally, as a result of continuing dialogue with the EPA, we executed further repackaging and relabeling plans on certain additional humidifier products and certain additional air filtration products, which were also completed during fiscal 2023.

We recorded charges to cost of goods sold to write-off obsolete packaging for the affected products in our inventory on-hand and in-transit. We have also incurred additional compliance costs comprised of obsolete packaging, storage and other charges from vendors, which were recognized in cost of goods sold and incremental warehouse storage costs and legal fees, which were recognized in SG&A. We refer to these charges as “EPA compliance costs.” The following table provides a summary of EPA compliance costs incurred during the periods presented:

	Three Months Ended August 31,				Six Months Ended August 31,
(in thousands)	2023		2022		2023		2022
Cost of goods sold	$	—	$	7,103	$	—	$	16,558	1
SG&A	—		1,251		—		3,440
Total EPA compliance costs	$	—	$	8,354	$	—	$	19,998

(1)Includes a $4.4 million charge to write-off the obsolete packaging for the affected additional humidifier products and affected additional air filtration products in our inventory on-hand and in-transit as of the end of the first quarter of fiscal 2023.

In addition, we incurred and capitalized into inventory costs to repackage a portion of our existing inventory of the affected products beginning in the second quarter of fiscal 2022 through completion of the repackaging in the third quarter of fiscal 2023.

Although we are not aware of any fines or penalties related to this matter imposed against us by the EPA at this time, there can be no assurances that such fines or penalties will not be imposed in the future.

See Note 9 to our condensed consolidated financial statements for additional information.

Foreign Currency Exchange Rate Fluctuations

Due to the nature of our operations, we have exposure to the impact of fluctuations in exchange rates from transactions that are denominated in a currency other than our functional currency (the U.S. Dollar). Such transactions include sales and operating expenses. The most significant currencies affecting our operating results are the Euro, British Pound and Canadian Dollar.

For the three months ended August 31, 2023, changes in foreign currency exchange rates had a favorable year-over-year impact on consolidated U.S. Dollar reported net sales revenue of approximately $1.4 million, or 0.3%, compared to an unfavorable year-over-year impact of $4.2 million, or 0.9%, for the same period last year. For the six months ended August 31, 2023, changes in foreign currency exchange rates had a favorable year-over-year impact on consolidated U.S. Dollar reported net sales revenue of approximately $0.9 million, or 0.1%, compared to an unfavorable year-over-year impact of $7.7 million, or 0.8% for the same period last year.

Variability of the Cough/Cold/Flu Season

Sales in several of our Beauty & Wellness segment categories are highly correlated to the severity of winter weather and cough/cold/flu incidence. In the U.S., the cough/cold/flu season historically runs from November through March, with peak activity normally in January to March. The 2022-2023 cough/cold/flu season was above historical averages, primarily early in the season, as respiratory infections surged in both children and adults and COVID-19 continued to be prevalent. The 2021-2022 cough/cold/flu season was below historical averages.

32

RESULTS OF OPERATIONS

The following table provides selected operating data, in U.S. Dollars, as a percentage of net sales revenue, and as a year-over-year percentage change.

	Three Months Ended August 31,								% of Sales Revenue, net
(in thousands)	2023 (1)		2022 (1)		$ Change		% Change		2023		2022
Sales revenue by segment, net
Home & Outdoor	$	239,977	$	240,559	$	(582)	(0.2)	%	48.8	%	46.1	%
Beauty & Wellness	251,586		280,841		(29,255)		(10.4)	%	51.2	%	53.9	%
Total sales revenue, net	491,563		521,400		(29,837)		(5.7)	%	100.0	%	100.0	%
Cost of goods sold	261,910		299,954		(38,044)		(12.7)	%	53.3	%	57.5	%
Gross profit	229,653		221,446		8,207		3.7	%	46.7	%	42.5	%
SG&A	179,191		169,724		9,467		5.6	%	36.5	%	32.6	%
Restructuring charges	3,617		4,776		(1,159)		(24.3)	%	0.7	%	0.9	%
Operating income	46,845		46,946		(101)		(0.2)	%	9.5	%	9.0	%
Non-operating income, net	148		113		35		31.0	%	—	%	—	%
Interest expense	13,654		9,166		4,488		49.0	%	2.8	%	1.8	%
Income before income tax	33,339		37,893		(4,554)		(12.0)	%	6.8	%	7.3	%
Income tax expense	5,958		7,221		(1,263)		(17.5)	%	1.2	%	1.4	%
Net income	$	27,381	$	30,672	$	(3,291)	(10.7)	%	5.6	%	5.9	%
	Six Months Ended August 31,								% of Sales Revenue, net
(in thousands)	2023 (1)		2022 (1)		$ Change		% Change		2023		2022
Sales revenue by segment, net
Home & Outdoor	$	457,121	$	474,822	$	(17,701)	(3.7)	%	47.3	%	46.1	%
Beauty & Wellness	509,114		554,656		(45,542)		(8.2)	%	52.7	%	53.9	%
Total sales revenue, net	966,235		1,029,478		(63,243)		(6.1)	%	100.0	%	100.0	%
Cost of goods sold	520,951		596,861		(75,910)		(12.7)	%	53.9	%	58.0	%
Gross profit	445,284		432,617		12,667		2.9	%	46.1	%	42.0	%
SG&A	346,826		346,954		(128)		—	%	35.9	%	33.7	%
Restructuring charges	10,972		4,778		6,194		*		1.1	%	0.5	%
Operating income	87,486		80,885		6,601		8.2	%	9.1	%	7.9	%
Non-operating income, net	285		180		105		58.3	%	—	%	—	%
Interest expense	27,706		13,539		14,167		*		2.9	%	1.3	%
Income before income tax	60,065		67,526		(7,461)		(11.0)	%	6.2	%	6.6	%
Income tax expense	10,103		12,259		(2,156)		(17.6)	%	1.0	%	1.2	%
Net income	$	49,962	$	55,267	$	(5,305)	(9.6)	%	5.2	%	5.4	%

(1)The three and six month periods ended August 31, 2023 includes a full three and six months, respectively, of operating results from Curlsmith, acquired on April 22, 2022, compared to approximately thirteen and nineteen weeks of operating results in the three and six month periods ended August 31, 2022, respectively. For additional information see Note 4 to the accompanying condensed consolidated financial statements.

* Calculation is not meaningful.

33

Second Quarter Fiscal 2024 Financial Results

•Consolidated net sales revenue decreased 5.7%, or $29.8 million, to $491.6 million for the three months ended August 31, 2023, compared to $521.4 million for the same period last year.

•Consolidated operating income decreased 0.2%, or $0.1 million, to $46.8 million for the three months ended August 31, 2023, compared to $46.9 million for the same period last year. Consolidated operating margin increased 0.5 percentage points to 9.5% of consolidated net sales revenue for the three months ended August 31, 2023, compared to 9.0% for the same period last year.

•Consolidated adjusted operating income decreased 13.8%, or $10.0 million, to $62.3 million for the three months ended August 31, 2023, compared to $72.3 million for the same period last year. Consolidated adjusted operating margin decreased 1.2 percentage points to 12.7% of consolidated net sales revenue for the three months ended August 31, 2023, compared to 13.9% for the same period last year.

•Net income decreased 10.7%, or $3.3 million, to $27.4 million for the three months ended August 31, 2023, compared to $30.7 million for the same period last year. Diluted EPS decreased 10.9% to $1.14 for the three months ended August 31, 2023, compared to $1.28 for the same period last year.

•Adjusted income decreased 23.6%, or $12.9 million, to $41.8 million for the three months ended August 31, 2023, compared to $54.7 million for the same period last year. Adjusted diluted EPS decreased 23.3% to $1.74 for the three months ended August 31, 2023, compared to $2.27 for the same period last year.

Year-To-Date Fiscal 2024 Financial Results

•Consolidated net sales revenue decreased 6.1%, or $63.2 million, to $966.2 million for the six months ended August 31, 2023, compared to $1,029.5 million for the same period last year.

•Consolidated operating income increased 8.2%, or $6.6 million, to $87.5 million for the six months ended August 31, 2023, compared to $80.9 million for the same period last year. Consolidated operating margin increased 1.2 percentage points to 9.1% of consolidated net sales revenue for the six months ended August 31, 2023, compared to 7.9% for the same period last year.

•Consolidated adjusted operating income decreased 9.3%, or $13.1 million, to $128.4 million for the six months ended August 31, 2023, compared to $141.6 million for the same period last year. Consolidated adjusted operating margin decreased 0.5 percentage points to 13.3% of consolidated net sales revenue for the six months ended August 31, 2023, compared to 13.8% for the same period last year.

•Net income decreased 9.6%, or $5.3 million, to $50.0 million for the six months ended August 31, 2023, compared to $55.3 million for the same period last year. Diluted EPS decreased 9.6% to $2.07 for the six months ended August 31, 2023, compared to $2.29 for the same period last year.

•Adjusted income decreased 21.6%, or $24.4 million, to 88.5 million for the six months ended August 31, 2023, compared to $112.9 million for the same period last year. Adjusted diluted EPS decreased 21.7% to $3.67 for the six months ended August 31, 2023, compared to $4.69 for the same period last year.

34

Consolidated and Segment Net Sales Revenue

The following table summarizes the impact that Organic business, foreign currency and acquisitions had on our net sales revenue by segment: 

	Three Months Ended August 31,
(in thousands)	Home & Outdoor			Beauty & Wellness			Total
Fiscal 2023 sales revenue, net	$	240,559		$	280,841		$	521,400
Organic business	(1,084)			(30,124)			(31,208)
Impact of foreign currency	502			869			1,371
Change in sales revenue, net	(582)			(29,255)			(29,837)
Fiscal 2024 sales revenue, net	$	239,977		$	251,586		$	491,563
Total net sales revenue growth (decline)	(0.2)		%	(10.4)		%	(5.7)		%
Organic business	(0.5)		%	(10.7)		%	(6.0)		%
Impact of foreign currency	0.2		%	0.3		%	0.3		%

	Six Months Ended August 31,
(in thousands)	Home & Outdoor			Beauty & Wellness			Total
Fiscal 2023 sales revenue, net	$	474,822		$	554,656		$	1,029,478
Organic business	(17,835)			(52,372)			(70,207)
Impact of foreign currency	134			728			862
Acquisition (1)	—			6,102			6,102
Change in sales revenue, net	(17,701)			(45,542)			(63,243)
Fiscal 2024 sales revenue, net	$	457,121		$	509,114		$	966,235
Total net sales revenue growth (decline)	(3.7)		%	(8.2)		%	(6.1)		%
Organic business	(3.8)		%	(9.4)		%	(6.8)		%
Impact of foreign currency	—		%	0.1		%	0.1		%
Acquisition	—		%	1.1		%	0.6		%

(1)On April 22, 2022, we completed the acquisition of Curlsmith. Curlsmith sales prior to the first annual anniversary of the acquisition are reported in Acquisition for the Beauty & Wellness segment in the six month period ended August 31, 2023 and consist of approximately seven weeks of incremental operating results. For additional information see Note 4 to the accompanying condensed consolidated financial statements.

In the above tables, Organic business refers to our net sales revenue associated with product lines or brands after the first twelve months from the date the product line or brand was acquired, excluding the impact that foreign currency remeasurement had on reported net sales revenue. Net sales revenue from internally developed brands or product lines is considered Organic business activity.

Leadership Brand and Other Net Sales Revenue

The following table summarizes our Leadership Brand and other net sales revenue:

	Three Months Ended August 31,
(in thousands)	2023		2022		$ Change		% Change
Leadership Brand sales revenue, net	$	429,051	$	452,191	$	(23,140)	(5.1)	%
All other sales revenue, net	62,512		69,209		(6,697)		(9.7)	%
Total sales revenue, net	$	491,563	$	521,400	$	(29,837)	(5.7)	%

35

	Six Months Ended August 31,
(in thousands)	2023		2022		$ Change		% Change
Leadership Brand sales revenue, net	$	831,327	$	887,349	$	(56,022)	(6.3)	%
All other sales revenue, net	134,908		142,129		(7,221)		(5.1)	%
Total sales revenue, net	$	966,235	$	1,029,478	$	(63,243)	(6.1)	%

Consolidated Net Sales Revenue

Comparison of Second Quarter Fiscal 2024 to Second Quarter Fiscal 2023

Consolidated net sales revenue decreased $29.8 million, or 5.7%, to $491.6 million, compared to $521.4 million, primarily driven by a decrease from Organic business of $31.2 million, or 6.0%. The decline in Organic business was primarily due to:

•lower sales of heaters, fans, and humidification products in Beauty & Wellness primarily driven by softer consumer demand, our SKU rationalization efforts, and reduced orders from retail customers as they rebalance trade inventory in line with softer consumer demand in certain categories; and

•a decline in Home & Outdoor primarily due to lower brick and mortar sales in the insulated beverage category.

These factors were partially offset by an increase in consolidated online channel sales, stronger consumer demand for travel-related products in Home & Outdoor and overall growth in Beauty and international sales.

Net sales revenue was favorably impacted by net foreign currency fluctuations of approximately $1.4 million, or 0.3%.

Net sales revenue from our Leadership Brands was $429.1 million, compared to $452.2 million for the same period last year, representing a decrease of 5.1%.

Comparison of First Six Months of Fiscal 2024 to First Six Months of Fiscal 2023

Consolidated net sales revenue decreased $63.2 million, or 6.1%, to $966.2 million, compared to $1,029.5 million, primarily driven by a decrease from Organic business of $70.2 million, or 6.8%. The decline in Organic business was primarily due to:

•lower sales of fans, heaters, air filtration and humidification products in Beauty & Wellness primarily driven by softer consumer demand, our SKU rationalization efforts, and reduced orders from retail customers as they rebalance trade inventory in line with softer consumer demand in certain categories; and

•a decline in Home & Outdoor primarily due to lower home category sales in the club and closeout channels and lower brick and mortar sales in the insulated beverage category.

These factors were partially offset by:

•an increase in consolidated online channel sales reflecting improved replenishment orders from certain retail customers;

•stronger consumer demand for travel-related products in Home & Outdoor; and

•higher sales of prestige market hair care products in Beauty & Wellness.

The Curlsmith acquisition contributed $6.1 million, or 0.6%, to consolidated net sales revenue growth.

Net sales revenue was favorably impacted by net foreign currency fluctuations of approximately $0.9 million, or 0.1%.

36

Net sales revenue from our Leadership Brands was $831.3 million, compared to $887.3 million for the same period last year, representing a decrease of 6.3%.

Segment Net Sales Revenue 

Home & Outdoor

Comparison of Second Quarter Fiscal 2024 to Second Quarter Fiscal 2023

Net sales revenue decreased $0.6 million, or 0.2%, to $240.0 million, compared to $240.6 million. The decrease was driven by a decline from Organic business of $1.1 million, or 0.5%, primarily due to:

•a brick and mortar sales decline in the insulated beverage category;

•lower home category sales in the club and closeout channels; and

•reduced sales to Bed, Bath & Beyond as a result of their bankruptcy.

These factors were partially offset by:

•an increase in online channel sales, primarily driven by the launch of our new travel tumbler;

•stronger consumer demand for travel-related products;

•higher brick and mortar home category sales due to new retailer distribution and improved replenishment orders from certain retail customers; and

•an increase in closeout channel sales in the insulated beverage and travel categories.

Net sales revenue was favorably impacted by net foreign currency fluctuations of approximately $0.5 million, or 0.2%.

Comparison of First Six Months of Fiscal 2024 to First Six Months of Fiscal 2023

Net sales revenue decreased $17.7 million, or 3.7%, to $457.1 million, compared to $474.8 million. The decrease was driven by a decline from Organic business of $17.8 million, or 3.8%, primarily due to:

•lower home category sales in the club and closeout channels;

•reduced sales to Bed, Bath & Beyond as a result of their bankruptcy; and

•a brick and mortar sales decline in the insulated beverage category.

These factors were partially offset by:

•an increase in online channel sales reflecting improved replenishment orders from certain retail customers and the launch of our new travel tumbler;

•stronger consumer demand for travel-related products;

•an increase in closeout channel sales in the insulated beverage and travel categories; and

•higher brick and mortar home category sales due to new retailer distribution and improved replenishment orders from certain retail customers.

Net sales revenue was favorably impacted by net foreign currency fluctuations of approximately $0.1 million, or less than 0.1%.

Beauty & Wellness

Comparison of Second Quarter Fiscal 2024 to Second Quarter Fiscal 2023

Net sales revenue decreased $29.3 million, or 10.4%, to $251.6 million, compared to $280.8 million. The decline was driven by a decrease from Organic business of $30.1 million, or 10.7%, primarily due to:

•lower sales of heaters and fans primarily driven by softer consumer demand, our SKU rationalization efforts, and reduced orders from retail customers as they rebalance trade inventory in line with softer consumer demand in certain categories; and

•a decline in humidification reflecting reduced orders from retail customers as they rebalance trade inventory levels and the comparative impact of high COVID-related incidence in the prior year period.

37

The decline was partially offset by an increase in Beauty, higher sales of air and water filtration products and growth in international sales primarily driven by thermometry.

Net sales revenue was favorably impacted by net foreign currency fluctuations of approximately $0.9 million, or 0.3%.

Comparison of First Six Months of Fiscal 2024 to First Six Months of Fiscal 2023

Net sales revenue decreased $45.5 million, or 8.2%, to $509.1 million, compared to $554.7 million. The decline was driven by a decrease from Organic business of $52.4 million, or 9.4%, primarily due to:

•lower sales of fans, heaters and air filtration products, primarily driven by softer consumer demand, our SKU rationalization efforts, and reduced orders from retail customers as they rebalance trade inventory in line with softer consumer demand in certain categories;

•a decline in humidification reflecting reduced orders from retail customers as they rebalance trade inventory levels and the comparative impact of high COVID-related incidence in the prior year period; and

•a decline in sales of hair appliances.

The decline was partially offset by:

•an increase in sales of prestige market hair care products;

•growth in international sales primarily driven by thermometry; and

•an increase in water filtration product sales.

The Curlsmith acquisition contributed $6.1 million, or 1.1%, to segment net sales revenue growth.

Net sales revenue was favorably impacted by net foreign currency fluctuations of approximately $0.7 million, or 0.1%.

Consolidated Gross Profit Margin

Comparison of Second Quarter Fiscal 2024 to Second Quarter Fiscal 2023

Consolidated gross profit margin increased 4.2 percentage points to 46.7%, compared to 42.5%. The increase in consolidated gross profit margin was primarily due to:

•lower inbound freight costs;

•the favorable comparative impact of EPA compliance costs of $7.1 million incurred in the prior year period;

•the favorable impact of our SKU rationalization efforts in Beauty & Wellness;

•lower inventory obsolescence expense; and

•a more favorable customer mix within Home & Outdoor.

These factors were partially offset by a less favorable product mix within Beauty & Wellness.

Comparison of First Six Months of Fiscal 2024 to First Six Months of Fiscal 2023

Consolidated gross profit margin increased 4.1 percentage points to 46.1%, compared to 42.0%. The increase in consolidated gross profit margin was primarily due to:

•lower inbound freight costs;

•the favorable comparative impact of EPA compliance costs of $16.6 million incurred in the prior year period;

•the favorable impact of our SKU rationalization efforts in Beauty & Wellness; and

•a more favorable customer mix within Home & Outdoor.

38

Consolidated SG&A

Comparison of Second Quarter Fiscal 2024 to Second Quarter Fiscal 2023

Consolidated SG&A ratio increased 3.9 percentage points to 36.5%, compared to 32.6%. The increase in the consolidated SG&A ratio was primarily due to:

•an increase in annual incentive compensation expense;

•higher marketing expense;

•increased distribution expense;

•the unfavorable leverage impact of the overall decrease in net sales; and

•an increase in depreciation expense primarily due to our new distribution facility.

These factors were partially offset by lower outbound freight costs and the favorable comparative impact of EPA compliance costs of $1.3 million incurred in the prior year period.

Comparison of First Six Months of Fiscal 2024 to First Six Months of Fiscal 2023

Consolidated SG&A ratio increased 2.2 percentage points to 35.9%, compared to 33.7%. The increase in the consolidated SG&A ratio was primarily due to:

•increased distribution expense;

•an increase in annual incentive compensation expense;

•higher marketing expense;

•a charge of $4.2 million related to the bankruptcy of Bed, Bath & Beyond; and

•the unfavorable leverage impact of the overall decrease in net sales.

These factors were partially offset by:

•lower share-based compensation expense;

•the favorable comparative impact of EPA compliance costs of $3.4 million incurred in the prior year period; and

•the favorable comparative impact of acquisition-related expense incurred in connection with the Curlsmith transaction during the prior year period.

Restructuring Charges

During the three and six month periods ended August 31, 2023, we incurred $3.6 million and $11.0 million, respectively, of pre-tax restructuring costs in connection with Project Pegasus, which were primarily comprised of professional fees. We recognized $4.8 million of pre-tax restructuring costs during both the three and six month periods ended August 31, 2022, in connection with Project Pegasus, which primarily included severance and employee related costs. During the six month periods ended August 31, 2023 and August 31, 2022, we made total cash restructuring payments of $15.2 million and $1.2 million, respectively. We had a remaining liability of $2.3 million as of August 31, 2023.

39

Operating Income, Operating Margin, Adjusted Operating Income (non-GAAP), and Adjusted Operating Margin (non-GAAP) by Segment

In order to provide a better understanding of the impact of certain items on our operating income, the tables that follow report the comparative pre-tax impact of acquisition-related expenses, Bed, Bath & Beyond bankruptcy, EPA compliance costs, restructuring charges, amortization of intangible assets, and non-cash share-based compensation, as applicable, on operating income and operating margin for each segment and in total for the periods presented below. Adjusted operating income and adjusted operating margin may be considered non-GAAP financial measures as contemplated by SEC Regulation G, Rule 100. For additional information regarding management’s decision to present this non-GAAP financial information, see the introduction to this Item 2., “Management’s Discussion and Analysis of Financial Condition and Results of Operations.”

	Three Months Ended August 31, 2023
(in thousands)	Home & Outdoor				Beauty & Wellness (1)				Total
Operating income, as reported (GAAP)	$	36,099	15.0	%	$	10,746	4.3	%	$	46,845	9.5	%
Restructuring charges	1,271		0.5	%	2,346		0.9	%	3,617		0.7	%
Subtotal	37,370		15.6	%	13,092		5.2	%	50,462		10.3	%
Amortization of intangible assets	1,764		0.7	%	2,830		1.1	%	4,594		0.9	%
Non-cash share-based compensation	3,287		1.4	%	3,942		1.6	%	7,229		1.5	%
Adjusted operating income (non-GAAP)	$	42,421	17.7	%	$	19,864	7.9	%	$	62,285	12.7	%

	Three Months Ended August 31, 2022
(in thousands)	Home & Outdoor				Beauty & Wellness (1)				Total
Operating income, as reported (GAAP)	$	42,082	17.5	%	$	4,864	1.7	%	$	46,946	9.0	%
Acquisition-related expenses	41		—	%	(11)		—	%	30		—	%
EPA compliance costs	—		—	%	8,354		3.0	%	8,354		1.6	%
Restructuring charges	472		0.2	%	4,304		1.5	%	4,776		0.9	%
Subtotal	42,595		17.7	%	17,511		6.2	%	60,106		11.5	%
Amortization of intangible assets	1,753		0.7	%	2,896		1.0	%	4,649		0.9	%
Non-cash share-based compensation	2,640		1.1	%	4,855		1.7	%	7,495		1.4	%
Adjusted operating income (non-GAAP)	$	46,988	19.5	%	$	25,262	9.0	%	$	72,250	13.9	%

	Six Months Ended August 31, 2023
(in thousands)	Home & Outdoor				Beauty & Wellness (1)				Total
Operating income, as reported (GAAP)	$	58,215	12.7	%	$	29,271	5.7	%	$	87,486	9.1	%
Bed, Bath & Beyond bankruptcy	3,087		0.7	%	1,126		0.2	%	4,213		0.4	%
Restructuring charges	4,061		0.9	%	6,911		1.4	%	10,972		1.1	%
Subtotal	65,363		14.3	%	37,308		7.3	%	102,671		10.6	%
Amortization of intangible assets	3,541		0.8	%	5,710		1.1	%	9,251		1.0	%
Non-cash share-based compensation	7,785		1.7	%	8,741		1.7	%	16,526		1.7	%
Adjusted operating income (non-GAAP)	$	76,689	16.8	%	$	51,759	10.2	%	$	128,448	13.3	%

40

	Six Months Ended August 31, 2022
(in thousands)	Home & Outdoor				Beauty & Wellness (1)				Total
Operating income, as reported (GAAP)	$	71,875	15.1	%	$	9,010	1.6	%	$	80,885	7.9	%
Acquisition-related expenses	119		—	%	2,665		0.5	%	2,784		0.3	%
EPA compliance costs	—		—	%	19,998		3.6	%	19,998		1.9	%
Restructuring charges	472		0.1	%	4,306		0.8	%	4,778		0.5	%
Subtotal	72,466		15.3	%	35,979		6.5	%	108,445		10.5	%
Amortization of intangible assets	3,499		0.7	%	5,511		1.0	%	9,010		0.9	%
Non-cash share-based compensation	8,638		1.8	%	15,476		2.8	%	24,114		2.3	%
Adjusted operating income (non-GAAP)	$	84,603	17.8	%	$	56,966	10.3	%	$	141,569	13.8	%

(1)The three and six month periods ended August 31, 2023 includes a full three and six months, respectively, of operating results from Curlsmith, acquired on April 22, 2022, compared to approximately thirteen and nineteen weeks of operating results in the three and six month periods ended August 31, 2022, respectively. For additional information see Note 4 to the accompanying condensed consolidated financial statements.

Consolidated Operating Income

Comparison of Second Quarter Fiscal 2024 to Second Quarter Fiscal 2023

Consolidated operating income was $46.8 million, or 9.5% of net sales revenue, compared to $46.9 million, or 9.0% of net sales revenue. The 0.5 percentage point increase in consolidated operating margin was primarily due to:

•the favorable comparative impact of EPA compliance costs of $8.4 million incurred in the prior year period;

•lower inbound and outbound freight costs;

•a decrease in inventory obsolescence expense;

•the favorable impact of our SKU rationalization efforts in Beauty & Wellness; and

•a more favorable customer mix within Home & Outdoor.

These factors were partially offset by:

•an increase in annual incentive compensation expense;

•higher marketing expense;

•increased distribution expense;

•unfavorable leverage impact of the overall decrease in net sales;

•a less favorable product mix within Beauty & Wellness; and

•an increase in depreciation expense primarily due to our new distribution facility.

Consolidated adjusted operating income decreased 13.8% to $62.3 million, or 12.7% of net sales revenue, compared to $72.3 million, or 13.9% of net sales revenue.

Comparison of First Six Months of Fiscal 2024 to First Six Months of Fiscal 2023

Consolidated operating income was $87.5 million, or 9.1% of net sales revenue, compared to $80.9 million, or 7.9% of net sales revenue. The 1.2 percentage point increase in consolidated operating margin was primarily due to:

•the favorable comparative impact of EPA compliance costs of $20.0 million incurred in the prior year period;

•lower inbound freight costs;

•reduced share-based compensation expense;

•the favorable comparative impact of acquisition-related expense incurred in connection with the Curlsmith transaction during the prior year period;

•the favorable impact of our SKU rationalization efforts in Beauty & Wellness; and

•a more favorable customer mix within Home & Outdoor.

41

These factors were partially offset by:

•higher distribution expense;

•increased annual incentive compensation expense;

•an increase in restructuring charges of $6.2 million;

•higher marketing expense; and

•a charge of $4.2 million related to the bankruptcy of Bed, Bath & Beyond.

Consolidated adjusted operating income decreased 9.3% to $128.4 million, or 13.3% of net sales revenue, compared to $141.6 million, or 13.8% of net sales revenue.

Home & Outdoor

Comparison of Second Quarter Fiscal 2024 to Second Quarter Fiscal 2023

Operating income was $36.1 million, or 15.0% of segment net sales revenue, compared to $42.1 million, or 17.5% of segment net sales revenue. The 2.5 percentage point decrease in segment operating margin was primarily due to:

•increased annual incentive compensation expense;

•higher distribution expense;

•increased marketing expense;

•an increase in depreciation expense primarily due to our new distribution facility;

•higher share-based compensation expense; and

•an increase in restructuring charges of $0.8 million.

These factors were partially offset by:

•lower inbound freight costs;

•a more favorable customer mix; and

•the net favorable impact of foreign currency fluctuations.

Adjusted operating income decreased 9.7% to $42.4 million, or 17.7% of segment net sales revenue, compared to $47.0 million, or 19.5% of segment net sales revenue.

Comparison of First Six Months of Fiscal 2024 to First Six Months of Fiscal 2023

Operating income was $58.2 million, or 12.7% of segment net sales revenue, compared to $71.9 million, or 15.1% of segment net sales revenue. The 2.4 percentage point decrease in segment operating margin was primarily due to:

•higher distribution expense;

•increased annual incentive compensation expense;

•increased marketing expense;

•an increase in restructuring charges of $3.6 million;

•a charge of $3.1 million related to the bankruptcy of Bed, Bath & Beyond;

•an increase in outbound freight costs; and

•unfavorable operating leverage.

These factors were partially offset by:

•lower inbound freight costs;

•the net favorable impact of foreign currency fluctuations; and

•a more favorable customer mix.

Adjusted operating income decreased 9.4% to $76.7 million, or 16.8% of segment net sales revenue, compared to $84.6 million, or 17.8% of segment net sales revenue.

42

Beauty & Wellness

Comparison of Second Quarter Fiscal 2024 to Second Quarter Fiscal 2023

Operating income was $10.7 million, or 4.3% of segment net sales revenue, compared to $4.9 million, or 1.7% of segment net sales revenue. The 2.6 percentage point increase in segment operating margin was primarily due to:

•the favorable comparative impact of EPA compliance costs of $8.4 million incurred in the prior year period;

•lower inbound and outbound freight costs;

•reduced inventory obsolescence expense;

•decreased distribution expense;

•the favorable impact of our SKU rationalization efforts; and

•a decrease in restructuring charges of $2.0 million.

These factors were partially offset by:

•an increase in annual incentive compensation expense;

•higher marketing expense;

•unfavorable operating leverage; and

•a less favorable product mix.

Adjusted operating income decreased 21.4% to $19.9 million, or 7.9% of segment net sales revenue, compared to $25.3 million, or 9.0% of segment net sales revenue.

Comparison of First Six Months of Fiscal 2024 to First Six Months of Fiscal 2023

Operating income was $29.3 million, or 5.7% of segment net sales revenue, compared to $9.0 million, or 1.6% of segment net sales revenue. The 4.1 percentage point increase in segment operating margin was primarily due to:

•the favorable comparative impact of EPA compliance costs of $20.0 million incurred in the prior year period;

•lower inbound and outbound freight costs;

•reduced share-based compensation expense;

•decreased distribution expense;

•the favorable impact of our SKU rationalization efforts; and

•the favorable comparative impact of acquisition-related expense incurred in connection with the Curlsmith transaction during the prior year period.

These factors were partially offset by:

•higher annual incentive compensation expense;

•unfavorable operating leverage;

•an increase in restructuring charges of 2.6 million; and

•a charge of $1.1 million related to the bankruptcy of Bed, Bath & Beyond.

Adjusted operating income decreased 9.1% to $51.8 million, or 10.2% of segment net sales revenue, compared to $57.0 million, or 10.3% of segment net sales revenue.

Interest Expense

Comparison of Second Quarter Fiscal 2024 to Second Quarter Fiscal 2023

Interest expense was $13.7 million, compared to $9.2 million. The increase in interest expense was primarily due to a higher average interest rate, partially offset by lower average levels of debt outstanding compared to the same period last year.

43

Comparison of First Six Months of Fiscal 2024 to First Six Months of Fiscal 2023

Interest expense was $27.7 million, compared to $13.5 million. The increase in interest expense was primarily due to a higher average interest rate, partially offset by lower average levels of debt outstanding compared to the same period last year.

Income Tax Expense

The period-over-period comparison of our effective tax rate is often impacted by the mix of taxable income in our various tax jurisdictions. Due to our organization in Bermuda and the ownership structure of our foreign subsidiaries, many of which are not owned directly or indirectly by a U.S. parent company, an immaterial amount of our foreign income is subject to U.S. taxation on a permanent basis under current law. Additionally, our intellectual property is largely owned by our foreign subsidiaries, resulting in proportionally higher earnings in jurisdictions with lower statutory tax rates, which decreases our overall effective tax rate.

For the three months ended August 31, 2023, income tax expense as a percentage of income before income tax was 17.9% compared to 19.1% for the same period last year. The year-over-year decrease in the effective tax rate is primarily due to a decrease in tax expense for discrete items, partially offset by shifts in the mix of income in our various tax jurisdictions. For the six months ended August 31, 2023, income tax expense as a percentage of income before income tax was 16.8% compared to 18.2% for the same period last year primarily due to a decrease in tax expense for discrete items, partially offset by shifts in the mix of income in our various tax jurisdictions.

44

Net Income, Diluted EPS, Adjusted Income (non-GAAP), and Adjusted Diluted EPS (non-GAAP)

In order to provide a better understanding of the impact of certain items on our income and diluted EPS, the tables that follow report the comparative after-tax impact of acquisition-related expenses, Bed, Bath & Beyond bankruptcy, EPA compliance costs, restructuring charges, amortization of intangible assets, and non-cash share-based compensation, as applicable, on income and diluted EPS for the periods presented below. Adjusted income and adjusted diluted EPS may be considered non-GAAP financial measures as contemplated by SEC Regulation G, Rule 100. For additional information regarding management’s decision to present this non-GAAP financial information, see the introduction to this Item 2., “Management’s Discussion and Analysis of Financial Condition and Results of Operations.”

	Three Months Ended August 31, 2023
	Income						Diluted EPS
(in thousands, except per share data)	Before Tax		Tax		Net of Tax		Before Tax		Tax		Net of Tax
As reported (GAAP)	$	33,339	$	5,958	$	27,381	$	1.39	$	0.25	$	1.14
Restructuring charges	3,617		44		3,573		0.15		—		0.15
Subtotal	36,956		6,002		30,954		1.54		0.25		1.29
Amortization of intangible assets	4,594		607		3,987		0.19		0.03		0.17
Non-cash share-based compensation	7,229		385		6,844		0.30		0.02		0.28
Adjusted (non-GAAP)	$	48,779	$	6,994	$	41,785	$	2.03	$	0.29	$	1.74
Weighted average shares of common stock used in computing diluted EPS											24,041

	Three Months Ended August 31, 2022
	Income						Diluted EPS
(in thousands, except per share data)	Before Tax		Tax		Net of Tax		Before Tax		Tax		Net of Tax
As reported (GAAP)	$	37,893	$	7,221	$	30,672	$	1.58	$	0.30	$	1.28
Acquisition-related expenses	30		—		30		—		—		—
EPA compliance costs	8,354		125		8,229		0.35		0.01		0.34
Restructuring charges	4,776		61		4,715		0.20		—		0.20
Subtotal	51,053		7,407		43,646		2.12		0.31		1.81
Amortization of intangible assets	4,649		557		4,092		0.19		0.02		0.17
Non-cash share-based compensation	7,495		570		6,925		0.31		0.02		0.29
Adjusted (non-GAAP)	$	63,197	$	8,534	$	54,663	$	2.63	$	0.35	$	2.27
Weighted average shares of common stock used in computing diluted EPS											24,056

45

	Six Months Ended August 31, 2023
	Income						Diluted EPS
(in thousands, except per share data)	Before Tax		Tax		Net of Tax		Before Tax		Tax		Net of Tax
As reported (GAAP)	$	60,065	$	10,103	$	49,962	$	2.49	$	0.42	$	2.07
Bed, Bath & Beyond bankruptcy	4,213		53		4,160		0.17		—		0.17
Restructuring charges	10,972		136		10,836		0.46		0.01		0.45
Subtotal	75,250		10,292		64,958		3.12		0.43		2.70
Amortization of intangible assets	9,251		1,213		8,038		0.38		0.05		0.33
Non-cash share-based compensation	16,526		1,026		15,500		0.69		0.04		0.64
Adjusted (non-GAAP)	$	101,027	$	12,531	$	88,496	$	4.19	$	0.52	$	3.67
Weighted average shares of common stock used in computing diluted EPS											24,088

	Six Months Ended August 31, 2022
	Income						Diluted EPS
(in thousands, except per share data)	Before Tax		Tax		Net of Tax		Before Tax		Tax		Net of Tax
As reported (GAAP)	$	67,526	$	12,259	$	55,267	$	2.80	$	0.51	$	2.29
Acquisition-related expenses	2,784		2		2,782		0.12		—		0.12
EPA compliance costs	19,998		300		19,698		0.83		0.01		0.82
Restructuring charges	4,778		61		4,717		0.20		—		0.20
Subtotal	95,086		12,622		82,464		3.95		0.52		3.42
Amortization of intangible assets	9,010		1,047		7,963		0.37		0.04		0.33
Non-cash share-based compensation	24,114		1,654		22,460		1.00		0.07		0.93
Adjusted (non-GAAP)	$	128,210	$	15,323	$	112,887	$	5.32	$	0.64	$	4.69
Weighted average shares of common stock used in computing diluted EPS											24,089

Comparison of Second Quarter Fiscal 2024 to Second Quarter Fiscal 2023

Net income was $27.4 million, compared to $30.7 million. Diluted EPS was $1.14, compared to $1.28. Diluted EPS decreased primarily due to higher interest expense and lower operating income in Home & Outdoor, partially offset by higher operating income in Beauty & Wellness and a decrease in the effective income tax rate.

Adjusted income decreased $12.9 million, or 23.6%, to $41.8 million, compared to $54.7 million. Adjusted diluted EPS decreased 23.3% to $1.74, compared to $2.27.

Comparison of First Six Months of Fiscal 2024 to First Six Months of Fiscal 2023

Net income was $50.0 million, compared to $55.3 million. Diluted EPS was $2.07, compared to $2.29. Diluted EPS decreased primarily due to higher interest expense, higher restructuring charges and lower operating income in Home & Outdoor, partially offset by higher operating income in Beauty & Wellness and a decrease in the effective income tax rate.

Adjusted income decreased $24.4 million, or 21.6%, to $88.5 million, compared to $112.9 million. Adjusted diluted EPS decreased 21.7% to $3.67, compared to $4.69.

Liquidity and Capital Resources

We principally rely on our cash flow from operations and borrowings under our Credit Agreement (as defined below) to finance our operations, capital and intangible asset expenditures, acquisitions and share repurchases. Historically, our principal uses of cash to fund our operations have included operating

46

expenses, primarily SG&A, and working capital, predominantly for inventory purchases and the extension of credit to our retail customers. We have typically been able to generate positive cash flow from operations sufficient to fund our operating activities. In the past, we have utilized a combination of available cash and existing, or additional, sources of financing to fund strategic acquisitions, share repurchases and capital investments. We generated $157.7 million in cash from operations during the first six months of fiscal 2024 and had $24.2 million in cash and cash equivalents at August 31, 2023. As of August 31, 2023, the amount of cash and cash equivalents held by our foreign subsidiaries was $22.8 million. We have no existing activities involving special purpose entities or off-balance sheet financing.

We believe our short-term liquidity requirements will primarily consist of operating and working capital requirements, capital expenditures and interest payments on our debt. We maintained elevated outstanding borrowings under the Credit Agreement during fiscal 2023 in order to fund the acquisitions of Osprey and Curlsmith and the construction of our new distribution facility. With the completion of our new distribution facility in March 2023, we expect a more normalized level of capital expenditures in fiscal 2024. As a result of our expected decrease in cash utilized for investing activities, we plan to continue to repay amounts outstanding under our Credit Agreement. Accordingly, we generally expect a decrease in borrowings outstanding under the Credit Agreement sequentially during the remainder of fiscal 2024 compared to fiscal 2023. If interest rates continue to increase and adverse economic changes occur, our access to credit on favorable interest rate terms may be impacted. In an economic downturn, we may also be unable to raise capital through debt or equity financings on terms acceptable to us or at all. Covenants in our Credit Agreement could also have consequences on our operations, including restricting or delaying our ability to obtain additional financing, potentially limiting our ability to adjust to rapidly changing market conditions or respond to business opportunities. Additionally, in challenging and uncertain economic environments, we cannot predict when macroeconomic uncertainty may arise, whether or when such circumstances may improve or worsen or what impact such circumstances could have on our business and our liquidity requirements.

Based on our current financial condition and current operations, we believe that cash flows from operations and available financing sources will continue to provide sufficient capital resources to fund our foreseeable short- and long-term liquidity requirements.

We continue to evaluate acquisition opportunities on a regular basis. We may finance acquisition activity with available cash, the issuance of shares of common stock, additional debt, or other sources of financing, depending upon the size and nature of any such transaction and the status of the capital markets at the time of such acquisition.

We may also elect to repurchase additional shares of common stock under our Board of Directors' authorization, subject to limitations contained in our debt agreements and based upon our assessment of a number of factors, including share price, trading volume and general market conditions, working capital requirements, general business conditions, financial conditions, any applicable contractual limitations, and other factors, including alternative investment opportunities. We may finance share repurchases with available cash, additional debt or other sources of financing. For additional information, see Part II, Item 5. “Market for Registrant’s Common Equity, Related Shareholder Matters and Issuer Purchases of Equity Securities” in our Form 10-K and Part II, Item 2., “Unregistered Sales of Equity Securities, Use of Proceeds, and Issuer Purchases of Equity Securities” in this report.

Operating Activities

Operating activities provided net cash of $157.7 million for the six months ended August 31, 2023, compared to net cash used of $75.5 million for the same period last year. The increase in cash provided by operating activities was primarily driven by decreases in cash used for inventory purchases, accounts

47

receivable, annual incentive compensation payments, and income taxes partially offset by increases in cash paid primarily for interest and restructuring activities.

Investing Activities

Investing activities used net cash of $20.3 million during the six months ended August 31, 2023, compared to net cash used of $258.9 million for the same period last year. The decrease in cash used by investing activities was primarily due to the comparative impacts of the Curlsmith acquisition during the first quarter of fiscal 2023, and a decrease in capital and intangible asset expenditures during the first and second quarters of fiscal 2024. We made investments in capital and intangible asset expenditures of $20.6 million during the six months ended August 31, 2023, compared to $112.6 million for the same period last year. The decrease in capital and intangible asset expenditures was primarily due to the completion of our new two million square foot distribution facility in March 2023 for which we incurred the bulk of capital expenditures during the prior year period. Capital and intangible asset expenditures during both periods also included expenditures for computer, software, furniture and other equipment and tools, molds, and other production equipment.

Financing Activities

Financing activities used net cash of $142.3 million during the six months ended August 31, 2023, compared to net cash provided of $340.6 million for the same period last year. The increase in cash used by financing activities is primarily due to repayments made on our revolving loans and payments for repurchases of common stock during the six months ended August 31, 2023 in comparison to net borrowings of $356.0 million during the same period last year.

Credit Agreement

We have a credit agreement (the “Credit Agreement”) with Bank of America, N.A., as administrative agent, and other lenders that provides for an unsecured total revolving commitment of $1.25 billion and a $300 million accordion, which can be used for term loan commitments. In June 2022, we exercised $250 million of the $300 million accordion under the Credit Agreement and borrowed $250 million as term loans. The proceeds from the term loans were used to repay revolving loans under the Credit Agreement. The term loans are payable at the end of each fiscal quarter in equal installments of 0.625% of the term loans made, which began in the third quarter of fiscal 2023, with the remaining balance due at the maturity date. The maturity date of the term loans and the revolving loans under the Credit Agreement is March 13, 2025. Borrowings under the Credit Agreement bear floating interest at either the Base Rate or Term SOFR (as defined in the Credit Agreement), plus a margin based on the Net Leverage Ratio (as defined in the Credit Agreement) of 0% to 1.0% and 1.0% to 2.0% for Base Rate and Term SOFR borrowings, respectively, plus a credit spread of 0.10% for Term SOFR borrowings.

The floating interest rates on our borrowings under the Credit Agreement are hedged with interest rate swaps to effectively fix interest rates on $625 million and $425 million of the outstanding principal balance under the revolving loans as of August 31, 2023 and February 28, 2023, respectively. For additional information regarding our interest rate swaps, see Notes 11, 12, and 13 to the accompanying condensed consolidated financial statements.

As of August 31, 2023, the outstanding Credit Agreement principal balance was $846.8 million (excluding prepaid financing fees), the balance of outstanding letters of credit was $17.8 million and the amount available for borrowings under the Credit Agreement was $629.2 million. Covenants in the Credit Agreement limit the amount of total indebtedness we can incur. As of August 31, 2023, these covenants effectively limited our ability to incur more than $231.1 million of additional debt from all sources, including the Credit Agreement, or $465.8 million in the event a qualified acquisition is consummated.

48

As of August 31, 2023, we were in compliance with all covenants as defined under the terms of the Credit Agreement.

Critical Accounting Policies and Estimates

The SEC defines critical accounting estimates as those made in accordance with generally accepted accounting principles that involve a significant level of estimation uncertainty and have had or are reasonably likely to have a material impact on a company's financial condition or results of operations. For a discussion of the estimates that we consider to meet this definition and represent our more critical estimates and assumptions used in the preparation of our consolidated financial statements, see the section entitled “Critical Accounting Policies and Estimates” in our Form 10-K. Since the filing of our Form 10-K, there have been no material changes in our critical accounting policies and estimates from those disclosed therein.

Information Regarding Forward-Looking Statements

Certain statements in this report, including those in documents and our other filings with the SEC referenced herein, may constitute “forward-looking statements” as defined under the Private Securities Litigation Reform Act of 1995. Generally, the words “anticipates”, “believes”, “expects”, “plans”, “may”, “will”, “might”, “would”, “should”, “seeks”, “estimates”, “project”, “predict”, “potential”, “currently”, “continue”, “intends”, “outlook”, “forecasts”, “targets”, “could”, and other similar words identify forward-looking statements. All statements that address operating results, events or developments that we expect or anticipate may occur in the future, including statements related to sales, expenses, EPS results, and statements expressing general expectations about future operating results, are forward-looking statements and are based upon our current expectations and various assumptions. We believe there is a reasonable basis for our expectations and assumptions, but there can be no assurance that we will realize our expectations or that our assumptions will prove correct. Forward-looking statements are only as of the date they are made and are subject to risks that could cause them to differ materially from actual results. Accordingly, we caution readers not to place undue reliance on forward-looking statements. We believe that these risks include but are not limited to the risks described or referenced in this report and that are otherwise described from time to time in our SEC reports as filed. We undertake no obligation to publicly update or revise any forward-looking statements as a result of new information, future events or otherwise.

Such risks are not limited to, but may include:

•the occurrence of cyber incidents, or failure by us or our third-party service providers to maintain cybersecurity and the integrity of confidential internal or customer data;

•a cybersecurity breach, obsolescence or interruptions in the operation of our central global Enterprise Resource Planning systems and other peripheral information systems;

•the geographic concentration of certain U.S. distribution facilities which increases our risk to disruptions that could affect our ability to deliver products in a timely manner;

•our ability to develop and introduce a continuing stream of innovative new products to meet changing consumer preferences;

•actions taken by large customers that may adversely affect our gross profit and operating results;

•our dependence on sales to several large customers and the risks associated with any loss of, or substantial decline in, sales to top customers;

•our dependence on third-party manufacturers, most of which are located in Asia, and any inability to obtain products from such manufacturers;

•our ability to deliver products to our customers in a timely manner and according to their fulfillment standards;

•the risks associated with trade barriers, exchange controls, expropriations, and other risks associated with domestic and foreign operations including uncertainty and business interruptions

49

resulting from political changes and actions in the U.S. and abroad, such as the current conflict between Russia and Ukraine, and volatility in the global credit and financial markets and economy;

•our dependence on the strength of retail economies and vulnerabilities to any prolonged economic downturn, including a downturn from the effects of macroeconomic conditions, any public health crises or similar conditions;

•the risks associated with the use of licensed trademarks from or to third parties;

•the risks associated with weather conditions, the duration and severity of the cold and flu season and other related factors;

•our reliance on our CEO and a limited number of other key senior officers to operate our business;

•our ability to execute and realize expected synergies from strategic business initiatives such as acquisitions, divestitures and global restructuring plans, including Project Pegasus;

•the risks of potential changes in laws and regulations, including environmental, employment and health and safety and tax laws, and the costs and complexities of compliance with such laws;

•the risks associated with increased focus and expectations on climate change and other environmental, social and governance matters;

•the risks associated with significant changes in or our compliance with regulations, interpretations or product certification requirements;

•the risks associated with global legal developments regarding privacy and data security that could result in changes to our business practices, penalties, increased cost of operations, or otherwise harm our business;

•our dependence on whether we are classified as a “controlled foreign corporation” for U.S. federal income tax purposes which impacts the tax treatment of its non-U.S. income;

•the risks associated with legislation enacted in Bermuda and Barbados in response to the European Union’s review of harmful tax competition;

•the risks associated with accounting for tax positions and the resolution of tax disputes;

•the risks of significant tariffs or other restrictions being placed on imports from China, Mexico or Vietnam or any retaliatory trade measures taken by China, Mexico or Vietnam;

•the risks associated with product recalls, product liability and other claims against us;

•associated financial risks including but not limited to, significant impairment of our goodwill, indefinite-lived and definite-lived intangible assets or other long-lived assets;

•increased costs of raw materials, energy and transportation;

•the risks to our liquidity or cost of capital which may be materially adversely affected by constraints or changes in the capital and credit markets, interest rates and limitations under our financing arrangements;

•the risks associated with foreign currency exchange rate fluctuations; and

•projections of product demand, sales and net income, which are highly subjective in nature, and from which future sales and net income could vary in a material amount.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

There have been no material changes in the information provided in the section entitled “Quantitative and Qualitative Disclosures about Market Risk” in our Form 10-K. Additional information regarding our risk management activities can be found in Notes 10, 11 and 12 to the accompanying condensed consolidated financial statements.

50

ITEM 4. CONTROLS AND PROCEDURES

DISCLOSURE CONTROLS AND PROCEDURES

Our management, under the supervision and with the participation of our Chief Executive Officer (“CEO”) and Chief Financial Officer (“CFO”), maintains disclosure controls and procedures as defined in Rule 13a-15(e) promulgated under the Securities Exchange Act of 1934 (the “Exchange Act”) that are designed to provide reasonable assurance that information required to be disclosed in the reports that we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to management, including the CEO and CFO, as appropriate to allow timely decisions regarding required disclosures. Because of inherent limitations, disclosure controls and procedures, no matter how well designed and operated, can provide only reasonable, and not absolute, assurance that the objectives of disclosure controls and procedures are met.

Our management, including our CEO and CFO, has evaluated the effectiveness of our disclosure controls and procedures as of the end of the fiscal quarter ended August 31, 2023. Based upon that evaluation, the CEO and CFO concluded that our disclosure controls and procedures were effective at a reasonable level of assurance as of August 31, 2023, the end of the period covered by this quarterly report on Form 10-Q.

CHANGES IN INTERNAL CONTROL OVER FINANCIAL REPORTING

In connection with the evaluation described above, we identified no change in our internal control over financial reporting as defined in Rule 13a-15(f) promulgated under the Exchange Act that occurred during our fiscal quarter ended August 31, 2023, that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

PART II. OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS 

We are involved in various legal claims and proceedings in the normal course of operations. We believe the outcome of these matters will not have a material adverse effect on our consolidated financial position, results of operations or liquidity, except as described in Part 1, Item 3. “Legal Proceedings” of our Form 10-K. Since the filing of our Form 10-K, there have been no material changes in our legal proceedings from those disclosed therein except as updated herein in the discussion in Note 9 to the accompanying condensed consolidated financial statements.

ITEM 1A. RISK FACTORS

The ownership of our common stock involves a number of risks and uncertainties. When evaluating the Company and our business before making an investment decision regarding our securities, potential investors should carefully consider the risk factors and uncertainties described in Part 1, Item 1A. “Risk Factors” of our Form 10-K. Since the filing of our Form 10-K, there have been no material changes in our risk factors from those disclosed therein.

51

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES, USE OF PROCEEDS, AND ISSUER PURCHASES OF EQUITY SECURITIES

In August 2021, our Board of Directors authorized the repurchase of up to $500 million of our outstanding common stock. The authorization became effective August 25, 2021, for a period of three years, and replaced our former repurchase authorization. These repurchases may include open market purchases, privately negotiated transactions, block trades, accelerated stock repurchase transactions, or any combination of such methods. The number of shares purchased and the timing of the purchases will depend on a number of factors, including share price, trading volume and general market conditions, working capital requirements, general business conditions, financial conditions, any applicable contractual limitations, and other factors, including alternative investment opportunities. See Note 7 to the accompanying condensed consolidated financial statements for additional information.

Our current equity-based compensation plans include provisions that allow for the “net exercise” of share-settled awards by all plan participants. In a net exercise, any required payroll taxes, federal withholding taxes and exercise price of the shares due from the option or other share-based award holders are settled by having the holder tender back to us a number of shares at fair value equal to the amounts due. Net exercises are treated as purchases and retirements of shares. The following table summarizes our share repurchase activity for the periods shown:

Period	Total Number of Shares  Purchased (1)	Average Price Paid per Share		Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs (1)	Maximum Dollar  Value of Shares  that May Yet be  Purchased Under the  Plans or Programs (in thousands) (2)
June 1 through June 30, 2023	477	$	97.01	477	$	399,131
July 1 through July 31, 2023	381,221	131.18		381,221	349,122
August 1 through August 31, 2023	267	125.86		267	349,088
Total	381,965	$	131.14	381,965

(1)The number of shares includes shares of common stock acquired from associates who tendered shares to: (i) satisfy the tax withholding on equity awards as part of our long-term incentive plans or (ii) satisfy the exercise price on stock option exercises. For the three months ended August 31, 2023, 765 shares were acquired from associates at an average per share price of $108.00.

(2)Reflects the remaining dollar value of shares that could be purchased under our current stock repurchase authorization through the expiration or termination of the plan. For additional information, see Note 7 to the accompanying condensed consolidated financial statements.

ITEM 5. OTHER INFORMATION

Rule 10b5-1 Trading Plans

During the three month period ended August 31, 2023, none of our officers or directors adopted or terminated any contract, instruction or written plan for the purchase or sale of our securities that was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) or any “non-Rule 10b5-1 trading arrangement.”

52

ITEM 6.	EXHIBITS
		(a)	Exhibits
			31.1*	Certification of the Chief Executive Officer required by Rule 13a-14(a) or Rule 15d-14(a) pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
			31.2*	Certification of the Chief Financial Officer required by Rule 13a-14(a) or Rule 15d-14(a) pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
			32**	Joint certification of the Chief Executive Officer and the Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
			101	Financial statements from the Quarterly Report on Form 10-Q of the Company for the quarter ended August 31, 2023, formatted in Inline eXtensible Business Reporting Language (“iXBRL”): (i) Condensed Consolidated Balance Sheets, (ii) Condensed Consolidated Statements of Income, (iii) Condensed Consolidated Statements of Comprehensive Income, (iv) Condensed Consolidated Statements of Stockholders' Equity, (v) Condensed Consolidated Statements of Cash Flows and (vi) Notes to the Condensed Consolidated Financial Statements.
			104	Cover Page, Interactive Data File formatted in iXBRL and contained in Exhibit 101.
			*     Filed herewith.
			**   Furnished herewith.

53

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

		HELEN OF TROY LIMITED
		(Registrant)
Date:	October 4, 2023	/s/ Julien R. Mininberg
		Julien R. Mininberg
		Chief Executive Officer,   Director and Principal Executive Officer
Date:	October 4, 2023	/s/ Brian L. Grass
		Brian L. Grass
		Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer

54

EX-31.1

EXHIBIT 31.1

CERTIFICATION

I, Julien R. Mininberg, certify that:

1.I have reviewed this quarterly report on Form 10-Q for the fiscal quarter ended August 31, 2023 of Helen of Troy Limited;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c)Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d)Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5.The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Dated: October 4, 2023

/s/ Julien R. Mininberg

Julien R. Mininberg

Chief Executive Officer,

Director and Principal Executive Officer

EX-31.2

EXHIBIT 31.2

CERTIFICATION

I, Brian L. Grass, certify that:

1.I have reviewed this quarterly report on Form 10-Q for the fiscal quarter ended August 31, 2023 of Helen of Troy Limited;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c)Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d)Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5.The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Dated: October 4, 2023

/s/ Brian L. Grass

Brian L. Grass

Chief Financial Officer, Principal Financial

Officer and Principal Accounting Officer

EX-32

EXHIBIT 32

CERTIFICATION

In connection with the quarterly report of Helen of Troy Limited (the “Company”) on Form 10-Q for the fiscal quarter ended August 31, 2023, as filed with the Securities and Exchange Commission (the “Report”), and pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, each of the undersigned, the Chief Executive Officer and Chief Financial Officer of the Company, hereby certifies that to the best of their knowledge:

1.The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2.The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated: October 4, 2023

/s/ Julien R. Mininberg

Julien R. Mininberg

Chief Executive Officer,

Director and Principal Executive Officer

/s/ Brian L. Grass

Brian L. Grass

Chief Financial Officer, Principal Financial Officer

and Principal Accounting Officer

This certification is not deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, or otherwise subject to the liability of that section. This certification is not deemed to be incorporated by reference into any filing under the Securities Act of 1933 or Securities Exchange Act of 1934, except to the extent that the Company specifically incorporates it by reference.

XML

Cover page - shares	6 Months Ended
	Aug. 31, 2023	Sep. 28, 2023
Entity Addresses [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Aug. 31, 2023
Document Transition Report	false
Entity File Number	001-14669
Entity Registrant Name	HELEN OF TROY LIMITED
Entity Incorporation, State or Country Code	D0
Entity Tax Identification Number	74-2692550
Entity Address, Address Line One	1 Helen of Troy Plaza
Entity Address, City or Town	El Paso
Entity Address, State or Province	TX
Entity Address, Postal Zip Code	79912
City Area Code	915
Local Phone Number	225-8000
Title of 12(b) Security	Common Shares, $0.10 par value per share
Trading Symbol	HELE
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		23,742,747
Entity Central Index Key	0000916789
Current Fiscal Year End Date	--02-28
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q2
Amendment Flag	false
Other Address
Entity Addresses [Line Items]
Entity Address, Address Line One	Clarendon House
Entity Address, Address Line Two	2 Church Street
Entity Address, City or Town	Hamilton
Entity Address, Country	BM

XML

Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Aug. 31, 2023	Feb. 28, 2023
Assets, current:
Cash and cash equivalents	$ 24,214	$ 29,073
Receivables, less allowances of $5,144 and $1,678	387,498	377,604
Inventory	435,681	455,485
Prepaid expenses and other current assets	28,950	24,721
Income taxes receivable	12,349	5,158
Total assets, current	888,692	892,041
Property and equipment, net of accumulated depreciation of $156,406 and $178,961	336,349	351,793
Goodwill	1,066,730	1,066,479
Other intangible assets, net of accumulated amortization of $177,825 and $168,574	544,958	553,883
Operating lease assets	37,555	38,751
Deferred tax assets, net	2,996	2,781
Assets held for sale	17,179	0
Other assets	7,201	7,987
Total assets	2,901,660	2,913,715
Liabilities, current:
Accounts payable	258,669	190,598
Accrued expenses and other current liabilities	195,359	200,718
Income taxes payable	12,132	14,778
Long-term debt, current maturities	6,235	6,064
Total liabilities, current	472,395	412,158
Long-term debt, excluding current maturities	838,668	928,348
Lease liabilities, non-current	41,036	42,672
Deferred tax liabilities, net	34,747	28,048
Other liabilities, non-current	12,931	13,678
Total liabilities	1,399,777	1,424,904
Commitments and contingencies
Stockholders' equity:
Cumulative preferred stock, non-voting, $1.00 par. Authorized 2,000,000 shares; none issued	0	0
Common stock, $0.10 par. Authorized 50,000,000 shares; 23,719,204 and 23,994,405 shares issued and outstanding	2,372	2,399
Additional paid in capital	330,227	317,277
Accumulated other comprehensive income	3,686	4,947
Retained earnings	1,165,598	1,164,188
Total stockholders' equity	1,501,883	1,488,811
Total liabilities and stockholders' equity	$ 2,901,660	$ 2,913,715

XML

Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - USD ($) $ in Thousands	Aug. 31, 2023	Feb. 28, 2023
Statement of Financial Position [Abstract]
Allowance on receivables	$ 5,144	$ 1,678
Property and equipment, accumulated depreciation	156,406	178,961
Other intangible assets, accumulated amortization	$ 177,825	$ 168,574
Cumulative preferred stock, nonvoting, par value (in dollars per share)	$ 1.00	$ 1.00
Cumulative preferred stock, non-voting, authorized shares (in shares)	2,000,000	2,000,000
Cumulative preferred stock, non-voting, issued shares (in shares)	0	0
Common stock, par value (in dollars per share)	$ 0.10	$ 0.10
Common stock, authorized shares (in shares)	50,000,000	50,000,000
Common stock, shares issued (in shares)	23,719,204	23,994,405
Common stock, shares outstanding (in shares)	23,719,204	23,994,405

XML

Condensed Consolidated Statements of Income (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Aug. 31, 2023	Aug. 31, 2022	Aug. 31, 2023	Aug. 31, 2022
Income Statement [Abstract]
Sales revenue, net	$ 491,563	$ 521,400	$ 966,235	$ 1,029,478
Cost of goods sold	261,910	299,954	520,951	596,861
Gross profit	229,653	221,446	445,284	432,617
Selling, general and administrative expense (“SG&A”)	179,191	169,724	346,826	346,954
Restructuring charges	3,617	4,776	10,972	4,778
Operating income	46,845	46,946	87,486	80,885
Non-operating income, net	148	113	285	180
Interest expense	13,654	9,166	27,706	13,539
Income before income tax	33,339	37,893	60,065	67,526
Income tax expense	5,958	7,221	10,103	12,259
Net income	$ 27,381	$ 30,672	$ 49,962	$ 55,267
Earnings per share (“EPS”):
Basic (in dollars per share)	$ 1.14	$ 1.28	$ 2.08	$ 2.31
Diluted (in dollars per share)	$ 1.14	$ 1.28	$ 2.07	$ 2.29
Weighted average shares used in computing EPS:
Basic (in shares)	23,918	23,969	23,984	23,917
Diluted (in shares)	24,041	24,056	24,088	24,089

XML

Condensed Consolidated Statements of Comprehensive Income (Unaudited) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Aug. 31, 2023	Aug. 31, 2022	Aug. 31, 2023	Aug. 31, 2022
Statement of Comprehensive Income [Abstract]
Net income	$ 27,381	$ 30,672	$ 49,962	$ 55,267
Other comprehensive income (loss), net of tax:
Cash flow hedge activity - interest rate swaps	2,768	1,301	(324)	3,507
Cash flow hedge activity - foreign currency contracts	(314)	2,538	(937)	3,491
Total other comprehensive income (loss), net of tax	2,454	3,839	(1,261)	6,998
Comprehensive income	$ 29,835	$ 34,511	$ 48,701	$ 62,265

XML

Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($) shares in Thousands, $ in Thousands	Total	Common Stock	Additional Paid in Capital	Accumulated Other Comprehensive Income	Retained Earnings
Beginning balance (in shares) at Feb. 28, 2022		23,800
Beginning balance at Feb. 28, 2022	$ 1,327,339	$ 2,380	$ 303,740	$ 202	$ 1,021,017
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	24,595				24,595
Other comprehensive income, net of tax	3,159			3,159
Exercise of stock options (in shares)		8
Exercise of stock options	659	$ 1	658
Issuance and settlement of restricted stock (in shares)		235
Issuance and settlement of restricted stock	0	$ 24	(24)
Issuance of common stock related to stock purchase plan (in shares)		13
Issuance of common stock related to stock purchase plan	2,275	$ 1	2,274
Common stock repurchased and retired (in shares)		(89)
Common stock repurchased and retired	(18,224)	$ (9)	(18,113)		(102)
Share-based compensation	16,619		16,619
Ending balance (in shares) at May. 31, 2022		23,967
Ending balance at May. 31, 2022	1,356,422	$ 2,397	305,154	3,361	1,045,510
Beginning balance (in shares) at Feb. 28, 2022		23,800
Beginning balance at Feb. 28, 2022	1,327,339	$ 2,380	303,740	202	1,021,017
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Other comprehensive income, net of tax	6,998
Ending balance (in shares) at Aug. 31, 2022		23,969
Ending balance at Aug. 31, 2022	1,398,346	$ 2,397	312,567	7,200	1,076,182
Beginning balance (in shares) at May. 31, 2022		23,967
Beginning balance at May. 31, 2022	1,356,422	$ 2,397	305,154	3,361	1,045,510
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	30,672				30,672
Other comprehensive income, net of tax	3,839			3,839
Issuance and settlement of restricted stock (in shares)		2
Issuance and settlement of restricted stock	(1)		(1)
Common stock repurchased and retired	(81)		(81)
Share-based compensation	7,495		7,495
Ending balance (in shares) at Aug. 31, 2022		23,969
Ending balance at Aug. 31, 2022	1,398,346	$ 2,397	312,567	7,200	1,076,182
Beginning balance (in shares) at Feb. 28, 2023		23,994
Beginning balance at Feb. 28, 2023	1,488,811	$ 2,399	317,277	4,947	1,164,188
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	22,581				22,581
Other comprehensive income, net of tax	(3,715)			(3,715)
Exercise of stock options (in shares)		5
Exercise of stock options	212	$ 1	211
Issuance and settlement of restricted stock (in shares)		120
Issuance and settlement of restricted stock	0	$ 12	(12)
Issuance of common stock related to stock purchase plan (in shares)		23
Issuance of common stock related to stock purchase plan	2,168	$ 2	2,166
Common stock repurchased and retired (in shares)		(45)
Common stock repurchased and retired	(4,446)	$ (4)	(4,442)
Share-based compensation	9,297		9,297
Ending balance (in shares) at May. 31, 2023		24,097
Ending balance at May. 31, 2023	1,514,908	$ 2,410	324,497	1,232	1,186,769
Beginning balance (in shares) at Feb. 28, 2023		23,994
Beginning balance at Feb. 28, 2023	1,488,811	$ 2,399	317,277	4,947	1,164,188
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Other comprehensive income, net of tax	(1,261)
Ending balance (in shares) at Aug. 31, 2023		23,719
Ending balance at Aug. 31, 2023	1,501,883	$ 2,372	330,227	3,686	1,165,598
Beginning balance (in shares) at May. 31, 2023		24,097
Beginning balance at May. 31, 2023	1,514,908	$ 2,410	324,497	1,232	1,186,769
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	27,381				27,381
Other comprehensive income, net of tax	2,454			2,454
Issuance and settlement of restricted stock (in shares)		4
Issuance and settlement of restricted stock	0
Common stock repurchased and retired (in shares)		(382)
Common stock repurchased and retired	(50,089)	$ (38)	(1,499)		(48,552)
Share-based compensation	7,229		7,229
Ending balance (in shares) at Aug. 31, 2023		23,719
Ending balance at Aug. 31, 2023	$ 1,501,883	$ 2,372	$ 330,227	$ 3,686	$ 1,165,598

XML

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	6 Months Ended
	Aug. 31, 2023	Aug. 31, 2022
Cash provided (used) by operating activities:
Net income	$ 49,962	$ 55,267
Adjustments to reconcile net income to net cash provided (used) by operating activities:
Depreciation and amortization	24,606	21,617
Amortization of financing costs	616	512
Non-cash operating lease expense	3,941	5,186
Provision for credit losses	3,671	963
Non-cash share-based compensation	16,526	24,114
Gain on sale of Personal Care business	0	(1,336)
Gain on the sale or disposal of property and equipment	(246)	(20)
Deferred income taxes and tax credits	6,845	3,977
Changes in operating capital, net of effects of acquisitions of businesses:
Receivables	(14,427)	(46,754)
Inventory	19,804	(77,348)
Prepaid expenses and other current assets	(5,391)	575
Other assets and liabilities, net	(253)	(2,040)
Accounts payable	71,990	3,333
Accrued expenses and other current liabilities	(10,317)	(43,767)
Accrued income taxes	(9,595)	(19,731)
Net cash provided (used) by operating activities	157,732	(75,452)
Cash used by investing activities:
Capital and intangible asset expenditures	(20,557)	(112,635)
Net payments to acquire businesses, net of cash acquired	0	(148,111)
Proceeds from sale of Personal Care business	0	1,804
Proceeds from the sale of property and equipment	246	20
Net cash used by investing activities	(20,311)	(258,922)
Cash (used) provided by financing activities:
Proceeds from revolving loans	261,150	573,500
Repayment of revolving loans	(348,150)	(465,000)
Proceeds from term loans	0	250,000
Repayment of long-term debt	(3,125)	(1,900)
Payment of financing costs	0	(586)
Proceeds from share issuances under share-based compensation plans	2,380	2,934
Payments for repurchases of common stock	(54,535)	(18,305)
Net cash (used) provided by financing activities	(142,280)	340,643
Net (decrease) increase in cash and cash equivalents	(4,859)	6,269
Cash and cash equivalents, beginning balance	29,073	33,381
Cash and cash equivalents, ending balance	24,214	39,650
Supplemental non-cash investing activity:
Capital expenditures included in accounts payable	$ 2,790	$ 8,484

XML

Basis of Presentation and Related Information

6 Months Ended

Aug. 31, 2023

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Basis of Presentation and Related Information

Note 1 - Basis of Presentation and Related Information

Corporate Overview

The accompanying condensed consolidated financial statements contain all adjustments (consisting of normal recurring adjustments) necessary to present fairly our consolidated financial position as of August 31, 2023 and February 28, 2023, and the results of our consolidated operations for the interim periods presented. We follow the same accounting policies when preparing quarterly financial data as we use for preparing annual data. These statements should be read in conjunction with the consolidated financial statements and the notes included in our latest annual report on Form 10-K for the fiscal year ended February 28, 2023 (“Form 10-K”), and our other reports on file with the Securities and Exchange Commission (the “SEC”).

When used in these notes, unless otherwise indicated or the context suggests otherwise, references to “the Company”, “our Company”, “Helen of Troy”, “we”, “us”, or “our” refer to Helen of Troy Limited and its subsidiaries, which are all wholly-owned. We refer to our common shares, par value $0.10 per share, as “common stock.” References to “the FASB” refer to the Financial Accounting Standards Board. References to “GAAP” refer to accounting principles generally accepted in the United States of America (the “U.S.”). References to “ASU” refer to the codification of GAAP in the Accounting Standards Updates issued by the FASB. References to “ASC” refer to the codification of GAAP in the Accounting Standards Codification issued by the FASB.

We incorporated as Helen of Troy Corporation in Texas in 1968 and were reorganized as Helen of Troy Limited in Bermuda in 1994. We are a leading consumer products company offering creative products and solutions for our customers through a diversified portfolio of brands. As of August 31, 2023, we operated two reportable segments: Home & Outdoor and Beauty & Wellness. During the fourth quarter of fiscal 2023, we made changes to the structure of our organization in connection with our global restructuring plan (as further described below and in Note 8) that resulted in our previous Health & Wellness and Beauty operating segments being combined into a single reportable segment, which is referred to herein as “Beauty & Wellness.” In connection with these organizational structure changes, corresponding changes were made to how our business is managed, how results are reported internally and how our Chief Executive Officer (“CEO”), our chief operating decision maker, assesses performance and allocates resources. We believe that these changes better align internal resources and external go to market activities in order to create a more efficient and effective organizational structure. There were no changes to the products or brands included within our Home & Outdoor reportable segment as part of these organizational changes nor to the way in which our CEO assesses performance and allocates resources for the Home & Outdoor segment. As a result of these changes, our disclosures reflect two reportable segments, Home & Outdoor and Beauty & Wellness. Comparative prior period segment information in this report has been recast to conform to this change in our reportable segments. Our external reportable segments will continue to align with our internal reporting to enable users of the financial statements to better understand our performance, better assess our future net cash flows, and make more informed judgments about the Company as a whole.

Our Home & Outdoor segment provides a broad range of outstanding world-class brands that help consumers enjoy an outdoor lifestyle and make everyday living better. Our innovative products for home activities include food preparation, cooking, cleaning, organization, and beverage service. Our outdoor performance range includes hydration products, backpacks, and travel gear to ease your journey and inspire your next adventure. The Beauty & Wellness segment provides consumers with a broad range of

outstanding world-class brands for beauty and wellness. In Beauty, we deliver innovation through products such as hair styling appliances, grooming tools, and liquid-, solid-, and powder-based personal care products that help make everyone look and feel more beautiful. On the Wellness side, we are there when you need us most with highly regarded humidifiers, thermometers, water and air purifiers, heaters, and fans.

Our business is seasonal due to different calendar events, holidays and seasonal weather and illness patterns. Our fiscal reporting period ends on the last day in February. Historically, our highest sales volume and operating income occur in our third fiscal quarter ending November 30th. We purchase our products from unaffiliated manufacturers, most of which are located in China, Mexico, Vietnam and the U.S.

During the second quarter of fiscal 2023, we focused on developing a global restructuring plan intended to expand operating margins through initiatives designed to improve efficiency and reduce costs (referred to as “Project Pegasus”). See Note 8 for additional information.

On April 22, 2022, we completed the acquisition of Recipe Products Ltd., a producer of innovative prestige hair care products for all types of curly and wavy hair under the Curlsmith brand (“Curlsmith”). The total purchase consideration was $147.9 million in cash, net of a final net working capital adjustment and cash acquired. The Curlsmith brand and products were added to the Beauty & Wellness segment. See Note 4 for additional information.

During fiscal 2022 and fiscal 2023, we divested certain assets within our Beauty & Wellness segment's mass channel personal care business, which included liquid, powder and aerosol products under brands such as Pert, Brut, Sure and Infusium (“Personal Care”). On June 7, 2021, we completed the sale of our North America Personal Care business to HRB Brands LLC, for $44.7 million in cash and recognized a gain on the sale in SG&A totaling $0.5 million. On March 25, 2022, we completed the sale of the Latin America and Caribbean Personal Care business to HRB Brands LLC, for $1.8 million in cash and recognized a gain on the sale in SG&A totaling $1.3 million.

Principles of Consolidation

The accompanying condensed consolidated financial statements are prepared in accordance with GAAP and include all of our subsidiaries. Our condensed consolidated financial statements are prepared in U.S. Dollars. All intercompany balances and transactions are eliminated in consolidation.

The preparation of consolidated financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the amounts reported in our condensed consolidated financial statements and accompanying notes. Actual results may differ materially from those estimates.

Reclassifications

We have reclassified or combined certain amounts in the prior year's accompanying footnotes to conform with the current year's presentation.

XML

New Accounting Pronouncements

6 Months Ended

Aug. 31, 2023

Accounting Changes and Error Corrections [Abstract]

New Accounting Pronouncements

Note 2 - New Accounting Pronouncements

Except for the changes discussed below, there have been no changes in the information provided in our Form 10-K.

Adopted

In September 2022, the FASB issued ASU 2022-04, Liabilities—Supplier Finance Programs (Subtopic 405-50): Disclosure of Supplier Finance Program Obligations, which requires a buyer in a supplier finance program to disclose qualitative and quantitative information about its program to allow a user of the financial statements to understand the program’s nature, activity during the period, changes from period to period, and potential magnitude. The amendments in ASU 2022-04 are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2022, with the exception for the amendment on rollforward information, which is effective for fiscal years beginning after December 15, 2023. The guidance should be applied retrospectively, except for the amendment on rollforward information, which should be applied prospectively. This ASU was effective for us in the first quarter of fiscal 2024, with the exception of the amendment on rollforward information, which will be effective for us in our Form 10-K for fiscal 2025. We adopted this ASU during the first quarter of fiscal 2024 and the adoption did not have an impact on our consolidated financial statement disclosures.

In October 2021, the FASB issued ASU 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers, which requires contract assets and contract liabilities acquired in a business combination to be recognized and measured by the acquirer on the acquisition date in accordance with ASC 606, Revenue from Contracts with Customers. Prior to the issuance of this guidance, contract assets and contract liabilities were recognized by the acquirer at fair value on the acquisition date. The amendments in ASU 2021-08 are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2022, and should be applied prospectively to acquisitions occurring on or after the effective date. We adopted this ASU during the first quarter of fiscal 2024 and the adoption did not have an impact on our consolidated financial statements.

XML

Assets Held for Sale

6 Months Ended

Aug. 31, 2023

Discontinued Operations and Disposal Groups [Abstract]

Assets Held for Sale

Note 3 - Assets Held for Sale

On August 29, 2023, we entered into an agreement to sell our distribution and office facilities in El Paso, Texas, which provides for closing subsequent to a due diligence period. Accordingly, we classified the associated property and equipment totaling $17.2 million, net of accumulated depreciation of $36.8 million, as held for sale as of August 31, 2023.

Subsequent to the end of our second quarter of fiscal 2024, on September 28, 2023, we completed the sale of our distribution and office facilities in El Paso, Texas for a sales price of $50.6 million, less transaction costs of $1.1 million. Concurrently, we entered into an agreement to leaseback the office facilities for a period of up to 18 months substantially rent free, which we estimate to have a fair value of approximately $1.9 million. The transaction qualifies for sales recognition under the sale leaseback accounting requirements. Accordingly, we increased the sales price by the $1.9 million of prepaid rent and expect to recognize a gain on the sale of approximately $34.2 million within SG&A during the third quarter of fiscal year 2024, of which approximately $18.0 million and $16.2 million will be recognized by our Beauty & Wellness and Home & Outdoor segments, respectively. The related assets will be derecognized from the consolidated balance sheet, and at lease commencement, we will record an operating lease asset, which includes the imputed rent payments described above, and an operating lease liability. We plan to use the proceeds from the sale to repay amounts outstanding under our long-term debt agreement.

XML

Acquisition of Curlsmith

6 Months Ended

Aug. 31, 2023

Business Combination and Asset Acquisition [Abstract]

Acquisition of Curlsmith

Note 4 - Acquisition of Curlsmith

On April 22, 2022, we completed the acquisition of Recipe Products Ltd., a producer of innovative prestige hair care products for all types of curly and wavy hair under the Curlsmith brand. Curlsmith's products are a category leader in the market for prestige haircare products for curly hair and include conditioners, shampoos and co-washes purposefully designed for the unique joys and challenges of all types of curls and textured hair. The Curlsmith brand and products were added to the Beauty & Wellness segment. The total purchase consideration was $147.9 million in cash, net of a final net working capital adjustment of $2.1 million and cash acquired. The acquisition was funded with cash on hand and borrowings under our existing revolving credit facility. We incurred pre-tax acquisition-related expenses of $2.7 million during the six months ended August 31, 2022, which were recognized in SG&A within our condensed consolidated statement of income.

We accounted for the acquisition as a purchase of a business and recorded the excess of the purchase price over the estimated fair value of the assets acquired and liabilities assumed as goodwill. The goodwill recognized is attributable primarily to expected synergies including leveraging our Beauty & Wellness segment's existing marketing and sales structure, as well as our global sourcing, distribution, shared service, and international go-to-market capabilities. The goodwill is not expected to be deductible for income tax purposes. We have determined the appropriate fair values of the acquired intangible assets and completed our analysis of the economic lives of the assets acquired. We assigned $21.0 million to trade names and are amortizing over a 20 year expected life. We assigned $12.0 million to customer relationships and are amortizing over a 19.5 year expected life, based on historical attrition rates.

During fiscal 2023, we made adjustments to provisional asset and liability balances, which resulted in a corresponding net increase to goodwill of $0.1 million. We also finalized the net working capital adjustment during fiscal 2023, which resulted in a $1.8 million reduction to the total purchase consideration and goodwill. During the first quarter of fiscal 2024, we made final adjustments to provisional liability balances, which resulted in a corresponding increase to goodwill of $0.3 million.

The following table presents the estimated fair values of assets acquired and liabilities assumed at the acquisition date:

(in thousands)
Assets:
Receivables	$	4,211
Inventory	7,890
Prepaid expenses and other current assets	119
Property and equipment	212
Goodwill	117,108
Trade names - definite	21,000
Customer relationships - definite	12,000
Deferred tax assets, net	360
Total assets	162,900
Liabilities:
Accounts payable	1,401
Accrued expenses and other current liabilities	2,813
Income taxes payable	2,572
Deferred tax liabilities, net	8,187
Total liabilities	14,973
Net assets recorded	$	147,927

Both the fair value and gross contractual amount of receivables acquired was $4.2 million, as an immaterial amount was expected to be uncollectible.

The impact of the acquisition of Curlsmith on our condensed consolidated statements of income for the periods presented was as follows:

(in thousands, except earnings per share data)	Three Months Ended August 31, 2022 (1)		Six Months Ended August 31, 2022 (1) (2)
Sales revenue, net	$	10,207	$	13,453
Net income	1,437		1,876
EPS:
Basic	$	0.06	$	0.08
Diluted	$	0.06	$	0.08

(1)Net income and EPS amounts include allocations for corporate expenses, interest expense and income tax expense.

(2)Represents approximately nineteen weeks of operating results from Curlsmith, acquired April 22, 2022.

The following supplemental unaudited pro forma information presents our financial results as if the acquisition of Curlsmith had occurred on March 1, 2021. This supplemental pro forma information has been prepared for comparative purposes and does not necessarily indicate what may have occurred if the acquisition had been completed on March 1, 2021, and this information is not intended to be indicative of future results.

(in thousands, except earnings per share data)	Three Months Ended August 31, 2022		Six Months Ended August 31, 2022
Sales revenue, net	$	521,400	$	1,036,570
Net income	30,672		57,180
EPS:
Basic	$	1.28	$	2.39
Diluted	$	1.28	$	2.37

These amounts have been calculated after applying our accounting policies and adjusting the results of Curlsmith to reflect the effect of definite-lived intangible assets recognized as part of the business combination on amortization expense as if the acquisition had occurred on March 1, 2021.

XML

Accrued Expenses and Other Current Liabilities

6 Months Ended

Aug. 31, 2023

Payables and Accruals [Abstract]

Accrued Expenses and Other Current Liabilities

Note 5 - Accrued Expenses and Other Current Liabilities

A summary of accrued expenses and other current liabilities was as follows:

(in thousands)	August 31, 2023		February 28, 2023
Accrued compensation, benefits and payroll taxes	$	31,947	$	17,380
Accrued sales discounts and allowances	48,908		63,881
Accrued sales returns	23,240		28,498
Accrued advertising	35,112		36,931
Other	56,152		54,028
Total accrued expenses and other current liabilities	$	195,359	$	200,718

XML

Share-Based Compensation Plans

6 Months Ended

Aug. 31, 2023

Share-Based Payment Arrangement [Abstract]

Share-Based Compensation Plans

Note 6 - Share-Based Compensation Plans

As part of our compensation structure, we grant share-based compensation awards to certain employees and non-employee members of our Board of Directors during the fiscal year. These awards may be subject to attainment of certain service conditions, performance conditions and/or market conditions.

During the first quarter of fiscal 2024, we granted 94,807 service condition awards (“Service Condition Awards”) with a weighted average grant date fair value of $110.85. Additionally, we granted 252,522 performance-based awards during the first quarter of fiscal 2024, of which 126,318 contained performance conditions (“Performance Condition Awards”) and 126,204 contained market conditions (“Market Condition Awards”), with weighted average grant date fair values of $110.85 and $80.50, respectively. Refer to our Form 10-K for further information on the Company's share-based compensation plans.

We recorded share-based compensation expense in SG&A as follows:

	Three Months Ended August 31,				Six Months Ended August 31,
(in thousands)	2023		2022		2023		2022
Directors stock compensation	$	196	$	222	$	393	$	395
Service Condition Awards	2,878		2,160		6,198		5,277
Performance Condition Awards	1,113		3,196		3,136		14,041
Market Condition Awards	3,042		1,917		6,189		3,827
Employee stock purchase plan	—		—		610		574
Share-based compensation expense	7,229		7,495		16,526		24,114
Less income tax benefits	(385)		(570)		(1,026)		(1,654)
Share-based compensation expense, net of income tax benefits	$	6,844	$	6,925	$	15,500	$	22,460

Unrecognized Share-Based Compensation Expense

As of August 31, 2023, our total unrecognized share-based compensation for all awards was $32.9 million, which will be recognized over a weighted average amortization period of 2.0 years. The total unrecognized share-based compensation reflects an estimate of target achievement for Performance Condition Awards granted during the first quarter of fiscal 2024, and an estimate of zero percent of target achievement for Performance Condition Awards granted in fiscal 2023 and fiscal 2022.

XML

Repurchases of Common Stock

6 Months Ended

Aug. 31, 2023

Equity [Abstract]

Repurchases of Common Stock

Note 7 - Repurchases of Common Stock

In August 2021, our Board of Directors authorized the repurchase of up to $500 million of our outstanding common stock. The authorization became effective August 25, 2021, for a period of three years, and replaced our former repurchase authorization. As of August 31, 2023, our repurchase authorization allowed for the purchase of $349.1 million of common stock.

Our current equity-based compensation plans include provisions that allow for the “net exercise” of share-settled awards by all plan participants. In a net exercise, any required payroll taxes, federal withholding taxes and exercise price of the shares due from the option or other share-based award holders are settled by having the holder tender back to us a number of shares at fair value equal to the amounts due. Net exercises are treated as purchases and retirements of shares.

The following table summarizes our share repurchase activity for the periods shown:

	Three Months Ended August 31,				Six Months Ended August 31,
(in thousands, except share and per share data)	2023		2022		2023		2022
Common stock repurchased on the open market:
Number of shares	381,200		—		381,200		—
Aggregate value of shares	$	50,006	$	—	$	50,006	$	—
Average price per share	$	131.18	$	—	$	131.18	$	—
Common stock received in connection with share-based compensation:
Number of shares	765		501		45,397		89,959
Aggregate value of shares	$	83	$	81	$	4,529	$	18,305
Average price per share	$	108.00	$	163.28	$	99.75	$	203.49

XML

Restructuring Plan

6 Months Ended

Aug. 31, 2023

Restructuring and Related Activities [Abstract]

Restructuring Plan

Note 8 - Restructuring Plan

During the second quarter of fiscal 2023, we focused on developing Project Pegasus, a global restructuring plan intended to expand operating margins through initiatives designed to improve efficiency and reduce costs. Project Pegasus includes initiatives to further optimize our brand portfolio, streamline and simplify the organization, accelerate cost of goods savings projects, enhance the efficiency of our supply chain network, optimize our indirect spending, and improve our cash flow and working capital, as well as other activities. We anticipate these initiatives will create operating efficiencies, as well as provide a platform to fund future growth investments.

During the fourth quarter of fiscal 2023, we made changes to the structure of our organization in connection with Project Pegasus that resulted in our previous Health & Wellness and Beauty operating segments being combined into a single reportable segment, which is referred to herein as “Beauty & Wellness.” In connection with these organizational structure changes, corresponding changes were made to how our business is managed, how results are reported internally and how our CEO, our chief operating decision maker, assesses performance and allocates resources. We believe that these changes better align internal resources and external go to market activities in order to create a more efficient and effective organizational structure. There were no changes to the products or brands included within our Home & Outdoor reportable segment as part of these organizational changes.

As part of our initiative focused on streamlining and simplifying the organization, we made further changes to the structure of our organization, during the fourth quarter of fiscal 2023, which include the creation of a North America Regional Market Organization (“RMO”) responsible for sales and go to market strategies for all categories and channels in the U.S. and Canada, and further centralization of certain functions under shared services, particularly in operations and finance to better support our business segments and RMOs. This new structure, inclusive of the organizational structure changes described above resulting in the reportable segment change, will reduce the size of our global workforce by approximately 10%. The majority of these role reductions were completed by March 1, 2023. We believe that these changes better focus business segment resources on brand development, consumer-centric innovation and marketing, the RMOs on sales and go to market strategies, and shared services on their respective areas of expertise while also creating a more efficient and effective organizational structure.

During the second quarter of fiscal 2024, we announced plans to geographically consolidate the U.S. Beauty business, currently located in El Paso, Texas, and Irvine, California, and co-locate it with our Wellness business in the Boston, Massachusetts area. This geographical consolidation and relocation is the next step in our initiative to streamline and simplify the organization and it is expected to be

completed during fiscal 2025. We expect these changes will enable a greater opportunity to capture synergies and enhance collaboration and innovation within the Beauty & Wellness segment.

We have updated our expectations regarding Project Pegasus charges. We now estimate lower total one-time pre-tax restructuring charges of approximately $60 million to $65 million over the duration of the plan. We now expect these charges to be completed during fiscal 2025. We previously had estimated total pre-tax restructuring charges of approximately $85 million to $95 million, which was initially expected to be substantially completed by the end of fiscal 2024. In addition, we now have the following expectations regarding Project Pegasus charges:

•Pre-tax restructuring charges to be comprised of approximately $22 million to $25 million of severance and employee related costs, $30 million of professional fees, $5 million of contract termination costs, and $3 million to $5 million of other exit and disposal costs.

•All of our operating segments and shared services will be impacted by the plan and pre-tax restructuring charges include approximately $17 million to $19 million in Home & Outdoor and $43 million to $46 million in Beauty & Wellness.

•Pre-tax restructuring charges represent primarily cash expenditures, which are expected to be substantially paid by the end of fiscal 2025.

We continue to have the following expectations regarding Project Pegasus savings:

•Targeted annualized pre-tax operating profit improvements of approximately $75 million to $85 million, which we expect to substantially begin in fiscal 2024 and be substantially achieved by the end of fiscal 2026.

•Estimated cadence of the recognition of the savings will be approximately 25% in fiscal 2024, approximately 50% in fiscal 2025 and approximately 25% in fiscal 2026.

•Total profit improvements to be realized approximately 60% through reduced cost of goods sold and 40% through lower SG&A.

During the three and six month periods ended August 31, 2023, we incurred $3.6 million and $11.0 million, respectively, of pre-tax restructuring costs in connection with Project Pegasus, which were recorded as “Restructuring charges” in the condensed consolidated statement of income. We recognized $4.8 million of pre-tax restructuring costs during both the three and six month periods ended August 31, 2022 in connection with Project Pegasus.

The following tables summarize restructuring charges recorded as a result of Project Pegasus for the periods presented:

	Three Months Ended August 31, 2023
(in thousands)	Home & Outdoor		Beauty & Wellness		Total
Severance and employee related costs	$	87	$	501	$	588
Professional fees	1,182		1,719		2,901
Contract termination	—		108		108
Other	2		18		20
Total restructuring charges	$	1,271	$	2,346	$	3,617

	Three Months Ended August 31, 2022
(in thousands)	Home & Outdoor		Beauty & Wellness		Total
Severance and employee related costs	$	472	$	2,369	$	2,841
Professional fees	—		128		128
Contract termination	—		1,500		1,500
Other	—		307		307
Total restructuring charges	$	472	$	4,304	$	4,776

	Six Months Ended August 31, 2023						Total Incurred Since Inception
(in thousands)	Home & Outdoor		Beauty & Wellness		Total
Severance and employee related costs	$	571	$	909	$	1,480	$	10,933
Professional fees	3,451		5,076		8,527		25,276
Contract termination	—		796		796		1,331
Other	39		130		169		794
Total restructuring charges	$	4,061	$	6,911	$	10,972	$	38,334

	Six Months Ended August 31, 2022
(in thousands)	Home & Outdoor		Beauty & Wellness		Total
Severance and employee related costs	$	472	$	2,371	$	2,843
Professional fees	—		128		128
Contract termination	—		1,500		1,500
Other	—		307		307
Total restructuring charges	$	472	$	4,306	$	4,778

The tables below present a rollforward of our accruals related to Project Pegasus, which are included in accounts payable and accrued expenses and other current liabilities:

(in thousands)	Balance at February 28, 2023		Charges		Payments		Balance at August 31, 2023
Severance and employee related costs	$	3,173	$	1,480	$	(3,422)	$	1,231
Professional fees	3,201		8,527		(10,635)		1,093
Contract termination	160		796		(956)		—
Other	34		169		(203)		—
Total	$	6,568	$	10,972	$	(15,216)	$	2,324

(in thousands)	Balance at February 28, 2022		Charges		Payments		Balance at August 31, 2022
Severance and employee related costs	$	—	$	2,843	$	(802)	$	2,041
Professional fees	—		128		(128)		—
Contract termination	—		1,500		—		1,500
Other	—		307		(307)		—
Total	$	—	$	4,778	$	(1,237)	$	3,541

XML

Commitments and Contingencies

6 Months Ended

Aug. 31, 2023

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies

Note 9 - Commitments and Contingencies

Legal Matters

We are involved in various legal claims and proceedings in the normal course of operations. We believe the outcome of these matters will not have a material adverse effect on our consolidated financial position, results of operations or liquidity, except as described below.

On December 23, 2021, Brita LP filed a complaint against Kaz USA, Inc. and Helen of Troy Limited in the United States District Court for the Western District of Texas (the “Patent Litigation”), alleging patent infringement by the Company relating to its PUR gravity-fed water filtration systems. In the Patent Litigation, Brita LP seeks monetary damages and injunctive relief relating to the alleged infringement. Brita LP simultaneously filed a complaint with the United States International Trade Commission (“ITC”) against Kaz USA, Inc., Helen of Troy Limited and five other unrelated companies that sell water filtration systems (the “ITC Action”). The complaint in the ITC Action also alleges patent infringement by the Company with respect to a limited set of PUR gravity-fed water filtration systems. In the ITC Action, Brita LP requested the ITC to initiate an unfair import investigation relating to such filtration systems. This

action seeks injunctive relief to prevent entry of certain accused PUR products (and certain other products) into the U.S. and cessation of marketing and sales of existing inventory that is already in the U.S. On January 25, 2022, the ITC instituted the investigation requested by the ITC Action. Discovery closed in the ITC Action in May 2022, and approximately half of the originally identified PUR gravity-fed water filters were removed from the case and are no longer included in the ITC Action. In August 2022, the parties participated in the evidentiary hearing, with additional supplemental hearings in October 2022. On February 28, 2023, the ITC issued an Initial Determination in the ITC Action, tentatively ruling against Kaz USA, Inc. and the other unrelated respondents. The ITC has a guaranteed review process, and thus all respondents, including Kaz USA, Inc., filed a petition with the ITC for a full review of the Initial Determination. On September 19, 2023, the ITC issued its Final Determination in the Company’s favor. The ITC determined there was no violation by the Company and terminated the investigation. The Patent Litigation remains stayed for the time being, but we believe the stay will be lifted in the near future. We cannot predict the outcome of these legal proceedings, the amount or range of any potential loss, when the proceedings will be resolved, or customer acceptance of any replacement water filter. Litigation is inherently unpredictable, and the resolution or disposition of these proceedings could, if adversely determined, have a material and adverse impact on our financial position and results of operations.

Regulatory Matters

Our operations are subject to national, state, local, and provincial jurisdictions’ environmental, health and safety laws and regulations and industry-specific product certifications. Many of the products we sell are subject to product safety laws and regulations in various jurisdictions. These laws and regulations specify the maximum allowable levels of certain materials that may be contained in our products, provide statutory prohibitions against misbranded and adulterated products, establish ingredients and manufacturing procedures for certain products, specify product safety testing requirements, and set product identification, labeling and claim requirements. Some product lines within our Beauty & Wellness segment are subject to product identification, labeling and claim requirements, which are monitored and enforced by regulatory agencies, such as the U.S. Environmental Protection Agency (the “EPA”), U.S. Customs and Border Protection, the U.S. Food and Drug Administration, and the U.S. Consumer Product Safety Commission.

During fiscal 2022, we were in discussions with the EPA regarding the compliance of packaging claims on certain of our products in the air and water filtration categories and a limited subset of humidifier products within the Beauty & Wellness segment that are sold in the U.S. The EPA did not raise any product quality, safety or performance issues. As a result of these packaging compliance discussions, we voluntarily implemented a temporary stop shipment action on the impacted products as we worked with the EPA towards an expedient resolution. We resumed normalized levels of shipping of the affected inventory during fiscal 2022 and we completed the repackaging of our existing inventory of impacted products during fiscal 2023. Additionally, as a result of continuing dialogue with the EPA, we executed further repackaging and relabeling plans on certain additional humidifier products and certain additional air filtration products, which were also completed during fiscal 2023. Although we are not aware of any fines or penalties related to this matter imposed against us by the EPA at this time, there can be no assurances that such fines or penalties will not be imposed in the future.

We recorded charges to cost of goods sold to write-off obsolete packaging for the affected products in our inventory on-hand and in-transit. We have also incurred additional compliance costs comprised of obsolete packaging, storage and other charges from vendors, which were recognized in cost of goods sold and incremental warehouse storage costs and legal fees, which were recognized in SG&A. We refer to these charges as “EPA compliance costs.”

The following table provides a summary of EPA compliance costs incurred during the periods presented:

	Three Months Ended August 31,				Six Months Ended August 31,
(in thousands)	2023		2022		2023		2022
Cost of goods sold	$	—	$	7,103	$	—	$	16,558	1
SG&A	—		1,251		—		3,440
Total EPA compliance costs	$	—	$	8,354	$	—	$	19,998

(1)Includes a $4.4 million charge to write-off the obsolete packaging for the affected additional humidifier products and affected additional air filtration products in our inventory on-hand and in-transit as of the end of the first quarter of fiscal 2023.

In addition, we incurred and capitalized into inventory costs to repackage a portion of our existing inventory of the affected products beginning in the second quarter of fiscal 2022 through completion of the repackaging in the third quarter of fiscal 2023. For additional information refer to Part I, Item 2., “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” including “EPA Compliance Costs”.

Weather-Related Incident

On March 30, 2022, a third-party facility that we utilized for inventory storage incurred severe damage from a weather-related incident. The inventory that was stored at this facility primarily related to our Beauty & Wellness segment. While the inventory was insured, some seasonal inventory and inventory designated for specific customer promotions was not accessible and subsequently determined to be damaged, and as a result, unfavorably impacted our net sales revenue during the first quarter of fiscal 2023. As a result of the damages to the inventory stored at the facility, we recorded a charge to write-off the damaged inventory totaling $34.4 million during the first quarter of fiscal 2023. These charges were fully offset by probable insurance recoveries of $34.4 million also recorded during the first quarter of fiscal 2023, which represented anticipated insurance proceeds, not to exceed the amount of the associated losses, for which receipt was deemed probable. The charges for the damaged inventory and the expected insurance recoveries are included in cost of goods sold in our condensed consolidated statement of income for the six months ended August 31, 2022. During the third and fourth quarters of fiscal 2023, we received proceeds totaling $46.0 million from our insurance carriers related to this incident, which were included in cash flows from operating activities in our condensed consolidated statements of cash flows. As a result, during the third quarter of fiscal 2023, the Company recorded a gain of $9.7 million, net of costs incurred to dispose of the inventory, as a reduction of SG&A expense in our condensed consolidated statement of income.

XML

Long-Term Debt

6 Months Ended

Aug. 31, 2023

Debt Disclosure [Abstract]

Long-Term Debt

Note 10 - Long-Term Debt

A summary of our long-term debt follows:

(in thousands)	August 31, 2023		February 28, 2023
Credit Agreement (1):
Revolving loans	603,000		690,000
Term loans	243,750		246,875
Total borrowings under Credit Agreement	846,750		936,875
Unamortized prepaid financing fees	(1,847)		(2,463)
Total long-term debt	844,903		934,412
Less: current maturities of long-term debt	(6,235)		(6,064)
Long-term debt, excluding current maturities	$	838,668	$	928,348

(1)The weighted average interest rates on borrowings outstanding under the Credit Agreement (defined below) as of August 31, 2023 and February 28, 2023 were 7.1% and 6.6%, respectively.

Capitalized Interest

During the three month period ended August 31, 2023, we incurred interest costs totaling $13.7 million, of which none was capitalized, compared to $10.1 million for the same period last year, of which we capitalized $0.9 million as part of property and equipment in connection with the construction of a new distribution facility. During the six month periods ended August 31, 2023 and August 31, 2022, we incurred interest costs totaling $28.6 million and $15.2 million, respectively, of which we capitalized $0.9 million and $1.6 million, respectively, in connection with the previously mentioned distribution facility.

Credit Agreement

We have a credit agreement (the “Credit Agreement”) with Bank of America, N.A., as administrative agent, and other lenders that provides for an unsecured total revolving commitment of $1.25 billion and a $300 million accordion, which can be used for term loan commitments. In June 2022, we exercised $250 million of the $300 million accordion under the Credit Agreement and borrowed $250 million as term loans. The proceeds from the term loans were used to repay revolving loans under the Credit Agreement. The term loans are payable at the end of each fiscal quarter in equal installments of 0.625% of the term loans made, which began in the third quarter of fiscal 2023, with the remaining balance due at the maturity date. The maturity date of the term loans and the revolving loans under the Credit Agreement is March 13, 2025. Borrowings under the Credit Agreement bear floating interest at either the Base Rate or Term SOFR (as defined in the Credit Agreement), plus a margin based on the Net Leverage Ratio (as defined in the Credit Agreement) of 0% to 1.0% and 1.0% to 2.0% for Base Rate and Term SOFR borrowings, respectively, plus a credit spread of 0.10% for Term SOFR borrowings.

The floating interest rates on our borrowings under the Credit Agreement are hedged with interest rate swaps to effectively fix interest rates on $625 million and $425 million of the outstanding principal balance under the revolving loans as of August 31, 2023 and February 28, 2023, respectively. See Notes 11, 12, and 13 for additional information regarding our interest rate swaps.

As of August 31, 2023, the balance of outstanding letters of credit was $17.8 million and the amount available for revolving loans under the Credit Agreement was $629.2 million. Covenants in the Credit Agreement limit the amount of total indebtedness we can incur. As of August 31, 2023, these covenants effectively limited our ability to incur more than $231.1 million of additional debt from all sources, including the Credit Agreement, or $465.8 million in the event a qualified acquisition is consummated.

Debt Covenants

As of August 31, 2023, we were in compliance with all covenants as defined under the terms of the Credit Agreement.

XML

Fair Value

6 Months Ended

Aug. 31, 2023

Fair Value Disclosures [Abstract]

Fair Value

Note 11 - Fair Value 

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Valuation techniques under the accounting guidance related to fair value measurements are based on observable and unobservable inputs. These inputs are classified into the following hierarchy:

Level 1:Quoted prices for identical assets or liabilities in active markets;

Level 2:Observable inputs other than quoted prices that are directly or indirectly observable for the asset or liability, including quoted prices for similar assets or liabilities in active markets; quoted prices for similar or identical assets or liabilities in markets that are not active; and model-derived valuations whose inputs are observable or whose significant value drivers are observable; and

Level 3:Unobservable inputs that reflect the reporting entity’s own assumptions.

Our financial assets and liabilities are classified as Level 2 because their valuation is dependent on observable inputs and other quoted prices for similar assets or liabilities, or model-derived valuations whose significant value drivers are observable. The following table presents the carrying amount and fair value of our financial assets and liabilities measured and recorded at fair value on a recurring basis and classified as Level 2:

	Carrying Amount and Fair Value
(in thousands)	August 31, 2023		February 28, 2023
Assets:
Cash equivalents (money market accounts)	$	469	$	381
Interest rate swaps	5,322		5,746
Foreign currency derivatives	617		1,423
Total assets	$	6,408	$	7,550
Liabilities:
Foreign currency derivatives	1,153		711
Total liabilities	$	1,153	$	711

The carrying amounts of cash, accounts payable, accrued expenses and other current liabilities and income taxes payable approximate fair value because of the short maturity of these items. The carrying amounts of receivables approximate fair value due to the effect of the related allowance for credit losses. The carrying amount of our floating rate long-term debt approximates its fair value.

We use derivatives to manage our exposure to changes in foreign currency exchange rates, which include foreign currency forward contracts and cross-currency debt swaps. In addition, we use interest rate swaps to manage our exposure to changes in interest rates. All of our derivative assets and liabilities are recorded at fair value. See Notes 12 and 13 for more information on our derivatives.

XML

Financial Instruments and Risk Management

6 Months Ended

Aug. 31, 2023

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Financial Instruments and Risk Management

Note 12 - Financial Instruments and Risk Management

Foreign Currency Risk

The U.S. Dollar is the functional currency for the Company and all of its subsidiaries and is also the reporting currency for the Company. By operating internationally, we are subject to foreign currency risk from transactions denominated in currencies other than the U.S. Dollar (“foreign currencies”). Such transactions include sales and operating expenses. As a result of such transactions, portions of our cash, trade accounts receivable and trade accounts payable are denominated in foreign currencies. Approximately 12% and 14% of our net sales revenue was denominated in foreign currencies during the three and six month periods ended August 31, 2023, respectively, compared to 12% for both of the same periods last year. These sales were primarily denominated in Euros, British Pounds and Canadian Dollars. We make most of our inventory purchases from manufacturers in Asia and primarily use the U.S. Dollar for such purchases.

During the three and six month periods ended August 31, 2023, we recorded foreign currency exchange rate net losses of $0.8 million and $0.4 million, respectively, in SG&A, compared to net losses of $2.7 million and $2.5 million, respectively, for the same periods last year. We mitigate certain foreign currency exchange rate risk by using forward contracts and cross-currency debt swaps to protect against the foreign currency exchange rate risk inherent in our transactions denominated in foreign currencies. We do not enter into any derivatives or similar instruments for trading or other speculative purposes. Certain of our forward contracts are designated as cash flow hedges (“foreign currency contracts”) and are recorded on the balance sheet at fair value with changes in fair value recorded in Other Comprehensive Income (Loss) (“OCI”) until the hedge transaction is settled, at which point amounts are reclassified from Accumulated Other Comprehensive Income (Loss) (“AOCI”) to our condensed consolidated statements of income. Foreign currency derivatives for which we have not elected hedge accounting consist of certain forward contracts and cross-currency debt swaps, and any changes in the fair value of these derivatives are recorded in our condensed consolidated statements of income. These undesignated derivatives are used to hedge monetary net asset and liability positions. Cash flows from our foreign currency derivatives are classified as cash flows from operating activities in our condensed consolidated statements of cash flows, which is consistent with the classification of the cash flows from the underlying hedged item. We evaluate our derivatives designated as cash flow hedges each quarter to assess hedge effectiveness.

Interest Rate Risk

Interest on our outstanding debt as of August 31, 2023 is based on floating interest rates. If short-term interest rates increase, we will incur higher interest expense on any future outstanding balances of floating rate debt. Floating interest rates are hedged with interest rate swaps to effectively fix interest rates on a portion of our outstanding principal balance under the Credit Agreement, which totaled $846.8 million and $936.9 million as of August 31, 2023 and February 28, 2023, respectively. As of August 31, 2023 and February 28, 2023, $625.0 million and $425.0 million of the outstanding principal balance under the Credit Agreement, respectively, was hedged with interest rate swaps to fix the interest rate we pay. Our interest rate swaps are designated as cash flow hedges and are recorded on the balance sheet at fair value with changes in fair value recorded in OCI until the hedge transaction is settled, at which point amounts are reclassified from AOCI to our condensed consolidated statements of income. Cash flows from our interest rate swaps are classified as cash flows from operating activities in our condensed consolidated statements of cash flows, which is consistent with the classification of the cash flows from the underlying hedged item. We evaluate our derivatives designated as cash flow hedges each quarter to assess hedge effectiveness.

The following tables summarize the fair values of our derivative instruments as of the end of the periods presented:

(in thousands)	August 31, 2023
Derivatives designated as hedging instruments	Hedge Type	Final Settlement Date	Notional Amount		Prepaid Expenses and Other Current Assets		Other Assets		Accrued Expenses and Other Current Liabilities		Other Liabilities, Non- Current
Forward contracts - sell Euro	Cash flow	2/2024	€	21,500	$	67	$	—	$	165	$	—
Forward contracts - sell Canadian Dollars	Cash flow	12/2024	$	25,250	370		77		—		—
Forward contracts - sell Pounds	Cash flow	2/2024	£	20,925	—		—		949		—
Forward contracts - sell Norwegian Kroner	Cash flow	2/2024	kr	20,000	103		—		—		—
Interest rate swaps	Cash flow	2/2026	$	625,000	3,582		1,740		—		—
Subtotal					4,122		1,817		1,114		—
Derivatives not designated under hedge accounting
Forward contracts - buy Euro	(1)	9/2023	€	2,200	—		—		33		—
Forward contracts - buy Pounds	(1)	9/2023	£	1,100	—		—		6		—
Subtotal					—		—		39		—
Total fair value					$	4,122	$	1,817	$	1,153	$	—

(in thousands)	February 28, 2023
Derivatives designated as hedging instruments	Hedge Type	Final Settlement Date	Notional Amount		Prepaid Expenses and Other Current Assets		Other Assets		Accrued Expenses and Other Current Liabilities		Other Liabilities Non- Current
Forward contracts - sell Euro	Cash flow	2/2024	€	29,310	$	257	$	—	$	—	$	—
Forward contracts - sell Canadian Dollars	Cash flow	2/2024	$	30,000	962		11		—		—
Forward contracts - sell Pounds	Cash flow	1/2024	£	19,400	—		—		711		—
Forward contracts - sell Norwegian Kroner	Cash flow	2/2024	kr	40,000	185		—		—		—
Interest rate swaps	Cash flow	2/2026	$	425,000	3,941		1,805		—		—
Subtotal					5,345		1,816		711		—
Derivatives not designated under hedge accounting
Forward contracts - buy Euro	(1)	3/2023	€	500	6		—		—		—
Forward contracts - buy Pounds	(1)	3/2023	£	400	2		—		—		—
Subtotal					8		—		—		—
Total fair value					$	5,353	$	1,816	$	711	$	—

(1)These forward contracts, for which we have not elected hedge accounting, hedge monetary net asset and liability positions for the notional amounts reported, creating an economic hedge against currency movements.

The pre-tax effects of derivative instruments designated as cash flow hedges were as follows for the periods presented:

	Three Months Ended August 31,
	Gain (Loss) Recognized in AOCI				Gain (Loss) Reclassified from AOCI into Income
(in thousands)	2023		2022		Location	2023		2022
Foreign currency contracts - cash flow hedges	$	(779)	$	6,226	Sales revenue, net	$	(383)	$	2,715
Interest rate swaps - cash flow hedges	5,644		1,423		Interest expense	2,027		(281)
Total	$	4,865	$	7,649		$	1,644	$	2,434

	Six Months Ended August 31,
	Gain (Loss) Recognized in AOCI				Gain (Loss) Reclassified from AOCI into Income
(in thousands)	2023		2022		Location	2023		2022
Foreign currency contracts - cash flow hedges	$	(1,246)	$	8,545	Sales revenue, net	$	(45)	$	3,911
Interest rate swaps - cash flow hedges	3,010		3,629		Interest expense	3,434		(961)
Total	$	1,764	$	12,174		$	3,389	$	2,950

The pre-tax effects of derivative instruments not designated under hedge accounting were as follows for the periods presented:

	Gain (Loss)  Recognized in Income
		Three Months Ended August 31,				Six Months Ended August 31,
(in thousands)	Location	2023		2022		2023		2022
Forward contracts	SG&A	$	(16)	$	(250)	$	(40)	$	(250)
Cross-currency debt swaps - principal	SG&A	—		—		—		875
Total		$	(16)	$	(250)	$	(40)	$	625

We expect a net gain of $3.0 million associated with foreign currency contracts and interest rate swaps currently recorded in AOCI to be reclassified into income over the next twelve months. The amount ultimately realized, however, will differ as exchange rates and interest rates change and the underlying contracts settle. See Notes 11 and 13 to these condensed consolidated financial statements for more information.

Counterparty Credit Risk

Financial instruments, including foreign currency contracts, forward contracts, cross-currency debt swaps and interest rate swaps, expose us to counterparty credit risk for non-performance. We manage our exposure to counterparty credit risk by only dealing with counterparties who are substantial international financial institutions with significant experience using such derivative instruments. We believe that the risk of incurring credit losses is remote.

XML

Accumulated Other Comprehensive Income (Loss)

6 Months Ended

Aug. 31, 2023

Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]

Accumulated Other Comprehensive Income (Loss)

Note 13 - Accumulated Other Comprehensive Income (Loss)

The changes in AOCI by component and related tax effects for the periods presented were as follows:

(in thousands)	Interest Rate Swaps		Foreign Currency Contracts		Total
Balance at February 28, 2022	$	(2,126)	$	2,328	$	202
Other comprehensive income before reclassification	3,629		8,545		12,174
Amounts reclassified out of AOCI	961		(3,911)		(2,950)
Tax effects	(1,083)		(1,143)		(2,226)
Other comprehensive income	3,507		3,491		6,998
Balance at August 31, 2022	$	1,381	$	5,819	$	7,200
Balance at February 28, 2023	$	4,394	$	553	$	4,947
Other comprehensive income (loss) before reclassification	3,010		(1,246)		1,764
Amounts reclassified out of AOCI	(3,434)		45		(3,389)
Tax effects	100		264		364
Other comprehensive loss	(324)		(937)		(1,261)
Balance at August 31, 2023	$	4,070	$	(384)	$	3,686

See Notes 10, 11 and 12 to these condensed consolidated financial statements for additional information regarding our cash flow hedges.

XML

Segment Information

6 Months Ended

Aug. 31, 2023

Segment Reporting [Abstract]

Segment Information

Note 14 - Segment Information

We currently operate two reportable segments consisting of Home & Outdoor and Beauty & Wellness. During the fourth quarter of fiscal 2023, we made changes to the structure of our organization in connection with our global restructuring plan that resulted in our previous Health & Wellness and Beauty operating segments being combined into a single reportable segment, which is referred to herein as “Beauty & Wellness.” Comparative prior period segment information in this report has been recast to conform to this change in our reportable segments. See Note 1 to these condensed consolidated financial statements for additional information.

The following tables summarize segment information for the periods presented:

	Three Months Ended August 31, 2023
(in thousands)	Home & Outdoor		Beauty & Wellness		Total
Sales revenue, net	$	239,977	$	251,586	$	491,563
Restructuring charges	1,271		2,346		3,617
Operating income	36,099		10,746		46,845
Capital and intangible asset expenditures	4,879		3,801		8,680
Depreciation and amortization	6,606		7,285		13,891

	Three Months Ended August 31, 2022
(in thousands)	Home & Outdoor		Beauty & Wellness		Total
Sales revenue, net	$	240,559	$	280,841	$	521,400
Restructuring charges	472		4,304		4,776
Operating income	42,082		4,864		46,946
Capital and intangible asset expenditures	32,420		4,013		36,433
Depreciation and amortization	4,493		6,626		11,119

	Six Months Ended August 31, 2023
(in thousands)	Home & Outdoor		Beauty & Wellness		Total
Sales revenue, net	$	457,121	$	509,114	$	966,235
Restructuring charges	4,061		6,911		10,972
Operating income	58,215		29,271		87,486
Capital and intangible asset expenditures	15,839		4,718		20,557
Depreciation and amortization	11,008		13,598		24,606

	Six Months Ended August 31, 2022
(in thousands)	Home & Outdoor		Beauty & Wellness		Total
Sales revenue, net	$	474,822	$	554,656	$	1,029,478
Restructuring charges	472		4,306		4,778
Operating income	71,875		9,010		80,885
Capital and intangible asset expenditures	105,151		7,484		112,635
Depreciation and amortization	8,988		12,629		21,617

The following table presents net sales revenue by geographic region, in U.S. Dollars:

	Three Months Ended August 31,								Six Months Ended August 31,
(in thousands)	2023				2022				2023				2022
Domestic sales revenue, net (1)	$	388,049	78.9	%	$	419,905	80.5	%	$	747,608	77.4	%	$	816,651	79.3	%
International sales revenue, net	103,514		21.1	%	101,495		19.5	%	218,627		22.6	%	212,827		20.7	%
Total sales revenue, net	$	491,563	100.0	%	$	521,400	100.0	%	$	966,235	100.0	%	$	1,029,478	100.0	%

(1)Beginning in the fourth quarter of fiscal 2023, we included net sales revenue from the U.S. and Canada as domestic net sales revenue. Previously, we reported sales revenue from Canada within international net sales revenue. We have recast the prior period domestic and international net sales revenue presented to conform with this current presentation.

XML

Income Taxes

6 Months Ended

Aug. 31, 2023

Income Tax Disclosure [Abstract]

Income Taxes

Note 15 - Income Taxes

We reorganized the Company in Bermuda in 1994 and many of our foreign subsidiaries are not directly or indirectly owned by a U.S. parent. As such, a large portion of our foreign income is not subject to U.S. taxation on a permanent basis under current law. Additionally, our intellectual property is largely owned by foreign subsidiaries, resulting in proportionally higher earnings in jurisdictions with lower statutory tax rates, which decreases our overall effective tax rate. The taxable income earned in each jurisdiction, whether U.S. or foreign, is determined by the subsidiary's operating results and transfer pricing and tax regulations in the related jurisdictions.

For interim periods, our income tax expense and resulting effective tax rate are based upon an estimated annual effective tax rate adjusted for the effects of items required to be treated as discrete to the period, including changes in tax laws, changes in estimated exposures for uncertain tax positions and other items.

For the three months ended August 31, 2023, income tax expense as a percentage of income before income tax was 17.9% compared to 19.1% for the same period last year. The year-over-year decrease in the effective tax rate is primarily due to a decrease in tax expense for discrete items, partially offset by shifts in the mix of income in our various tax jurisdictions. For the six months ended August 31, 2023, income tax expense as a percentage of income before income tax was 16.8% compared to 18.2% for the same period last year primarily due to a decrease in tax expense for discrete items, partially offset by shifts in the mix of income in our various tax jurisdictions.

XML

Earnings Per Share

6 Months Ended

Aug. 31, 2023

Earnings Per Share [Abstract]

Earnings Per Share

Note 16 - Earnings Per Share

We compute basic earnings per share using the weighted average number of shares of common stock outstanding during the period. We compute diluted earnings per share using the weighted average number of shares of common stock outstanding plus the effect of dilutive securities. Dilutive securities at any given point in time may consist of outstanding options to purchase common stock and issued and contingently issuable unvested restricted stock units, performance stock units, restricted stock awards and performance restricted stock awards and other stock-based awards. Anti-dilutive securities are not included in the computation of diluted earnings per share under the treasury stock method. See Note 6 to these condensed consolidated financial statements for more information regarding stock-based awards.

The following table presents our weighted average basic and diluted shares outstanding for the periods shown:

	Three Months Ended August 31,		Six Months Ended August 31,
(in thousands)	2023	2022	2023	2022
Weighted average shares outstanding, basic	23,918	23,969	23,984	23,917
Incremental shares from share-based compensation arrangements	123	87	104	172
Weighted average shares outstanding, diluted	24,041	24,056	24,088	24,089
Anti-dilutive securities	7	54	81	42

XML

Pay vs Performance Disclosure - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Aug. 31, 2023	Aug. 31, 2022	Aug. 31, 2023	Aug. 31, 2022
Pay vs Performance Disclosure
Net income	$ 27,381	$ 30,672	$ 49,962	$ 55,267

XML

Insider Trading Arrangements	3 Months Ended
	Aug. 31, 2023
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

XML

Basis of Presentation and Related Information (Policies)

6 Months Ended

Aug. 31, 2023

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Principles of Consolidation

Principles of Consolidation

The accompanying condensed consolidated financial statements are prepared in accordance with GAAP and include all of our subsidiaries. Our condensed consolidated financial statements are prepared in U.S. Dollars. All intercompany balances and transactions are eliminated in consolidation.

The preparation of consolidated financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the amounts reported in our condensed consolidated financial statements and accompanying notes. Actual results may differ materially from those estimates.

Reclassifications

Reclassifications

We have reclassified or combined certain amounts in the prior year's accompanying footnotes to conform with the current year's presentation.

New Accounting Pronouncements, Adopted

Adopted

In September 2022, the FASB issued ASU 2022-04, Liabilities—Supplier Finance Programs (Subtopic 405-50): Disclosure of Supplier Finance Program Obligations, which requires a buyer in a supplier finance program to disclose qualitative and quantitative information about its program to allow a user of the financial statements to understand the program’s nature, activity during the period, changes from period to period, and potential magnitude. The amendments in ASU 2022-04 are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2022, with the exception for the amendment on rollforward information, which is effective for fiscal years beginning after December 15, 2023. The guidance should be applied retrospectively, except for the amendment on rollforward information, which should be applied prospectively. This ASU was effective for us in the first quarter of fiscal 2024, with the exception of the amendment on rollforward information, which will be effective for us in our Form 10-K for fiscal 2025. We adopted this ASU during the first quarter of fiscal 2024 and the adoption did not have an impact on our consolidated financial statement disclosures.

In October 2021, the FASB issued ASU 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers, which requires contract assets and contract liabilities acquired in a business combination to be recognized and measured by the acquirer on the acquisition date in accordance with ASC 606, Revenue from Contracts with Customers. Prior to the issuance of this guidance, contract assets and contract liabilities were recognized by the acquirer at fair value on the acquisition date. The amendments in ASU 2021-08 are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2022, and should be applied prospectively to acquisitions occurring on or after the effective date. We adopted this ASU during the first quarter of fiscal 2024 and the adoption did not have an impact on our consolidated financial statements.

XML

Acquisition of Curlsmith (Tables)

6 Months Ended

Aug. 31, 2023

Business Combination and Asset Acquisition [Abstract]

Schedule of business acquisitions, by acquisition

The following table presents the estimated fair values of assets acquired and liabilities assumed at the acquisition date:

(in thousands)
Assets:
Receivables	$	4,211
Inventory	7,890
Prepaid expenses and other current assets	119
Property and equipment	212
Goodwill	117,108
Trade names - definite	21,000
Customer relationships - definite	12,000
Deferred tax assets, net	360
Total assets	162,900
Liabilities:
Accounts payable	1,401
Accrued expenses and other current liabilities	2,813
Income taxes payable	2,572
Deferred tax liabilities, net	8,187
Total liabilities	14,973
Net assets recorded	$	147,927

Business acquisition, pro forma information

The impact of the acquisition of Curlsmith on our condensed consolidated statements of income for the periods presented was as follows:

(in thousands, except earnings per share data)	Three Months Ended August 31, 2022 (1)		Six Months Ended August 31, 2022 (1) (2)
Sales revenue, net	$	10,207	$	13,453
Net income	1,437		1,876
EPS:
Basic	$	0.06	$	0.08
Diluted	$	0.06	$	0.08

(1)Net income and EPS amounts include allocations for corporate expenses, interest expense and income tax expense.

(2)Represents approximately nineteen weeks of operating results from Curlsmith, acquired April 22, 2022.

The following supplemental unaudited pro forma information presents our financial results as if the acquisition of Curlsmith had occurred on March 1, 2021. This supplemental pro forma information has been prepared for comparative purposes and does not necessarily indicate what may have occurred if the acquisition had been completed on March 1, 2021, and this information is not intended to be indicative of future results.

(in thousands, except earnings per share data)	Three Months Ended August 31, 2022		Six Months Ended August 31, 2022
Sales revenue, net	$	521,400	$	1,036,570
Net income	30,672		57,180
EPS:
Basic	$	1.28	$	2.39
Diluted	$	1.28	$	2.37

XML

Accrued Expenses and Other Current Liabilities (Tables)

6 Months Ended

Aug. 31, 2023

Payables and Accruals [Abstract]

Schedule of accrued expenses and other current liabilities

A summary of accrued expenses and other current liabilities was as follows:

(in thousands)	August 31, 2023		February 28, 2023
Accrued compensation, benefits and payroll taxes	$	31,947	$	17,380
Accrued sales discounts and allowances	48,908		63,881
Accrued sales returns	23,240		28,498
Accrued advertising	35,112		36,931
Other	56,152		54,028
Total accrued expenses and other current liabilities	$	195,359	$	200,718

XML

Share-Based Compensation Plans (Tables)

6 Months Ended

Aug. 31, 2023

Share-Based Payment Arrangement [Abstract]

Share-based compensation expense in SG&A

We recorded share-based compensation expense in SG&A as follows:

	Three Months Ended August 31,				Six Months Ended August 31,
(in thousands)	2023		2022		2023		2022
Directors stock compensation	$	196	$	222	$	393	$	395
Service Condition Awards	2,878		2,160		6,198		5,277
Performance Condition Awards	1,113		3,196		3,136		14,041
Market Condition Awards	3,042		1,917		6,189		3,827
Employee stock purchase plan	—		—		610		574
Share-based compensation expense	7,229		7,495		16,526		24,114
Less income tax benefits	(385)		(570)		(1,026)		(1,654)
Share-based compensation expense, net of income tax benefits	$	6,844	$	6,925	$	15,500	$	22,460

XML

Repurchases of Common Stock (Tables)

6 Months Ended

Aug. 31, 2023

Equity [Abstract]

Summary of share repurchase activity

The following table summarizes our share repurchase activity for the periods shown:

	Three Months Ended August 31,				Six Months Ended August 31,
(in thousands, except share and per share data)	2023		2022		2023		2022
Common stock repurchased on the open market:
Number of shares	381,200		—		381,200		—
Aggregate value of shares	$	50,006	$	—	$	50,006	$	—
Average price per share	$	131.18	$	—	$	131.18	$	—
Common stock received in connection with share-based compensation:
Number of shares	765		501		45,397		89,959
Aggregate value of shares	$	83	$	81	$	4,529	$	18,305
Average price per share	$	108.00	$	163.28	$	99.75	$	203.49

XML

Restructuring Plan (Tables)

6 Months Ended

Aug. 31, 2023

Restructuring and Related Activities [Abstract]

Summary of restructuring charges recorded

The following tables summarize restructuring charges recorded as a result of Project Pegasus for the periods presented:

	Three Months Ended August 31, 2023
(in thousands)	Home & Outdoor		Beauty & Wellness		Total
Severance and employee related costs	$	87	$	501	$	588
Professional fees	1,182		1,719		2,901
Contract termination	—		108		108
Other	2		18		20
Total restructuring charges	$	1,271	$	2,346	$	3,617

	Three Months Ended August 31, 2022
(in thousands)	Home & Outdoor		Beauty & Wellness		Total
Severance and employee related costs	$	472	$	2,369	$	2,841
Professional fees	—		128		128
Contract termination	—		1,500		1,500
Other	—		307		307
Total restructuring charges	$	472	$	4,304	$	4,776

	Six Months Ended August 31, 2023						Total Incurred Since Inception
(in thousands)	Home & Outdoor		Beauty & Wellness		Total
Severance and employee related costs	$	571	$	909	$	1,480	$	10,933
Professional fees	3,451		5,076		8,527		25,276
Contract termination	—		796		796		1,331
Other	39		130		169		794
Total restructuring charges	$	4,061	$	6,911	$	10,972	$	38,334

	Six Months Ended August 31, 2022
(in thousands)	Home & Outdoor		Beauty & Wellness		Total
Severance and employee related costs	$	472	$	2,371	$	2,843
Professional fees	—		128		128
Contract termination	—		1,500		1,500
Other	—		307		307
Total restructuring charges	$	472	$	4,306	$	4,778

Rollforward of restructuring reserve

The tables below present a rollforward of our accruals related to Project Pegasus, which are included in accounts payable and accrued expenses and other current liabilities:

(in thousands)	Balance at February 28, 2023		Charges		Payments		Balance at August 31, 2023
Severance and employee related costs	$	3,173	$	1,480	$	(3,422)	$	1,231
Professional fees	3,201		8,527		(10,635)		1,093
Contract termination	160		796		(956)		—
Other	34		169		(203)		—
Total	$	6,568	$	10,972	$	(15,216)	$	2,324

(in thousands)	Balance at February 28, 2022		Charges		Payments		Balance at August 31, 2022
Severance and employee related costs	$	—	$	2,843	$	(802)	$	2,041
Professional fees	—		128		(128)		—
Contract termination	—		1,500		—		1,500
Other	—		307		(307)		—
Total	$	—	$	4,778	$	(1,237)	$	3,541

XML

Commitments and Contingencies (Tables)

6 Months Ended

Aug. 31, 2023

Commitments and Contingencies Disclosure [Abstract]

Schedule of production related impairments

We refer to these charges as “EPA compliance costs.”

The following table provides a summary of EPA compliance costs incurred during the periods presented:

	Three Months Ended August 31,				Six Months Ended August 31,
(in thousands)	2023		2022		2023		2022
Cost of goods sold	$	—	$	7,103	$	—	$	16,558	1
SG&A	—		1,251		—		3,440
Total EPA compliance costs	$	—	$	8,354	$	—	$	19,998

(1)Includes a $4.4 million charge to write-off the obsolete packaging for the affected additional humidifier products and affected additional air filtration products in our inventory on-hand and in-transit as of the end of the first quarter of fiscal 2023.

XML

Long-Term Debt (Tables)

6 Months Ended

Aug. 31, 2023

Debt Disclosure [Abstract]

Summary of long-term debt

A summary of our long-term debt follows:

(in thousands)	August 31, 2023		February 28, 2023
Credit Agreement (1):
Revolving loans	603,000		690,000
Term loans	243,750		246,875
Total borrowings under Credit Agreement	846,750		936,875
Unamortized prepaid financing fees	(1,847)		(2,463)
Total long-term debt	844,903		934,412
Less: current maturities of long-term debt	(6,235)		(6,064)
Long-term debt, excluding current maturities	$	838,668	$	928,348

(1)The weighted average interest rates on borrowings outstanding under the Credit Agreement (defined below) as of August 31, 2023 and February 28, 2023 were 7.1% and 6.6%, respectively.

XML

Fair Value (Tables)

6 Months Ended

Aug. 31, 2023

Fair Value Disclosures [Abstract]

Schedule of carrying value and fair value of financial assets and liabilities recorded at fair value and measured on a recurring basis and classified as level 2

The following table presents the carrying amount and fair value of our financial assets and liabilities measured and recorded at fair value on a recurring basis and classified as Level 2:

	Carrying Amount and Fair Value
(in thousands)	August 31, 2023		February 28, 2023
Assets:
Cash equivalents (money market accounts)	$	469	$	381
Interest rate swaps	5,322		5,746
Foreign currency derivatives	617		1,423
Total assets	$	6,408	$	7,550
Liabilities:
Foreign currency derivatives	1,153		711
Total liabilities	$	1,153	$	711

XML

Financial Instruments and Risk Management (Tables)

6 Months Ended

Aug. 31, 2023

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Schedule of fair values of derivative instruments

The following tables summarize the fair values of our derivative instruments as of the end of the periods presented:

(in thousands)	August 31, 2023
Derivatives designated as hedging instruments	Hedge Type	Final Settlement Date	Notional Amount		Prepaid Expenses and Other Current Assets		Other Assets		Accrued Expenses and Other Current Liabilities		Other Liabilities, Non- Current
Forward contracts - sell Euro	Cash flow	2/2024	€	21,500	$	67	$	—	$	165	$	—
Forward contracts - sell Canadian Dollars	Cash flow	12/2024	$	25,250	370		77		—		—
Forward contracts - sell Pounds	Cash flow	2/2024	£	20,925	—		—		949		—
Forward contracts - sell Norwegian Kroner	Cash flow	2/2024	kr	20,000	103		—		—		—
Interest rate swaps	Cash flow	2/2026	$	625,000	3,582		1,740		—		—
Subtotal					4,122		1,817		1,114		—
Derivatives not designated under hedge accounting
Forward contracts - buy Euro	(1)	9/2023	€	2,200	—		—		33		—
Forward contracts - buy Pounds	(1)	9/2023	£	1,100	—		—		6		—
Subtotal					—		—		39		—
Total fair value					$	4,122	$	1,817	$	1,153	$	—

(in thousands)	February 28, 2023
Derivatives designated as hedging instruments	Hedge Type	Final Settlement Date	Notional Amount		Prepaid Expenses and Other Current Assets		Other Assets		Accrued Expenses and Other Current Liabilities		Other Liabilities Non- Current
Forward contracts - sell Euro	Cash flow	2/2024	€	29,310	$	257	$	—	$	—	$	—
Forward contracts - sell Canadian Dollars	Cash flow	2/2024	$	30,000	962		11		—		—
Forward contracts - sell Pounds	Cash flow	1/2024	£	19,400	—		—		711		—
Forward contracts - sell Norwegian Kroner	Cash flow	2/2024	kr	40,000	185		—		—		—
Interest rate swaps	Cash flow	2/2026	$	425,000	3,941		1,805		—		—
Subtotal					5,345		1,816		711		—
Derivatives not designated under hedge accounting
Forward contracts - buy Euro	(1)	3/2023	€	500	6		—		—		—
Forward contracts - buy Pounds	(1)	3/2023	£	400	2		—		—		—
Subtotal					8		—		—		—
Total fair value					$	5,353	$	1,816	$	711	$	—

(1)These forward contracts, for which we have not elected hedge accounting, hedge monetary net asset and liability positions for the notional amounts reported, creating an economic hedge against currency movements.

Schedule of pre-tax effect of derivative instruments designated as hedges

The pre-tax effects of derivative instruments designated as cash flow hedges were as follows for the periods presented:

	Three Months Ended August 31,
	Gain (Loss) Recognized in AOCI				Gain (Loss) Reclassified from AOCI into Income
(in thousands)	2023		2022		Location	2023		2022
Foreign currency contracts - cash flow hedges	$	(779)	$	6,226	Sales revenue, net	$	(383)	$	2,715
Interest rate swaps - cash flow hedges	5,644		1,423		Interest expense	2,027		(281)
Total	$	4,865	$	7,649		$	1,644	$	2,434

	Six Months Ended August 31,
	Gain (Loss) Recognized in AOCI				Gain (Loss) Reclassified from AOCI into Income
(in thousands)	2023		2022		Location	2023		2022
Foreign currency contracts - cash flow hedges	$	(1,246)	$	8,545	Sales revenue, net	$	(45)	$	3,911
Interest rate swaps - cash flow hedges	3,010		3,629		Interest expense	3,434		(961)
Total	$	1,764	$	12,174		$	3,389	$	2,950

Schedule of pre-tax effect of derivative instruments not designated as hedges

The pre-tax effects of derivative instruments not designated under hedge accounting were as follows for the periods presented:

	Gain (Loss)  Recognized in Income
		Three Months Ended August 31,				Six Months Ended August 31,
(in thousands)	Location	2023		2022		2023		2022
Forward contracts	SG&A	$	(16)	$	(250)	$	(40)	$	(250)
Cross-currency debt swaps - principal	SG&A	—		—		—		875
Total		$	(16)	$	(250)	$	(40)	$	625

XML

Accumulated Other Comprehensive Income (Loss) (Tables)

6 Months Ended

Aug. 31, 2023

Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]

Summary of changes in accumulated other comprehensive income (loss)

The changes in AOCI by component and related tax effects for the periods presented were as follows:

(in thousands)	Interest Rate Swaps		Foreign Currency Contracts		Total
Balance at February 28, 2022	$	(2,126)	$	2,328	$	202
Other comprehensive income before reclassification	3,629		8,545		12,174
Amounts reclassified out of AOCI	961		(3,911)		(2,950)
Tax effects	(1,083)		(1,143)		(2,226)
Other comprehensive income	3,507		3,491		6,998
Balance at August 31, 2022	$	1,381	$	5,819	$	7,200
Balance at February 28, 2023	$	4,394	$	553	$	4,947
Other comprehensive income (loss) before reclassification	3,010		(1,246)		1,764
Amounts reclassified out of AOCI	(3,434)		45		(3,389)
Tax effects	100		264		364
Other comprehensive loss	(324)		(937)		(1,261)
Balance at August 31, 2023	$	4,070	$	(384)	$	3,686

XML

Segment Information (Tables)

6 Months Ended

Aug. 31, 2023

Segment Reporting [Abstract]

Schedule of segment information

The following tables summarize segment information for the periods presented:

	Three Months Ended August 31, 2023
(in thousands)	Home & Outdoor		Beauty & Wellness		Total
Sales revenue, net	$	239,977	$	251,586	$	491,563
Restructuring charges	1,271		2,346		3,617
Operating income	36,099		10,746		46,845
Capital and intangible asset expenditures	4,879		3,801		8,680
Depreciation and amortization	6,606		7,285		13,891

	Three Months Ended August 31, 2022
(in thousands)	Home & Outdoor		Beauty & Wellness		Total
Sales revenue, net	$	240,559	$	280,841	$	521,400
Restructuring charges	472		4,304		4,776
Operating income	42,082		4,864		46,946
Capital and intangible asset expenditures	32,420		4,013		36,433
Depreciation and amortization	4,493		6,626		11,119

	Six Months Ended August 31, 2023
(in thousands)	Home & Outdoor		Beauty & Wellness		Total
Sales revenue, net	$	457,121	$	509,114	$	966,235
Restructuring charges	4,061		6,911		10,972
Operating income	58,215		29,271		87,486
Capital and intangible asset expenditures	15,839		4,718		20,557
Depreciation and amortization	11,008		13,598		24,606

	Six Months Ended August 31, 2022
(in thousands)	Home & Outdoor		Beauty & Wellness		Total
Sales revenue, net	$	474,822	$	554,656	$	1,029,478
Restructuring charges	472		4,306		4,778
Operating income	71,875		9,010		80,885
Capital and intangible asset expenditures	105,151		7,484		112,635
Depreciation and amortization	8,988		12,629		21,617

The following table presents net sales revenue by geographic region, in U.S. Dollars:

	Three Months Ended August 31,								Six Months Ended August 31,
(in thousands)	2023				2022				2023				2022
Domestic sales revenue, net (1)	$	388,049	78.9	%	$	419,905	80.5	%	$	747,608	77.4	%	$	816,651	79.3	%
International sales revenue, net	103,514		21.1	%	101,495		19.5	%	218,627		22.6	%	212,827		20.7	%
Total sales revenue, net	$	491,563	100.0	%	$	521,400	100.0	%	$	966,235	100.0	%	$	1,029,478	100.0	%

(1)Beginning in the fourth quarter of fiscal 2023, we included net sales revenue from the U.S. and Canada as domestic net sales revenue. Previously, we reported sales revenue from Canada within international net sales revenue. We have recast the prior period domestic and international net sales revenue presented to conform with this current presentation.

XML

Earnings Per Share (Tables)

6 Months Ended

Aug. 31, 2023

Earnings Per Share [Abstract]

Schedule of components of basic and diluted shares

The following table presents our weighted average basic and diluted shares outstanding for the periods shown:

	Three Months Ended August 31,		Six Months Ended August 31,
(in thousands)	2023	2022	2023	2022
Weighted average shares outstanding, basic	23,918	23,969	23,984	23,917
Incremental shares from share-based compensation arrangements	123	87	104	172
Weighted average shares outstanding, diluted	24,041	24,056	24,088	24,089
Anti-dilutive securities	7	54	81	42

XML

Basis of Presentation and Related Information (Details) $ / shares in Units, $ in Thousands				3 Months Ended		6 Months Ended		12 Months Ended
	Apr. 22, 2022 USD ($)	Mar. 25, 2022 USD ($)	Jun. 07, 2021 USD ($)	Aug. 31, 2023 segment $ / shares	May 31, 2023 USD ($)	Aug. 31, 2023 USD ($) segment $ / shares	Aug. 31, 2022 USD ($)	Feb. 28, 2023 USD ($) $ / shares
Discontinued Operations
Common shares, par value (in dollars per share) | $ / shares				$ 0.10		$ 0.10		$ 0.10
Number of segments | segment				2		2
Net payments to acquire businesses, net of cash acquired						$ 0	$ 148,111
Proceeds from sale of personal care business			$ 44,700			0	1,804
Gain on sale of North America Personal Care business			$ 500			$ 0	$ 1,336
Insurance settlements receivable								$ 46,000
Latin America and Caribbean Personal Care Business
Discontinued Operations
Proceeds from sale of personal care business		$ 1,800
Gain on sale of North America Personal Care business		$ 1,300
Curlsmith
Discontinued Operations
Net payments to acquire businesses, net of cash acquired	$ 147,900
Adjustments to goodwill					$ 300			$ 100

XML

Assets Held for Sale (Details) - Distribution and Office Facilities, El Paso, Texas - USD ($) $ in Millions		3 Months Ended
	Sep. 28, 2023	Nov. 30, 2023	Aug. 31, 2023
Sale Leaseback Transaction [Line Items]
Accumulated depreciation on asset held-for-sale			$ 36.8
Subsequent Event
Sale Leaseback Transaction [Line Items]
Purchase price from sale	$ 50.6
Transaction costs	$ 1.1
Term of lease	18 months
Fair value of prepaid rent	$ 1.9
Increase in purchase price		$ 1.9
Disposal Group, Held-for-Sale, Not Discontinued Operations
Sale Leaseback Transaction [Line Items]
Property and equipment transferred to assets held-for-sale			$ 17.2
Disposal Group, Held-for-Sale, Not Discontinued Operations | Subsequent Event | Scenario, Forecast
Sale Leaseback Transaction [Line Items]
Expected gain on sale		34.2
Disposal Group, Held-for-Sale, Not Discontinued Operations | Subsequent Event | Beauty & Wellness | Scenario, Forecast
Sale Leaseback Transaction [Line Items]
Expected gain on sale		18.0
Disposal Group, Held-for-Sale, Not Discontinued Operations | Subsequent Event | Home & Outdoor | Scenario, Forecast
Sale Leaseback Transaction [Line Items]
Expected gain on sale		$ 16.2

XML

Acquisition of Curlsmith - Narrative (Details) - USD ($) $ in Thousands		3 Months Ended	6 Months Ended		12 Months Ended
	Apr. 22, 2022	May 31, 2023	Aug. 31, 2023	Aug. 31, 2022	Feb. 28, 2023
Business Acquisition [Line Items]
Net payments to acquire businesses			$ 0	$ 148,111
Curlsmith
Business Acquisition [Line Items]
Net payments to acquire businesses	$ 147,900
Net working capital adjustment	2,100
Acquisition related expenses				$ 2,700
Adjustments to goodwill		$ 300			$ 100
Net working capital adjustment, goodwill					1,800
Reduction to total purchase consideration					$ 1,800
Receivables	4,211
Curlsmith | Trade Names
Business Acquisition [Line Items]
Up-front license fee	$ 21,000
Expected life	20 years
Curlsmith | Customer Relationships
Business Acquisition [Line Items]
Up-front license fee	$ 12,000
Expected life	19 years 6 months

XML

Acquisition of Curlsmith - Business Acquisitions, by Acquisition (Details) - USD ($) $ in Thousands	Aug. 31, 2023	Feb. 28, 2023	Apr. 22, 2022
Assets
Goodwill	$ 1,066,730	$ 1,066,479
Curlsmith
Assets
Receivables			$ 4,211
Inventory			7,890
Prepaid expenses and other current assets			119
Property and equipment			212
Goodwill			117,108
Deferred tax assets, net			360
Total assets			162,900
Liabilities:
Accounts payable			1,401
Accrued expenses and other current liabilities			2,813
Income taxes payable			2,572
Deferred tax liabilities, net			8,187
Total liabilities			14,973
Net assets recorded			147,927
Curlsmith | Trade Names
Assets
Trade names and customer relationships - definite			21,000
Curlsmith | Customer Relationships
Assets
Trade names and customer relationships - definite			$ 12,000

XML

Acquisition of Curlsmith - Impact of the Acquisition of Curlsmith on Income (Details) - Curlsmith - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended	6 Months Ended
	Aug. 31, 2022	Aug. 31, 2022
Business Acquisition [Line Items]
Sales revenue, net	$ 10,207	$ 13,453
Net income	$ 1,437	$ 1,876
EPS:
Basic (in dollars per share)	$ 0.06	$ 0.08
Diluted (in dollars per share)	$ 0.06	$ 0.08

XML

Acquisition of Curlsmith - Pro Forma Information (Details) - Curlsmith - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended	6 Months Ended
	Aug. 31, 2022	Aug. 31, 2022
Business Acquisition [Line Items]
Sales revenue, net	$ 521,400	$ 1,036,570
Net income	$ 30,672	$ 57,180
EPS:
Basic (in dollars per share)	$ 1.28	$ 2.39
Diluted (in dollars per share)	$ 1.28	$ 2.37

XML

Accrued Expenses and Other Current Liabilities (Details) - USD ($) $ in Thousands	Aug. 31, 2023	Feb. 28, 2023
Payables and Accruals [Abstract]
Accrued compensation, benefits and payroll taxes	$ 31,947	$ 17,380
Accrued sales discounts and allowances	48,908	63,881
Accrued sales returns	23,240	28,498
Accrued advertising	35,112	36,931
Other	56,152	54,028
Accrued expenses and other current liabilities	$ 195,359	$ 200,718

XML

Share-Based Compensation Plans - Narrative (Details) - USD ($) $ / shares in Units, $ in Millions	3 Months Ended	6 Months Ended
	May 31, 2023	Aug. 31, 2023
Share-based compensation plans
Expected recognition period for unrecognized share-based compensation		2 years
Target achievement for performance condition awards, as a percentage		0.00%
Restricted Stock
Share-based compensation plans
Number of awards granted (in shares)	252,522
Unrecognized share-based compensation		$ 32.9
Service Condition Awards
Share-based compensation plans
Number of awards granted (in shares)	94,807
Grant date fair value of shares granted in period (in dollars per share)	$ 110.85
Market Condition Awards
Share-based compensation plans
Number of awards granted (in shares)	126,204
Grant date fair value of shares granted in period (in dollars per share)	$ 80.50
Performance Condition Awards
Share-based compensation plans
Number of awards granted (in shares)	126,318
Grant date fair value of shares granted in period (in dollars per share)	$ 110.85

XML

Share-Based Compensation Plans - Share-Based Compensation Expense in SG&A (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Aug. 31, 2023	Aug. 31, 2022	Aug. 31, 2023	Aug. 31, 2022
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Share-based compensation expense, net of income tax benefits	$ 6,844	$ 6,925	$ 15,500	$ 22,460
SG&A
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Share-based compensation expense	7,229	7,495	16,526	24,114
Less income tax benefits	(385)	(570)	(1,026)	(1,654)
Service Condition Awards | SG&A
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Share-based compensation expense	2,878	2,160	6,198	5,277
Performance Condition Awards | SG&A
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Share-based compensation expense	1,113	3,196	3,136	14,041
Market Condition Awards | SG&A
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Share-based compensation expense	3,042	1,917	6,189	3,827
Employee stock purchase plan | SG&A
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Share-based compensation expense	0	0	610	574
Directors stock compensation | SG&A
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Share-based compensation expense	$ 196	$ 222	$ 393	$ 395

XML

Repurchases of Common Stock - Narrative (Details) - USD ($)	Aug. 25, 2021	Aug. 31, 2023	Aug. 31, 2021
Equity [Abstract]
Amount of shares authorized for purchase			$ 500,000,000
Period for stock repurchase	3 years
Remaining share repurchase amount		$ 349,100,000

XML

Repurchases of Common Stock - Summary of Share Repurchase Activity (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended				6 Months Ended
	Aug. 31, 2023	May 31, 2023	Aug. 31, 2022	May 31, 2022	Aug. 31, 2023	Aug. 31, 2022
Repurchase of common stock
Aggregate value of shares	$ 50,089	$ 4,446	$ 81	$ 18,224
Stock Compensation Plan
Repurchase of common stock
Number of shares (in shares)	765		501		45,397	89,959
Aggregate value of shares	$ 83		$ 81		$ 4,529	$ 18,305
Average price per share (in dollars per share)	$ 108.00		$ 163.28		$ 99.75	$ 203.49
Open Market
Repurchase of common stock
Number of shares (in shares)	381,200		0		381,200	0
Aggregate value of shares	$ 50,006		$ 0		$ 50,006	$ 0
Average price per share (in dollars per share)	$ 131.18		$ 0		$ 131.18	$ 0

XML

Restructuring Plan - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended		15 Months Ended
	Aug. 31, 2023	Aug. 31, 2022	Aug. 31, 2023	Aug. 31, 2022	Aug. 31, 2023	Feb. 28, 2023
Restructuring Plan
Restructuring charges	$ 3,617	$ 4,776	$ 10,972	$ 4,778
Beauty & Wellness
Restructuring Plan
Restructuring charges	$ 2,346	4,304	6,911	4,306
Project Pegasus
Restructuring Plan
Estimated percentage of workforce reduction						10.00%
Estimated percentage reduction in cost of goods sold	60.00%
Estimated percentage reduction in SG&A expenses	40.00%
Restructuring charges	$ 3,617	4,776	10,972	4,778	$ 38,334
Project Pegasus | Home & Outdoor
Restructuring Plan
Restructuring charges	1,271	472	4,061	472
Project Pegasus | Beauty & Wellness
Restructuring Plan
Restructuring charges	2,346	$ 4,304	6,911	4,306
Project Pegasus | Severance and employee related costs
Restructuring Plan
Restructuring charges			1,480	2,843
Project Pegasus | Professional fees
Restructuring Plan
Expected restructuring costs	30,000		30,000		30,000
Restructuring charges			8,527	128
Project Pegasus | Contract termination
Restructuring Plan
Expected restructuring costs	5,000		5,000		5,000
Restructuring charges			796	1,500
Project Pegasus | Other
Restructuring Plan
Restructuring charges			$ 169	$ 307
Project Pegasus | Fiscal 2024
Restructuring Plan
Estimated percentage of savings recognized			25.00%
Project Pegasus | Fiscal 2025
Restructuring Plan
Estimated percentage of savings recognized			50.00%
Project Pegasus | Fiscal 2026
Restructuring Plan
Estimated percentage of savings recognized			25.00%
Project Pegasus | Minimum
Restructuring Plan
Annualized profit improvements	75,000
Expected restructuring costs	60,000		$ 60,000		60,000
Previously expected restructuring costs	85,000		85,000		85,000
Project Pegasus | Minimum | Home & Outdoor
Restructuring Plan
Expected restructuring costs	17,000		17,000		17,000
Project Pegasus | Minimum | Beauty & Wellness
Restructuring Plan
Expected restructuring costs	43,000		43,000		43,000
Project Pegasus | Minimum | Severance and employee related costs
Restructuring Plan
Expected restructuring costs	22,000		22,000		22,000
Project Pegasus | Minimum | Other
Restructuring Plan
Expected restructuring costs	3,000		3,000		3,000
Project Pegasus | Maximum
Restructuring Plan
Annualized profit improvements	85,000
Expected restructuring costs	65,000		65,000		65,000
Previously expected restructuring costs	95,000		95,000		95,000
Project Pegasus | Maximum | Home & Outdoor
Restructuring Plan
Expected restructuring costs	19,000		19,000		19,000
Project Pegasus | Maximum | Beauty & Wellness
Restructuring Plan
Expected restructuring costs	46,000		46,000		46,000
Project Pegasus | Maximum | Severance and employee related costs
Restructuring Plan
Expected restructuring costs	25,000		25,000		25,000
Project Pegasus | Maximum | Other
Restructuring Plan
Expected restructuring costs	$ 5,000		$ 5,000		$ 5,000

XML

Restructuring Plan - Restructuring Charges to Date (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended		15 Months Ended
	Aug. 31, 2023	Aug. 31, 2022	Aug. 31, 2023	Aug. 31, 2022	Aug. 31, 2023
Restructuring Plan
Total restructuring charges	$ 3,617	$ 4,776	$ 10,972	$ 4,778
Project Pegasus
Restructuring Plan
Severance and employee related costs	588	2,841	1,480	2,843	$ 10,933
Professional fees	2,901	128	8,527	128	25,276
Contract termination	108	1,500	796	1,500	1,331
Other	20	307	169	307	794
Total restructuring charges	3,617	4,776	10,972	4,778	$ 38,334
Home & Outdoor | Project Pegasus
Restructuring Plan
Severance and employee related costs	87	472	571	472
Professional fees	1,182	0	3,451	0
Contract termination	0	0	0	0
Other	2	0	39	0
Total restructuring charges	1,271	472	4,061	472
Beauty & Wellness
Restructuring Plan
Total restructuring charges	2,346	4,304	6,911	4,306
Beauty & Wellness | Project Pegasus
Restructuring Plan
Severance and employee related costs	501	2,369	909	2,371
Professional fees	1,719	128	5,076	128
Contract termination	108	1,500	796	1,500
Other	18	307	130	307
Total restructuring charges	$ 2,346	$ 4,304	$ 6,911	$ 4,306

XML

Restructuring Plan - Reserve Roll Forward (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended		15 Months Ended
	Aug. 31, 2023	Aug. 31, 2022	Aug. 31, 2023	Aug. 31, 2022	Aug. 31, 2023
Restructuring Reserve [Roll Forward]
Charges	$ 3,617	$ 4,776	$ 10,972	$ 4,778
Project Pegasus
Restructuring Reserve [Roll Forward]
Restructuring liability, beginning balance			6,568	0
Charges	3,617	4,776	10,972	4,778	$ 38,334
Payments			(15,216)	(1,237)
Restructuring liability, ending balance	2,324	3,541	2,324	3,541	2,324
Severance and employee related costs | Project Pegasus
Restructuring Reserve [Roll Forward]
Restructuring liability, beginning balance			3,173	0
Charges			1,480	2,843
Payments			(3,422)	(802)
Restructuring liability, ending balance	1,231	2,041	1,231	2,041	1,231
Professional fees | Project Pegasus
Restructuring Reserve [Roll Forward]
Restructuring liability, beginning balance			3,201	0
Charges			8,527	128
Payments			(10,635)	(128)
Restructuring liability, ending balance	1,093	0	1,093	0	1,093
Contract termination | Project Pegasus
Restructuring Reserve [Roll Forward]
Restructuring liability, beginning balance			160	0
Charges			796	1,500
Payments			(956)	0
Restructuring liability, ending balance	0	1,500	0	1,500	0
Other | Project Pegasus
Restructuring Reserve [Roll Forward]
Restructuring liability, beginning balance			34	0
Charges			169	307
Payments			(203)	(307)
Restructuring liability, ending balance	$ 0	$ 0	$ 0	$ 0	$ 0

XML

Commitments and Contingencies (Details) $ in Thousands	3 Months Ended				6 Months Ended
	Aug. 31, 2023 USD ($)	Nov. 30, 2022 USD ($)	Aug. 31, 2022 USD ($)	May 31, 2022 USD ($)	Aug. 31, 2023 USD ($)	Aug. 31, 2022 USD ($)	Feb. 28, 2023 USD ($)	Dec. 23, 2021 renewal
Commitments and contingencies
Number of other companies named in litigation | renewal								5
Insurance settlements receivable							$ 46,000
Gain from insurance recoveries		$ 9,700
Weather-Related Incident
Commitments and contingencies
Weather related inventory write-down				$ 34,400
Probable insurance recoveries				34,400
Health & Wellness
Commitments and contingencies
Charge to write off obsolete packaging	$ 0		$ 8,354		$ 0	$ 19,998
Health & Wellness | Cost of Sales
Commitments and contingencies
Charge to write off obsolete packaging	0		7,103		0	16,558
Health & Wellness | Cost of Sales | Obsolete Packaging
Commitments and contingencies
Charge to write off obsolete packaging				$ 4,400
Health & Wellness | SG&A
Commitments and contingencies
Charge to write off obsolete packaging	$ 0		$ 1,251		$ 0	$ 3,440

XML

Long-Term Debt - Schedule (Details) - USD ($) $ in Thousands	Aug. 31, 2023	Feb. 28, 2023
Long-term debt
Unamortized prepaid financing fees	$ (1,847)	$ (2,463)
Total long-term debt	844,903	934,412
Less: current maturities of long-term debt	(6,235)	(6,064)
Long-term debt, excluding current maturities	$ 838,668	$ 928,348
Line of credit
Long-term debt
Weighted average effective interest rate	7.10%	6.60%
Line of credit | Credit Agreement
Long-term debt
Aggregate principal balance	$ 846,750	$ 936,875
Line of credit | Credit Agreement | Revolving loans
Long-term debt
Aggregate principal balance	603,000	690,000
Line of credit | Credit Agreement | Term loans
Long-term debt
Aggregate principal balance	$ 243,750	$ 246,875

XML

Long-Term Debt - Narrative (Details) - USD ($) $ in Thousands	1 Months Ended	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Aug. 31, 2023	Aug. 31, 2022	Aug. 31, 2023	Aug. 31, 2022	Feb. 28, 2023
Debt Instrument [Line Items]
Interest costs incurred		$ 13,700	$ 10,100	$ 28,600	$ 15,200
Interest costs capitalized		0	$ 900	900	$ 1,600
Revolving loans
Debt Instrument [Line Items]
Maximum revolving commitment		1,250,000		1,250,000
Line of credit
Debt Instrument [Line Items]
Fixed rate debt		625,000		625,000		$ 425,000
Maximum additional debt allowed under debt covenants		231,100		231,100
Maximum additional debt allowed in the event a qualified acquisition is consummated		465,800		$ 465,800
Line of credit | Minimum | Base rate
Debt Instrument [Line Items]
Margin (as a percent)				0.00%
Line of credit | Minimum | SOFR
Debt Instrument [Line Items]
Margin (as a percent)				1.00%
Line of credit | Maximum | Base rate
Debt Instrument [Line Items]
Margin (as a percent)				1.00%
Line of credit | Maximum | SOFR
Debt Instrument [Line Items]
Margin (as a percent)				2.00%
Line of credit | Credit Agreement | SOFR
Debt Instrument [Line Items]
Additional credit spread				0.10%
Line of credit | Letter of credit
Debt Instrument [Line Items]
Amount outstanding, letters of credit		17,800		$ 17,800
Line of credit | Revolving loans | Credit Agreement
Debt Instrument [Line Items]
Maximum allowable increase due to accordion feature				300,000
Proceeds from exercise of accordion feature	$ 250,000
Percent of term loans due quarterly	0.625%
Fixed rate debt						$ 425,000
Amount available for borrowings		$ 629,200		$ 629,200

XML

Fair Value (Details) - Recurring - Fair Values - Fair Value, Inputs, Level 2 - USD ($) $ in Thousands	Aug. 31, 2023	Feb. 28, 2023
Assets:
Total assets	$ 6,408	$ 7,550
Liabilities:
Total liabilities	1,153	711
Interest rate swaps
Assets:
Derivative assets	5,322	5,746
Foreign currency derivatives
Assets:
Derivative assets	617	1,423
Liabilities:
Derivative liabilities	1,153	711
Money market funds
Assets:
Cash equivalents (money market accounts)	$ 469	$ 381

XML

Financial Instruments and Risk Management - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Aug. 31, 2023	Aug. 31, 2022	Aug. 31, 2023	Aug. 31, 2022	Feb. 28, 2023
Foreign currency derivatives | Cash flow hedges
Foreign Currency Risk and Currency Exchange Uncertainties
Net gain reported in AOCI to be reclassified			$ (3,000)
Period of reclassification to AOCI			12 months
Credit agreement
Foreign Currency Risk and Currency Exchange Uncertainties
Fixed rate debt	$ 625,000		$ 625,000		$ 425,000
Credit agreement | Credit Agreement
Foreign Currency Risk and Currency Exchange Uncertainties
Aggregate principal balance	846,750		846,750		$ 936,875
SG&A
Foreign Currency Risk and Currency Exchange Uncertainties
Net foreign exchange gains (losses), including the impact of currency hedges and currency swaps	$ (800)	$ (2,700)	$ (400)	$ (2,500)
Net sales revenue | Geographic concentration | International operations - transactions denominated in foreign currencies
Foreign Currency Risk and Currency Exchange Uncertainties
Concentration risk percentage	12.00%	12.00%	14.00%	12.00%

XML

Financial Instruments and Risk Management - Derivative FV (Details) € in Thousands, £ in Thousands, kr in Thousands, $ in Thousands, $ in Thousands	Aug. 31, 2023 EUR (€)	Aug. 31, 2023 USD ($)	Aug. 31, 2023 CAD ($)	Aug. 31, 2023 GBP (£)	Aug. 31, 2023 NOK (kr)	Feb. 28, 2023 EUR (€)	Feb. 28, 2023 USD ($)	Feb. 28, 2023 CAD ($)	Feb. 28, 2023 GBP (£)	Feb. 28, 2023 NOK (kr)
Prepaid Expenses and Other Current Assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets		$ 4,122					$ 5,353
Other Assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets		1,817					1,816
Accrued Expenses and Other Current Liabilities
Fair values of derivative instruments in the consolidated balance sheet
Derivative liabilities		1,153					711
Other Liabilities, Non- Current
Fair values of derivative instruments in the consolidated balance sheet
Derivative liabilities		0					0
Derivatives designated as hedging instruments | Prepaid Expenses and Other Current Assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets		4,122					5,345
Derivatives designated as hedging instruments | Other Assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets		1,817					1,816
Derivatives designated as hedging instruments | Accrued Expenses and Other Current Liabilities
Fair values of derivative instruments in the consolidated balance sheet
Derivative liabilities		1,114					711
Derivatives designated as hedging instruments | Other Liabilities, Non- Current
Fair values of derivative instruments in the consolidated balance sheet
Derivative liabilities		0					0
Derivatives designated as hedging instruments | Foreign currency derivatives | Sell | Euros
Fair values of derivative instruments in the consolidated balance sheet
Notional Amount | €	€ 21,500					€ 29,310
Derivatives designated as hedging instruments | Foreign currency derivatives | Sell | Euros | Prepaid Expenses and Other Current Assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets		67					257
Derivatives designated as hedging instruments | Foreign currency derivatives | Sell | Euros | Other Assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets		0					0
Derivatives designated as hedging instruments | Foreign currency derivatives | Sell | Euros | Accrued Expenses and Other Current Liabilities
Fair values of derivative instruments in the consolidated balance sheet
Derivative liabilities		165					0
Derivatives designated as hedging instruments | Foreign currency derivatives | Sell | Euros | Other Liabilities, Non- Current
Fair values of derivative instruments in the consolidated balance sheet
Derivative liabilities		0					0
Derivatives designated as hedging instruments | Foreign currency derivatives | Sell | Canadian Dollars
Fair values of derivative instruments in the consolidated balance sheet
Notional Amount			$ 25,250					$ 30,000
Derivatives designated as hedging instruments | Foreign currency derivatives | Sell | Canadian Dollars | Prepaid Expenses and Other Current Assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets		370					962
Derivatives designated as hedging instruments | Foreign currency derivatives | Sell | Canadian Dollars | Other Assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets		77					11
Derivatives designated as hedging instruments | Foreign currency derivatives | Sell | Canadian Dollars | Accrued Expenses and Other Current Liabilities
Fair values of derivative instruments in the consolidated balance sheet
Derivative liabilities		0					0
Derivatives designated as hedging instruments | Foreign currency derivatives | Sell | Canadian Dollars | Other Liabilities, Non- Current
Fair values of derivative instruments in the consolidated balance sheet
Derivative liabilities		0					0
Derivatives designated as hedging instruments | Foreign currency derivatives | Sell | Pounds
Fair values of derivative instruments in the consolidated balance sheet
Notional Amount | £				£ 20,925					£ 19,400
Derivatives designated as hedging instruments | Foreign currency derivatives | Sell | Pounds | Prepaid Expenses and Other Current Assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets		0					0
Derivatives designated as hedging instruments | Foreign currency derivatives | Sell | Pounds | Other Assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets		0					0
Derivatives designated as hedging instruments | Foreign currency derivatives | Sell | Pounds | Accrued Expenses and Other Current Liabilities
Fair values of derivative instruments in the consolidated balance sheet
Derivative liabilities		949					711
Derivatives designated as hedging instruments | Foreign currency derivatives | Sell | Pounds | Other Liabilities, Non- Current
Fair values of derivative instruments in the consolidated balance sheet
Derivative liabilities		0					0
Derivatives designated as hedging instruments | Foreign currency derivatives | Sell | Norwegian Kroner
Fair values of derivative instruments in the consolidated balance sheet
Notional Amount | kr					kr 20,000					kr 40,000
Derivatives designated as hedging instruments | Foreign currency derivatives | Sell | Norwegian Kroner | Prepaid Expenses and Other Current Assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets		103					185
Derivatives designated as hedging instruments | Foreign currency derivatives | Sell | Norwegian Kroner | Other Assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets		0					0
Derivatives designated as hedging instruments | Foreign currency derivatives | Sell | Norwegian Kroner | Accrued Expenses and Other Current Liabilities
Fair values of derivative instruments in the consolidated balance sheet
Derivative liabilities		0					0
Derivatives designated as hedging instruments | Foreign currency derivatives | Sell | Norwegian Kroner | Other Liabilities, Non- Current
Fair values of derivative instruments in the consolidated balance sheet
Derivative liabilities		0					0
Derivatives designated as hedging instruments | Interest rate swaps
Fair values of derivative instruments in the consolidated balance sheet
Notional Amount		625,000					425,000
Derivatives designated as hedging instruments | Interest rate swaps | Prepaid Expenses and Other Current Assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets		3,582					3,941
Derivatives designated as hedging instruments | Interest rate swaps | Other Assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets		1,740					1,805
Derivatives designated as hedging instruments | Interest rate swaps | Accrued Expenses and Other Current Liabilities
Fair values of derivative instruments in the consolidated balance sheet
Derivative liabilities		0					0
Derivatives designated as hedging instruments | Interest rate swaps | Other Liabilities, Non- Current
Fair values of derivative instruments in the consolidated balance sheet
Derivative liabilities		0					0
Derivatives not designated under hedge accounting | Prepaid Expenses and Other Current Assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets		0					8
Derivatives not designated under hedge accounting | Other Assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets		0					0
Derivatives not designated under hedge accounting | Accrued Expenses and Other Current Liabilities
Fair values of derivative instruments in the consolidated balance sheet
Derivative liabilities		39					0
Derivatives not designated under hedge accounting | Other Liabilities, Non- Current
Fair values of derivative instruments in the consolidated balance sheet
Derivative liabilities		0					0
Derivatives not designated under hedge accounting | Foreign currency derivatives | Euros | Prepaid Expenses and Other Current Assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets							6
Derivatives not designated under hedge accounting | Foreign currency derivatives | Euros | Other Assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets							0
Derivatives not designated under hedge accounting | Foreign currency derivatives | Euros | Accrued Expenses and Other Current Liabilities
Fair values of derivative instruments in the consolidated balance sheet
Derivative liabilities							0
Derivatives not designated under hedge accounting | Foreign currency derivatives | Euros | Other Liabilities, Non- Current
Fair values of derivative instruments in the consolidated balance sheet
Derivative liabilities							0
Derivatives not designated under hedge accounting | Foreign currency derivatives | Pounds | Prepaid Expenses and Other Current Assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets							2
Derivatives not designated under hedge accounting | Foreign currency derivatives | Pounds | Other Assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets							0
Derivatives not designated under hedge accounting | Foreign currency derivatives | Pounds | Accrued Expenses and Other Current Liabilities
Fair values of derivative instruments in the consolidated balance sheet
Derivative liabilities							0
Derivatives not designated under hedge accounting | Foreign currency derivatives | Pounds | Other Liabilities, Non- Current
Fair values of derivative instruments in the consolidated balance sheet
Derivative liabilities							$ 0
Derivatives not designated under hedge accounting | Cross currency debt swaps | Euros
Fair values of derivative instruments in the consolidated balance sheet
Notional Amount | €	€ 2,200					€ 500
Derivatives not designated under hedge accounting | Cross currency debt swaps | Euros | Prepaid Expenses and Other Current Assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets		0
Derivatives not designated under hedge accounting | Cross currency debt swaps | Euros | Other Assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets		0
Derivatives not designated under hedge accounting | Cross currency debt swaps | Euros | Accrued Expenses and Other Current Liabilities
Fair values of derivative instruments in the consolidated balance sheet
Derivative liabilities		33
Derivatives not designated under hedge accounting | Cross currency debt swaps | Euros | Other Liabilities, Non- Current
Fair values of derivative instruments in the consolidated balance sheet
Derivative liabilities		0
Derivatives not designated under hedge accounting | Cross currency debt swaps | Pounds
Fair values of derivative instruments in the consolidated balance sheet
Notional Amount | £				£ 1,100					£ 400
Derivatives not designated under hedge accounting | Cross currency debt swaps | Pounds | Prepaid Expenses and Other Current Assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets		0
Derivatives not designated under hedge accounting | Cross currency debt swaps | Pounds | Other Assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets		0
Derivatives not designated under hedge accounting | Cross currency debt swaps | Pounds | Accrued Expenses and Other Current Liabilities
Fair values of derivative instruments in the consolidated balance sheet
Derivative liabilities		6
Derivatives not designated under hedge accounting | Cross currency debt swaps | Pounds | Other Liabilities, Non- Current
Fair values of derivative instruments in the consolidated balance sheet
Derivative liabilities		$ 0

XML

Financial Instruments and Risk Management - Derivative Tax Effect (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Aug. 31, 2023	Aug. 31, 2022	Aug. 31, 2023	Aug. 31, 2022
Pre-tax effect of derivative instruments
Gain (Loss) Recognized in AOCI	$ 4,865	$ 7,649	$ 1,764	$ 12,174
Gain (Loss) Reclassified from AOCI into Income	1,644	2,434	3,389	2,950
Gain (Loss)  Recognized in Income	(16)	(250)	(40)	625
Foreign currency derivatives | Cash flow hedges
Pre-tax effect of derivative instruments
Gain (Loss) Recognized in AOCI	(779)	6,226	(1,246)	8,545
Foreign currency derivatives | Cash flow hedges | SG&A
Pre-tax effect of derivative instruments
Gain (Loss) Reclassified from AOCI into Income	(383)	2,715	(45)	3,911
Interest rate swaps | Cash flow hedges
Pre-tax effect of derivative instruments
Gain (Loss) Recognized in AOCI	5,644	1,423	3,010	3,629
Interest rate swaps | Cash flow hedges | Interest expense
Pre-tax effect of derivative instruments
Gain (Loss) Reclassified from AOCI into Income	2,027	(281)	3,434	(961)
Cross currency debt swaps | SG&A
Pre-tax effect of derivative instruments
Gain (Loss)  Recognized in Income	0	0	0	875
Forward contracts | SG&A
Pre-tax effect of derivative instruments
Gain (Loss)  Recognized in Income	$ (16)	$ (250)	$ (40)	$ (250)

XML

Accumulated Other Comprehensive Income (Loss) (Details) - USD ($) $ in Thousands	3 Months Ended				6 Months Ended
	Aug. 31, 2023	May 31, 2023	Aug. 31, 2022	May 31, 2022	Aug. 31, 2023	Aug. 31, 2022
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning balance	$ 1,514,908	$ 1,488,811	$ 1,356,422	$ 1,327,339	$ 1,488,811	$ 1,327,339
Other comprehensive income (loss) before reclassification					1,764	12,174
Amounts reclassified out of AOCI					(3,389)	(2,950)
Tax effects					364	(2,226)
Total other comprehensive income (loss), net of tax	2,454	(3,715)	3,839	3,159	(1,261)	6,998
Ending balance	1,501,883	1,514,908	1,398,346	1,356,422	1,501,883	1,398,346
Interest Rate Swaps
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning balance		4,394		(2,126)	4,394	(2,126)
Other comprehensive income (loss) before reclassification					3,010	3,629
Amounts reclassified out of AOCI					(3,434)	961
Tax effects					100	(1,083)
Total other comprehensive income (loss), net of tax					(324)	3,507
Ending balance	4,070		1,381		4,070	1,381
Foreign Currency Contracts
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning balance		553		2,328	553	2,328
Other comprehensive income (loss) before reclassification					(1,246)	8,545
Amounts reclassified out of AOCI					45	(3,911)
Tax effects					264	(1,143)
Total other comprehensive income (loss), net of tax					(937)	3,491
Ending balance	(384)		5,819		(384)	5,819
Total
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning balance	1,232	4,947	3,361	202	4,947	202
Total other comprehensive income (loss), net of tax	2,454	(3,715)	3,839	3,159
Ending balance	$ 3,686	$ 1,232	$ 7,200	$ 3,361	$ 3,686	$ 7,200

XML

Segment Information - Segment Information by Segment (Details) $ in Thousands	3 Months Ended		6 Months Ended
	Aug. 31, 2023 USD ($) segment	Aug. 31, 2022 USD ($)	Aug. 31, 2023 USD ($) segment	Aug. 31, 2022 USD ($)
Segment information
Number of segments | segment	2		2
Sales revenue, net	$ 491,563	$ 521,400	$ 966,235	$ 1,029,478
Restructuring charges	3,617	4,776	10,972	4,778
Operating income	46,845	46,946	87,486	80,885
Capital and intangible asset expenditures	8,680	36,433	20,557	112,635
Depreciation and amortization	13,891	11,119	24,606	21,617
Home & Outdoor
Segment information
Sales revenue, net	239,977	240,559	457,121	474,822
Restructuring charges	1,271	472	4,061	472
Operating income	36,099	42,082	58,215	71,875
Capital and intangible asset expenditures	4,879	32,420	15,839	105,151
Depreciation and amortization	6,606	4,493	11,008	8,988
Beauty & Wellness
Segment information
Sales revenue, net	251,586	280,841	509,114	554,656
Restructuring charges	2,346	4,304	6,911	4,306
Operating income	10,746	4,864	29,271	9,010
Capital and intangible asset expenditures	3,801	4,013	4,718	7,484
Depreciation and amortization	$ 7,285	$ 6,626	$ 13,598	$ 12,629

XML

Segment Information - Revenue by Domestic and International (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Aug. 31, 2023	Aug. 31, 2022	Aug. 31, 2023	Aug. 31, 2022
Segment information
Sales revenue, net	$ 491,563	$ 521,400	$ 966,235	$ 1,029,478
Domestic sales revenue, net
Segment information
Sales revenue, net	388,049	419,905	747,608	816,651
International sales revenue, net
Segment information
Sales revenue, net	$ 103,514	$ 101,495	$ 218,627	$ 212,827
Revenue from Contract with Customer Benchmark | Geographic concentration
Segment information
Concentration risk percentage	100.00%	100.00%	100.00%	100.00%
Revenue from Contract with Customer Benchmark | Geographic concentration | Domestic sales revenue, net
Segment information
Concentration risk percentage	78.90%	80.50%	77.40%	79.30%
Revenue from Contract with Customer Benchmark | Geographic concentration | International sales revenue, net
Segment information
Concentration risk percentage	21.10%	19.50%	22.60%	20.70%

XML

Income Taxes (Details)	3 Months Ended		6 Months Ended
	Aug. 31, 2023	Aug. 31, 2022	Aug. 31, 2023	Aug. 31, 2022
Income Tax Disclosure [Abstract]
Income tax expense (benefit) as a percent of income before income taxes	17.90%	19.10%	16.80%	18.20%

XML

Earnings per Share (Details) - shares shares in Thousands	3 Months Ended		6 Months Ended
	Aug. 31, 2023	Aug. 31, 2022	Aug. 31, 2023	Aug. 31, 2022
Weighted average diluted securities
Weighted average shares outstanding, basic (in shares)	23,918	23,969	23,984	23,917
Incremental shares from share-based payment arrangements (in shares)	123	87	104	172
Weighted average shares outstanding, diluted (in shares)	24,041	24,056	24,088	24,089
Anti-dilutive securities
Weighted average diluted securities
Antidilutive securities (in shares)	7	54	81	42